"usubjid","aeseq","studyid","domain","siteid","subjid","aeterm","aedecod","aebodsys","aesev","aeser","aesern","aerel","dsreasae","ontrtfl","trtemfl","aefn","bodfn","decodfn","saefn","sdecodfn","sbodfn","aedermfn","aestdt","aestdtf","aestdy","anlstdy","aeendt","aeendy","trtp","trtpcd","trtpn","age","agegrp","agegrpn","race","racen","sex","safety","itt","efficacy","complt24","aedict","aescan","aescong","aesdisab","aesdth","aeshosp","aeslife","hlgterm","hlterm","llterm","lstdosdt","trtdur","trtstdt"
"01-701-1015",1,"CDISCPILOT01","ADAE","701","1015","VERBATIM_0995","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,1/3/2014 0:00:00 AM,,2,2,,,"Placebo","Pbo",0,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",7/2/2014 0:00:00 AM,182,1/2/2014 0:00:00 AM
"01-701-1015",2,"CDISCPILOT01","ADAE","701","1015","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,1/3/2014 0:00:00 AM,,2,2,,,"Placebo","Pbo",0,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",7/2/2014 0:00:00 AM,182,1/2/2014 0:00:00 AM
"01-701-1015",3,"CDISCPILOT01","ADAE","701","1015","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,1/9/2014 0:00:00 AM,,8,8,1/11/2014 0:00:00 AM,10,"Placebo","Pbo",0,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",7/2/2014 0:00:00 AM,182,1/2/2014 0:00:00 AM
"01-701-1023",1,"CDISCPILOT01","ADAE","701","1023","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,8/7/2012 0:00:00 AM,,3,3,8/30/2012 0:00:00 AM,26,"Placebo","Pbo",0,64,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/1/2012 0:00:00 AM,28,8/5/2012 0:00:00 AM
"01-701-1023",2,"CDISCPILOT01","ADAE","701","1023","VERBATIM_1549","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,8/7/2012 0:00:00 AM,,3,3,,,"Placebo","Pbo",0,64,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","LOCALIZED ERYTHEMA",9/1/2012 0:00:00 AM,28,8/5/2012 0:00:00 AM
"01-701-1023",3,"CDISCPILOT01","ADAE","701","1023","VERBATIM_1650","ATRIOVENTRICULAR BLOCK SECOND DEGREE","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,8/26/2012 0:00:00 AM,,22,22,,,"Placebo","Pbo",0,64,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0086","HLT_0415","AV BLOCK SECOND DEGREE",9/1/2012 0:00:00 AM,28,8/5/2012 0:00:00 AM
"01-701-1023",4,"CDISCPILOT01","ADAE","701","1023","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,8/7/2012 0:00:00 AM,,3,3,8/30/2012 0:00:00 AM,26,"Placebo","Pbo",0,64,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/1/2012 0:00:00 AM,28,8/5/2012 0:00:00 AM
"01-701-1028",1,"CDISCPILOT01","ADAE","701","1028","VERBATIM_1157","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,7/21/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",1/14/2014 0:00:00 AM,180,7/19/2013 0:00:00 AM
"01-701-1028",2,"CDISCPILOT01","ADAE","701","1028","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,8/8/2013 0:00:00 AM,,21,21,,,"Xanomeline High Dose","Xan_Hi",2,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/14/2014 0:00:00 AM,180,7/19/2013 0:00:00 AM
"01-701-1034",1,"CDISCPILOT01","ADAE","701","1034","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,8/27/2014 0:00:00 AM,,58,58,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/30/2014 0:00:00 AM,183,7/1/2014 0:00:00 AM
"01-701-1034",2,"CDISCPILOT01","ADAE","701","1034","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,11/2/2014 0:00:00 AM,,125,125,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",12/30/2014 0:00:00 AM,183,7/1/2014 0:00:00 AM
"01-701-1047",1,"CDISCPILOT01","ADAE","701","1047","VERBATIM_0130","HIATUS HERNIA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,2/12/2013 0:00:00 AM,,1,1,2/12/2013 0:00:00 AM,1,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0109","HLT_0159","HERNIA HIATAL",3/9/2013 0:00:00 AM,26,2/12/2013 0:00:00 AM
"01-701-1047",2,"CDISCPILOT01","ADAE","701","1047","VERBATIM_0130","HIATUS HERNIA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,,2/12/2013 0:00:00 AM,,1,1,2/12/2013 0:00:00 AM,1,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0109","HLT_0159","HERNIA HIATAL",3/9/2013 0:00:00 AM,26,2/12/2013 0:00:00 AM
"01-701-1047",3,"CDISCPILOT01","ADAE","701","1047","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,3/6/2013 0:00:00 AM,,23,23,,,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/9/2013 0:00:00 AM,26,2/12/2013 0:00:00 AM
"01-701-1047",4,"CDISCPILOT01","ADAE","701","1047","VERBATIM_0197","BUNDLE BRANCH BLOCK LEFT","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","N","Y",,1,1,,,,,3/10/2013 0:00:00 AM,,27,27,,,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0721","HLT_0281","LEFT BUNDLE BRANCH BLOCK",3/9/2013 0:00:00 AM,26,2/12/2013 0:00:00 AM
"01-701-1097",1,"CDISCPILOT01","ADAE","701","1097","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,1/3/2014 0:00:00 AM,,3,3,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",2,"CDISCPILOT01","ADAE","701","1097","VERBATIM_0990","PRURITUS GENERALISED","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,2/20/2014 0:00:00 AM,,51,51,2/20/2014 0:00:00 AM,51,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0689","HLT_0123","GENERALIZED PRURITUS",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",3,"CDISCPILOT01","ADAE","701","1097","VERBATIM_1522","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,2/20/2014 0:00:00 AM,,51,51,2/22/2014 0:00:00 AM,53,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",4,"CDISCPILOT01","ADAE","701","1097","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,2/21/2014 0:00:00 AM,,52,52,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",5,"CDISCPILOT01","ADAE","701","1097","VERBATIM_0758","PRURITUS GENERALISED","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,3/21/2014 0:00:00 AM,,80,80,3/21/2014 0:00:00 AM,80,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0689","HLT_0123","GENERALIZED PRURITUS",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",6,"CDISCPILOT01","ADAE","701","1097","VERBATIM_0990","PRURITUS GENERALISED","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,3/31/2014 0:00:00 AM,,90,90,3/31/2014 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0689","HLT_0123","GENERALIZED PRURITUS",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",7,"CDISCPILOT01","ADAE","701","1097","VERBATIM_0758","PRURITUS GENERALISED","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,4/19/2014 0:00:00 AM,,109,109,4/20/2014 0:00:00 AM,110,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0689","HLT_0123","GENERALIZED PRURITUS",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",8,"CDISCPILOT01","ADAE","701","1097","VERBATIM_1230","PHARYNGOLARYNGEAL PAIN","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/19/2014 0:00:00 AM,,109,109,4/22/2014 0:00:00 AM,112,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0402","HLT_0130","SORE THROAT",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",9,"CDISCPILOT01","ADAE","701","1097","VERBATIM_1612","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,4/19/2014 0:00:00 AM,,109,109,4/22/2014 0:00:00 AM,112,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1097",10,"CDISCPILOT01","ADAE","701","1097","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,2/21/2014 0:00:00 AM,,52,52,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",7/9/2014 0:00:00 AM,190,1/1/2014 0:00:00 AM
"01-701-1111",1,"CDISCPILOT01","ADAE","701","1111","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,1,9/2/2012 0:00:00 AM,,-5,-4,9/7/2012 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",2,"CDISCPILOT01","ADAE","701","1111","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,1,9/2/2012 0:00:00 AM,,-5,-4,9/7/2012 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",3,"CDISCPILOT01","ADAE","701","1111","VERBATIM_1224","LOCALISED INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,,7/8/2012 0:00:00 AM,,-61,-60,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0557","HLT_0435","LOCALIZED INFECTION",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",4,"CDISCPILOT01","ADAE","701","1111","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,1,9/2/2012 0:00:00 AM,,-5,-4,9/7/2012 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",5,"CDISCPILOT01","ADAE","701","1111","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,1,9/2/2012 0:00:00 AM,,-5,-4,9/7/2012 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",6,"CDISCPILOT01","ADAE","701","1111","VERBATIM_1179","MICTURITION URGENCY","RENAL AND URINARY DISORDERS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,9/7/2012 0:00:00 AM,,1,1,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0483","HLT_0294","URINARY URGENCY",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",7,"CDISCPILOT01","ADAE","701","1111","VERBATIM_1614","ARTHRALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,9/13/2012 0:00:00 AM,,7,7,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0610","HLT_0375","GENERALIZED JOINT PAIN",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1111",8,"CDISCPILOT01","ADAE","701","1111","VERBATIM_0034","CELLULITIS","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,9/13/2012 0:00:00 AM,,7,7,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0066","HLT_0613","CELLULITIS OF LEG",9/16/2012 0:00:00 AM,10,9/7/2012 0:00:00 AM
"01-701-1115",1,"CDISCPILOT01","ADAE","701","1115","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,12/2/2012 0:00:00 AM,,3,3,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",2,"CDISCPILOT01","ADAE","701","1115","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,12/2/2012 0:00:00 AM,,3,3,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",3,"CDISCPILOT01","ADAE","701","1115","VERBATIM_0212","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,12/26/2012 0:00:00 AM,,27,27,12/26/2012 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",4,"CDISCPILOT01","ADAE","701","1115","VERBATIM_0212","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,12/26/2012 0:00:00 AM,,27,27,12/26/2012 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",5,"CDISCPILOT01","ADAE","701","1115","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/2/2012 0:00:00 AM,,3,3,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",6,"CDISCPILOT01","ADAE","701","1115","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/2/2012 0:00:00 AM,,3,3,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",7,"CDISCPILOT01","ADAE","701","1115","VERBATIM_1777","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE","Y","Y","Y",,,1,,,,,1/14/2013 0:00:00 AM,,46,46,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",8,"CDISCPILOT01","ADAE","701","1115","VERBATIM_0434","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,1/19/2013 0:00:00 AM,,51,51,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1115",9,"CDISCPILOT01","ADAE","701","1115","VERBATIM_0316","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,1/19/2013 0:00:00 AM,,51,51,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",1/23/2013 0:00:00 AM,55,11/30/2012 0:00:00 AM
"01-701-1118",1,"CDISCPILOT01","ADAE","701","1118","VERBATIM_1139","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,,,,,,,"Placebo","Pbo",0,52,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",9/9/2014 0:00:00 AM,182,3/12/2014 0:00:00 AM
"01-701-1130",1,"CDISCPILOT01","ADAE","701","1130","VERBATIM_1682","URINARY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,3/9/2014 0:00:00 AM,,23,23,3/16/2014 0:00:00 AM,30,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0093","HLT_0161","URINARY TRACT INFECTION",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",2,"CDISCPILOT01","ADAE","701","1130","VERBATIM_1401","PYREXIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/9/2014 0:00:00 AM,,23,23,3/9/2014 0:00:00 AM,23,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0652","HLT_0310","FEVER",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",3,"CDISCPILOT01","ADAE","701","1130","VERBATIM_1682","URINARY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/9/2014 0:00:00 AM,,23,23,3/16/2014 0:00:00 AM,30,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0093","HLT_0161","URINARY TRACT INFECTION",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",4,"CDISCPILOT01","ADAE","701","1130","VERBATIM_0805","EYE SWELLING","EYE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,5/9/2014 0:00:00 AM,,84,84,5/9/2014 0:00:00 AM,84,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0466","HLT_0008","EYES SWOLLEN",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",5,"CDISCPILOT01","ADAE","701","1130","VERBATIM_0299","EYE ALLERGY","EYE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,5/9/2014 0:00:00 AM,,84,84,5/9/2014 0:00:00 AM,84,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0071","HLT_0256","EYE ALLERGY",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",6,"CDISCPILOT01","ADAE","701","1130","VERBATIM_1731","EYE PRURITUS","EYE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,5/22/2014 0:00:00 AM,,97,97,,,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0240","HLT_0523","EYE ITCHING",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",7,"CDISCPILOT01","ADAE","701","1130","VERBATIM_0826","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,1,5/22/2014 0:00:00 AM,,97,97,,,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING BOTH HANDS",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1130",8,"CDISCPILOT01","ADAE","701","1130","VERBATIM_0615","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,5/22/2014 0:00:00 AM,,97,97,,,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",8/16/2014 0:00:00 AM,183,2/15/2014 0:00:00 AM
"01-701-1133",1,"CDISCPILOT01","ADAE","701","1133","VERBATIM_0995","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,12/27/2012 0:00:00 AM,,61,61,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",4/28/2013 0:00:00 AM,183,10/28/2012 0:00:00 AM
"01-701-1133",2,"CDISCPILOT01","ADAE","701","1133","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,12/27/2012 0:00:00 AM,,61,61,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/28/2013 0:00:00 AM,183,10/28/2012 0:00:00 AM
"01-701-1133",3,"CDISCPILOT01","ADAE","701","1133","VERBATIM_0995","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,12/27/2012 0:00:00 AM,,61,61,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",4/28/2013 0:00:00 AM,183,10/28/2012 0:00:00 AM
"01-701-1133",4,"CDISCPILOT01","ADAE","701","1133","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,12/27/2012 0:00:00 AM,,61,61,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/28/2013 0:00:00 AM,183,10/28/2012 0:00:00 AM
"01-701-1146",1,"CDISCPILOT01","ADAE","701","1146","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,1,5/16/2013 0:00:00 AM,,-4,-3,6/2/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",2,"CDISCPILOT01","ADAE","701","1146","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,1,5/16/2013 0:00:00 AM,,-4,-3,6/2/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",3,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0583","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,6/1/2013 0:00:00 AM,,13,13,6/2/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",4,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,6/3/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",5,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0349","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/10/2013 0:00:00 AM,,22,22,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",6,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/10/2013 0:00:00 AM,,22,22,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",7,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0349","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/10/2013 0:00:00 AM,,22,22,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",8,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/10/2013 0:00:00 AM,,22,22,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",9,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0516","APPLICATION SITE PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/22/2013 0:00:00 AM,,34,34,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0085","HLT_0342","APPLICATION SITE PAIN",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",10,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0347","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/26/2013 0:00:00 AM,,38,38,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE VESICLES",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1146",11,"CDISCPILOT01","ADAE","701","1146","VERBATIM_0244","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/26/2013 0:00:00 AM,,38,38,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",6/26/2013 0:00:00 AM,38,5/20/2013 0:00:00 AM
"01-701-1148",1,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0922","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,8/25/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",2,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,8/25/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",3,"CDISCPILOT01","ADAE","701","1148","VERBATIM_1765","LOWER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,10/12/2013 0:00:00 AM,,51,51,11/10/2013 0:00:00 AM,80,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0217","HLT_0052","CHEST COLD",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",4,"CDISCPILOT01","ADAE","701","1148","VERBATIM_1765","LOWER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,,,,,,,10/12/2013 0:00:00 AM,,51,51,11/10/2013 0:00:00 AM,80,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0217","HLT_0052","CHEST COLD",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",5,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0630","FLANK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,12/15/2013 0:00:00 AM,,115,115,12/17/2013 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0543","HLT_0484","FLANK PAIN",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",6,"CDISCPILOT01","ADAE","701","1148","VERBATIM_1748","CALCULUS URETHRAL","RENAL AND URINARY DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,12/17/2013 0:00:00 AM,,117,117,12/17/2013 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0414","HLT_0550","URETHRAL CALCULUS",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",7,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0847","EPISTAXIS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/3/2014 0:00:00 AM,,134,134,1/3/2014 0:00:00 AM,134,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0577","HLT_0386","NOSE BLEED",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",8,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0800","DYSPEPSIA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,2/1/2012 0:00:00 AM,"D",-569,-568,,,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0716","HLT_0244","INDIGESTION",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",9,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0591","DEPRESSED MOOD","PSYCHIATRIC DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,7/29/2013 0:00:00 AM,,-25,-24,,,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0122","HLT_0784","DEPRESSED MOOD",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1148",10,"CDISCPILOT01","ADAE","701","1148","VERBATIM_0022","ACTINIC KERATOSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,1,2/12/2014 0:00:00 AM,,174,174,,,"Xanomeline High Dose","Xan_Hi",2,57,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0490","HLT_0609","ACTINIC KERATOSIS",2/20/2014 0:00:00 AM,182,8/23/2013 0:00:00 AM
"01-701-1153",1,"CDISCPILOT01","ADAE","701","1153","VERBATIM_0156","INCREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,10/13/2013 0:00:00 AM,,21,21,11/6/2013 0:00:00 AM,45,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0769","HLT_0566","INCREASED APPETITE",3/16/2014 0:00:00 AM,175,9/23/2013 0:00:00 AM
"01-701-1153",2,"CDISCPILOT01","ADAE","701","1153","VERBATIM_0156","INCREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,10/13/2013 0:00:00 AM,,21,21,11/6/2013 0:00:00 AM,45,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0769","HLT_0566","INCREASED APPETITE",3/16/2014 0:00:00 AM,175,9/23/2013 0:00:00 AM
"01-701-1180",1,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1453","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,2/12/2013 0:00:00 AM,,1,1,2/12/2013 0:00:00 AM,1,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",2,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1453","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,2/12/2013 0:00:00 AM,,1,1,2/12/2013 0:00:00 AM,1,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",3,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1179","MICTURITION URGENCY","RENAL AND URINARY DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,2/15/2013 0:00:00 AM,,4,4,3/19/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0483","HLT_0294","URINARY URGENCY",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",4,"CDISCPILOT01","ADAE","701","1180","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,,,,,,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",5,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,3/6/2013 0:00:00 AM,,23,23,3/7/2013 0:00:00 AM,24,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",6,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1179","MICTURITION URGENCY","RENAL AND URINARY DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,2/15/2013 0:00:00 AM,,4,4,3/19/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0483","HLT_0294","URINARY URGENCY",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",7,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1474","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","N","Y",,1,1,,,,1,3/19/2013 0:00:00 AM,,36,36,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",8,"CDISCPILOT01","ADAE","701","1180","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","N","Y",,,1,,,,1,3/19/2013 0:00:00 AM,,36,36,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1180",9,"CDISCPILOT01","ADAE","701","1180","VERBATIM_0709","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","N","Y",,,1,,,,1,3/19/2013 0:00:00 AM,,36,36,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",3/18/2013 0:00:00 AM,35,2/12/2013 0:00:00 AM
"01-701-1181",1,"CDISCPILOT01","ADAE","701","1181","VERBATIM_0499","AGITATION","PSYCHIATRIC DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,12/9/2013 0:00:00 AM,,5,5,12/9/2013 0:00:00 AM,5,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0170","HLT_0140","AGITATION",12/9/2013 0:00:00 AM,5,12/5/2013 0:00:00 AM
"01-701-1188",1,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,2/16/2013 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",2,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,2/16/2013 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",3,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,2/16/2013 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",4,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,2/16/2013 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",5,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0252","URTICARIA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,3/4/2013 0:00:00 AM,,18,18,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0705","HLT_0420","WELTS",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",6,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0252","URTICARIA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,3/4/2013 0:00:00 AM,,18,18,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0705","HLT_0420","WELTS",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",7,"CDISCPILOT01","ADAE","701","1188","VERBATIM_0761","APPLICATION SITE URTICARIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,3/21/2013 0:00:00 AM,,35,35,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0233","HLT_0196","APPLICATION SITE URTICARIA",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1188",8,"CDISCPILOT01","ADAE","701","1188","VERBATIM_1569","URTICARIA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,3/21/2013 0:00:00 AM,,35,35,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0705","HLT_0420","WELTS",3/24/2013 0:00:00 AM,38,2/15/2013 0:00:00 AM
"01-701-1192",1,"CDISCPILOT01","ADAE","701","1192","VERBATIM_0819","NASAL MUCOSA BIOPSY","INVESTIGATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,8/3/2012 0:00:00 AM,,13,13,8/3/2012 0:00:00 AM,13,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0396","HLT_0680","NASAL MUCOSA BIOPSY",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",2,"CDISCPILOT01","ADAE","701","1192","VERBATIM_0589","SECRETION DISCHARGE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,8/7/2012 0:00:00 AM,,17,17,9/14/2012 0:00:00 AM,55,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0575","HLT_0683","SECRETION DISCHARGE",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",3,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1470","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,1,8/7/2012 0:00:00 AM,,17,17,9/14/2012 0:00:00 AM,55,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA FACIAL",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",4,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1421","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,6/1/2010 0:00:00 AM,"D",-782,-781,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",5,"CDISCPILOT01","ADAE","701","1192","VERBATIM_0589","SECRETION DISCHARGE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,8/7/2012 0:00:00 AM,,17,17,9/14/2012 0:00:00 AM,55,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0575","HLT_0683","SECRETION DISCHARGE",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",6,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1470","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,1,8/7/2012 0:00:00 AM,,17,17,9/14/2012 0:00:00 AM,55,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA FACIAL",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",7,"CDISCPILOT01","ADAE","701","1192","VERBATIM_0919","PNEUMONIA","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,9/7/2012 0:00:00 AM,,48,48,10/6/2012 0:00:00 AM,77,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0671","HLT_0251","PNEUMONIA",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",8,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1050","MUSCULAR WEAKNESS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,9/7/2012 0:00:00 AM,,48,48,9/30/2012 0:00:00 AM,71,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0211","HLT_0444","MUSCULAR WEAKNESS",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",9,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1421","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,6/1/2010 0:00:00 AM,"D",-782,-781,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",10,"CDISCPILOT01","ADAE","701","1192","VERBATIM_0919","PNEUMONIA","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,,,,,,,9/7/2012 0:00:00 AM,,48,48,10/6/2012 0:00:00 AM,77,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0671","HLT_0251","PNEUMONIA",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",11,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1050","MUSCULAR WEAKNESS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,,,,,,,9/7/2012 0:00:00 AM,,48,48,9/30/2012 0:00:00 AM,71,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0211","HLT_0444","MUSCULAR WEAKNESS",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",12,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1067","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,12/5/2012 0:00:00 AM,,137,137,12/16/2012 0:00:00 AM,148,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",13,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1444","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,12/5/2012 0:00:00 AM,,137,137,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",14,"CDISCPILOT01","ADAE","701","1192","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,12/5/2012 0:00:00 AM,,137,137,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1192",15,"CDISCPILOT01","ADAE","701","1192","VERBATIM_1067","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,12/5/2012 0:00:00 AM,,137,137,12/16/2012 0:00:00 AM,148,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",1/20/2013 0:00:00 AM,183,7/22/2012 0:00:00 AM
"01-701-1203",1,"CDISCPILOT01","ADAE","701","1203","VERBATIM_1020","EYE LASER SURGERY","SURGICAL AND MEDICAL PROCEDURES","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,3/21/2013 0:00:00 AM,,48,48,3/21/2013 0:00:00 AM,48,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0189","HLT_0355","EYE LASER SURGERY",8/3/2013 0:00:00 AM,183,2/2/2013 0:00:00 AM
"01-701-1211",1,"CDISCPILOT01","ADAE","701","1211","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,11/16/2012 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",2,"CDISCPILOT01","ADAE","701","1211","VERBATIM_0394","JOINT DISLOCATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,11/21/2012 0:00:00 AM,,7,7,11/21/2012 0:00:00 AM,7,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0227","HLT_0035","SHOULDER DISLOCATION",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",3,"CDISCPILOT01","ADAE","701","1211","VERBATIM_1643","SHOULDER PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,11/21/2012 0:00:00 AM,,7,7,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0288","HLT_0527","SHOULDER PAIN",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",4,"CDISCPILOT01","ADAE","701","1211","VERBATIM_0312","INCONTINENCE","RENAL AND URINARY DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,11/22/2012 0:00:00 AM,,8,8,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0503","HLT_0560","INCONTINENCE",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",5,"CDISCPILOT01","ADAE","701","1211","VERBATIM_0995","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,11/29/2012 0:00:00 AM,,15,15,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",6,"CDISCPILOT01","ADAE","701","1211","VERBATIM_0548","SKIN LACERATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,12/9/2012 0:00:00 AM,,25,25,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0118","HLT_0075","LACERATION OF FACE",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",7,"CDISCPILOT01","ADAE","701","1211","VERBATIM_1524","CONFUSIONAL STATE","PSYCHIATRIC DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,1/11/2013 0:00:00 AM,,58,58,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0329","HLT_0642","CONFUSION",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",8,"CDISCPILOT01","ADAE","701","1211","VERBATIM_1509","DYSPNOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,1/11/2013 0:00:00 AM,,58,58,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0255","HLT_0296","SHORTNESS OF BREATH",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1211",9,"CDISCPILOT01","ADAE","701","1211","VERBATIM_0484","SUDDEN DEATH","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"NONE",,"N","Y",,,1,,,,,1/14/2013 0:00:00 AM,,61,61,1/14/2013 0:00:00 AM,61,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","Y","N","Y","HLGT_0272","HLT_0142","SUDDEN DEATH",1/12/2013 0:00:00 AM,59,11/15/2012 0:00:00 AM
"01-701-1239",1,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,1/12/2014 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",2,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0385","SKIN ODOUR ABNORMAL","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,1,1/12/2014 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0184","HLT_0510","SKIN ODOR ABNORMAL",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",3,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,1/13/2014 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",4,"CDISCPILOT01","ADAE","701","1239","VERBATIM_1231","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,1/20/2014 0:00:00 AM,,10,10,2/8/2014 0:00:00 AM,29,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",5,"CDISCPILOT01","ADAE","701","1239","VERBATIM_1231","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,1/20/2014 0:00:00 AM,,10,10,2/8/2014 0:00:00 AM,29,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",6,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,1/12/2014 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",7,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,2/20/2014 0:00:00 AM,,41,41,3/12/2014 0:00:00 AM,61,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",8,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,2/20/2014 0:00:00 AM,,41,41,3/12/2014 0:00:00 AM,61,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",9,"CDISCPILOT01","ADAE","701","1239","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,3/1/2014 0:00:00 AM,"D",50,50,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1239",10,"CDISCPILOT01","ADAE","701","1239","VERBATIM_1306","HORDEOLUM","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,4/1/2014 0:00:00 AM,"D",81,81,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0290","HLT_0604","STYE",7/10/2014 0:00:00 AM,181,1/11/2014 0:00:00 AM
"01-701-1275",1,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,2/13/2014 0:00:00 AM,,7,7,6/3/2014 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",2,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,2/23/2014 0:00:00 AM,,17,17,2/23/2014 0:00:00 AM,17,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",3,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,2/24/2014 0:00:00 AM,,18,18,6/12/2014 0:00:00 AM,126,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",4,"CDISCPILOT01","ADAE","701","1275","VERBATIM_1572","SALIVARY HYPERSECRETION","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,2/24/2014 0:00:00 AM,,18,18,6/3/2014 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0488","HLT_0374","HYPERSALIVATION",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",5,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0923","PAROSMIA","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,2/24/2014 0:00:00 AM,,18,18,6/3/2014 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0471","HLT_0258","STRANGE SMELL SENSATION",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",6,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,2/24/2014 0:00:00 AM,,18,18,6/12/2014 0:00:00 AM,126,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",7,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/12/2014 0:00:00 AM,,34,34,3/27/2014 0:00:00 AM,49,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",8,"CDISCPILOT01","ADAE","701","1275","VERBATIM_1612","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,3/12/2014 0:00:00 AM,,34,34,3/27/2014 0:00:00 AM,49,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",9,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/12/2014 0:00:00 AM,,34,34,3/27/2014 0:00:00 AM,49,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",10,"CDISCPILOT01","ADAE","701","1275","VERBATIM_1612","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/12/2014 0:00:00 AM,,34,34,3/27/2014 0:00:00 AM,49,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",11,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/13/2014 0:00:00 AM,,7,7,6/3/2014 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",12,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,2/24/2014 0:00:00 AM,,18,18,6/12/2014 0:00:00 AM,126,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",13,"CDISCPILOT01","ADAE","701","1275","VERBATIM_1572","SALIVARY HYPERSECRETION","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/24/2014 0:00:00 AM,,18,18,6/3/2014 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0488","HLT_0374","HYPERSALIVATION",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",14,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0923","PAROSMIA","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/24/2014 0:00:00 AM,,18,18,6/3/2014 0:00:00 AM,117,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0471","HLT_0258","STRANGE SMELL SENSATION",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1275",15,"CDISCPILOT01","ADAE","701","1275","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,2/24/2014 0:00:00 AM,,18,18,6/12/2014 0:00:00 AM,126,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"OTHER (MIXED - RACIAL HERITAGE, AMERICAN INDIAN, ESKIMO)",6,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",5/31/2014 0:00:00 AM,114,2/7/2014 0:00:00 AM
"01-701-1287",1,"CDISCPILOT01","ADAE","701","1287","VERBATIM_1433","SALIVARY HYPERSECRETION","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,1/26/2014 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0488","HLT_0374","INCREASED SALIVATION",7/26/2014 0:00:00 AM,183,1/25/2014 0:00:00 AM
"01-701-1287",2,"CDISCPILOT01","ADAE","701","1287","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,2/22/2014 0:00:00 AM,,29,29,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",7/26/2014 0:00:00 AM,183,1/25/2014 0:00:00 AM
"01-701-1287",3,"CDISCPILOT01","ADAE","701","1287","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,3/9/2014 0:00:00 AM,,44,44,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",7/26/2014 0:00:00 AM,183,1/25/2014 0:00:00 AM
"01-701-1287",4,"CDISCPILOT01","ADAE","701","1287","VERBATIM_1075","RHINORRHOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/9/2014 0:00:00 AM,,166,166,7/12/2014 0:00:00 AM,169,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0460","HLT_0635","RUNNY NOSE",7/26/2014 0:00:00 AM,183,1/25/2014 0:00:00 AM
"01-701-1287",5,"CDISCPILOT01","ADAE","701","1287","VERBATIM_1075","RHINORRHOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,7/9/2014 0:00:00 AM,,166,166,7/12/2014 0:00:00 AM,169,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0460","HLT_0635","RUNNY NOSE",7/26/2014 0:00:00 AM,183,1/25/2014 0:00:00 AM
"01-701-1294",1,"CDISCPILOT01","ADAE","701","1294","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,1,3/22/2013 0:00:00 AM,,-2,-1,3/23/2013 0:00:00 AM,-1,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/14/2013 0:00:00 AM,83,3/24/2013 0:00:00 AM
"01-701-1294",2,"CDISCPILOT01","ADAE","701","1294","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,5/19/2013 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/14/2013 0:00:00 AM,83,3/24/2013 0:00:00 AM
"01-701-1294",3,"CDISCPILOT01","ADAE","701","1294","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,5/19/2013 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/14/2013 0:00:00 AM,83,3/24/2013 0:00:00 AM
"01-701-1294",4,"CDISCPILOT01","ADAE","701","1294","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,5/19/2013 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/14/2013 0:00:00 AM,83,3/24/2013 0:00:00 AM
"01-701-1294",5,"CDISCPILOT01","ADAE","701","1294","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,5/19/2013 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/14/2013 0:00:00 AM,83,3/24/2013 0:00:00 AM
"01-701-1294",6,"CDISCPILOT01","ADAE","701","1294","VERBATIM_1620","RASH ERYTHEMATOUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,6/10/2013 0:00:00 AM,,79,79,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0701","HLT_0336","ERYTHEMATOUS RASH",6/14/2013 0:00:00 AM,83,3/24/2013 0:00:00 AM
"01-701-1302",1,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0038","APPLICATION SITE PERSPIRATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,8/30/2013 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0403","HLT_0283","APPLICATION SITE PERSPIRATION",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",2,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0551","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,8/30/2013 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",3,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0350","STOMACH DISCOMFORT","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,8/30/2013 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0183","HLT_0065","STOMACH UPSET",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",4,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1314","PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,8/31/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0478","HLT_0314","STINGING",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",5,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1612","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,9/1/2013 0:00:00 AM,,4,4,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",6,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1230","PHARYNGOLARYNGEAL PAIN","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,9/2/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0402","HLT_0130","SORE THROAT",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",7,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0298","PRODUCTIVE COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,9/2/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0681","HLT_0545","PRODUCTIVE COUGH",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",8,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0734","MALAISE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE","Y","Y","Y",,,1,,,,,9/2/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0178","HLT_0456","MALAISE",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",9,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0327","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,9/2/2013 0:00:00 AM,,5,5,9/3/2013 0:00:00 AM,6,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZY",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",10,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0183","MYALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,9/2/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0121","HLT_0700","MYALGIA",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",11,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1049","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,9/4/2013 0:00:00 AM,,7,7,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","LIGHTHEADEDNESS",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",12,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1465","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,9/5/2013 0:00:00 AM,,8,8,10/8/2013 0:00:00 AM,41,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISE",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",13,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0735","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,9/15/2013 0:00:00 AM,,18,18,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",14,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1199","EPISTAXIS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,1,,,,,9/30/2013 0:00:00 AM,,33,33,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0577","HLT_0386","NOSE BLEED",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",15,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1465","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"REMOTE","Y","Y","Y",,,,,,,,9/5/2013 0:00:00 AM,,8,8,10/8/2013 0:00:00 AM,41,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISE",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",16,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1005","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,10/15/2013 0:00:00 AM,,48,48,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",17,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,10/15/2013 0:00:00 AM,,48,48,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",18,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0734","MALAISE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE","Y","Y","Y",,,,,,,,9/2/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0178","HLT_0456","MALAISE",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",19,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1148","RESPIRATORY TRACT CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,10/23/2013 0:00:00 AM,,56,56,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0424","HLT_0330","RESPIRATORY TRACT CONGESTION",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",20,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0358","RHINITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,10/23/2013 0:00:00 AM,,56,56,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0322","HLT_0239","CORYZA",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",21,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0374","FEELING ABNORMAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,10/24/2013 0:00:00 AM,,57,57,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0749","HLT_0524","FOGGY FEELING IN HEAD",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",22,"CDISCPILOT01","ADAE","701","1302","VERBATIM_0482","LISTLESS","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,10/24/2013 0:00:00 AM,,57,57,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0124","HLT_0657","LISTLESSNESS",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1302",23,"CDISCPILOT01","ADAE","701","1302","VERBATIM_1773","LIBIDO DECREASED","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,10/24/2013 0:00:00 AM,,57,57,,,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0496","HLT_0338","LIBIDO DECREASED",11/5/2013 0:00:00 AM,69,8/29/2013 0:00:00 AM
"01-701-1317",1,"CDISCPILOT01","ADAE","701","1317","VERBATIM_0468","ONYCHOMYCOSIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,5/13/2014 0:00:00 AM,,-9,-8,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0243","HLT_0275","ONYCHOMYCOSIS",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",2,"CDISCPILOT01","ADAE","701","1317","VERBATIM_1010","CYST","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,5/13/2014 0:00:00 AM,,-9,-8,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0341","HLT_0763","CYST",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",3,"CDISCPILOT01","ADAE","701","1317","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,6/23/2014 0:00:00 AM,,33,33,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",4,"CDISCPILOT01","ADAE","701","1317","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,6/23/2014 0:00:00 AM,,33,33,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",5,"CDISCPILOT01","ADAE","701","1317","VERBATIM_1456","APPLICATION SITE URTICARIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,6/23/2014 0:00:00 AM,,33,33,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0233","HLT_0196","APPLICATION SITE URTICARIA",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",6,"CDISCPILOT01","ADAE","701","1317","VERBATIM_0326","DEPRESSED MOOD","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,7/4/2014 0:00:00 AM,,44,44,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0122","HLT_0784","DEPRESSED MOOD",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",7,"CDISCPILOT01","ADAE","701","1317","VERBATIM_0326","DEPRESSED MOOD","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,7/4/2014 0:00:00 AM,,44,44,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0122","HLT_0784","DEPRESSED MOOD",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",8,"CDISCPILOT01","ADAE","701","1317","VERBATIM_1301","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,9/12/2014 0:00:00 AM,,114,114,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","TIREDNESS",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1317",9,"CDISCPILOT01","ADAE","701","1317","VERBATIM_0933","DYSPHONIA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,11/3/2014 0:00:00 AM,,166,166,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0274","HLT_0073","HOARSENESS",11/20/2014 0:00:00 AM,183,5/22/2014 0:00:00 AM
"01-701-1324",1,"CDISCPILOT01","ADAE","701","1324","VERBATIM_0013","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,10/22/2012 0:00:00 AM,,21,21,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",4/2/2013 0:00:00 AM,183,10/2/2012 0:00:00 AM
"01-701-1324",2,"CDISCPILOT01","ADAE","701","1324","VERBATIM_1035","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,12/2/2012 0:00:00 AM,,62,62,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/2/2013 0:00:00 AM,183,10/2/2012 0:00:00 AM
"01-701-1324",3,"CDISCPILOT01","ADAE","701","1324","VERBATIM_0996","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,12/25/2012 0:00:00 AM,,85,85,1/16/2013 0:00:00 AM,107,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",4/2/2013 0:00:00 AM,183,10/2/2012 0:00:00 AM
"01-701-1324",4,"CDISCPILOT01","ADAE","701","1324","VERBATIM_0996","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,12/25/2012 0:00:00 AM,,85,85,1/16/2013 0:00:00 AM,107,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",4/2/2013 0:00:00 AM,183,10/2/2012 0:00:00 AM
"01-701-1341",1,"CDISCPILOT01","ADAE","701","1341","VERBATIM_1271","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline Low Dose","Xan_Lo",1,51,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/26/2013 0:00:00 AM,22,1/5/2013 0:00:00 AM
"01-701-1341",2,"CDISCPILOT01","ADAE","701","1341","VERBATIM_0437","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline Low Dose","Xan_Lo",1,51,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",1/26/2013 0:00:00 AM,22,1/5/2013 0:00:00 AM
"01-701-1341",3,"CDISCPILOT01","ADAE","701","1341","VERBATIM_1318","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,1/26/2013 0:00:00 AM,,22,22,1/30/2013 0:00:00 AM,26,"Xanomeline Low Dose","Xan_Lo",1,51,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/26/2013 0:00:00 AM,22,1/5/2013 0:00:00 AM
"01-701-1341",4,"CDISCPILOT01","ADAE","701","1341","VERBATIM_1791","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,1/26/2013 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,51,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",1/26/2013 0:00:00 AM,22,1/5/2013 0:00:00 AM
"01-701-1341",5,"CDISCPILOT01","ADAE","701","1341","VERBATIM_0810","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,1/26/2013 0:00:00 AM,,22,22,1/30/2013 0:00:00 AM,26,"Xanomeline Low Dose","Xan_Lo",1,51,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",1/26/2013 0:00:00 AM,22,1/5/2013 0:00:00 AM
"01-701-1360",1,"CDISCPILOT01","ADAE","701","1360","VERBATIM_0709","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,8/2/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",8/5/2013 0:00:00 AM,6,7/31/2013 0:00:00 AM
"01-701-1360",2,"CDISCPILOT01","ADAE","701","1360","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,8/2/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",8/5/2013 0:00:00 AM,6,7/31/2013 0:00:00 AM
"01-701-1360",3,"CDISCPILOT01","ADAE","701","1360","VERBATIM_0996","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,8/5/2013 0:00:00 AM,,6,6,,,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",8/5/2013 0:00:00 AM,6,7/31/2013 0:00:00 AM
"01-701-1363",1,"CDISCPILOT01","ADAE","701","1363","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,6/14/2013 0:00:00 AM,,16,16,6/15/2013 0:00:00 AM,17,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",11/27/2013 0:00:00 AM,182,5/30/2013 0:00:00 AM
"01-701-1363",2,"CDISCPILOT01","ADAE","701","1363","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE",,"N","N",,,,,,,,,,,,,,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/27/2013 0:00:00 AM,182,5/30/2013 0:00:00 AM
"01-701-1363",3,"CDISCPILOT01","ADAE","701","1363","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,7/16/2013 0:00:00 AM,,48,48,,,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",11/27/2013 0:00:00 AM,182,5/30/2013 0:00:00 AM
"01-701-1363",4,"CDISCPILOT01","ADAE","701","1363","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,,,,,,,,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/27/2013 0:00:00 AM,182,5/30/2013 0:00:00 AM
"01-701-1363",5,"CDISCPILOT01","ADAE","701","1363","VERBATIM_1742","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,10/13/2013 0:00:00 AM,,137,137,10/15/2013 0:00:00 AM,139,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","BACKACHE",11/27/2013 0:00:00 AM,182,5/30/2013 0:00:00 AM
"01-701-1363",6,"CDISCPILOT01","ADAE","701","1363","VERBATIM_1742","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,10/13/2013 0:00:00 AM,,137,137,10/15/2013 0:00:00 AM,139,"Placebo","Pbo",0,81,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","BACKACHE",11/27/2013 0:00:00 AM,182,5/30/2013 0:00:00 AM
"01-701-1383",1,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1035","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,2/7/2013 0:00:00 AM,,4,4,2/7/2013 0:00:00 AM,4,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",2,"CDISCPILOT01","ADAE","701","1383","VERBATIM_0725","APPLICATION SITE PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,2/7/2013 0:00:00 AM,,4,4,2/7/2013 0:00:00 AM,4,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0085","HLT_0342","APPLICATION SITE PAIN",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",3,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1157","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,3/23/2013 0:00:00 AM,,48,48,3/26/2013 0:00:00 AM,51,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",4,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1035","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,3/23/2013 0:00:00 AM,,48,48,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",5,"CDISCPILOT01","ADAE","701","1383","VERBATIM_0349","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,4/12/2013 0:00:00 AM,,68,68,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",6,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1067","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,4/12/2013 0:00:00 AM,,68,68,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",7,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1035","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,3/23/2013 0:00:00 AM,,48,48,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",8,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1067","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,4/12/2013 0:00:00 AM,,68,68,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",9,"CDISCPILOT01","ADAE","701","1383","VERBATIM_0880","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,5/7/2013 0:00:00 AM,,93,93,5/24/2013 0:00:00 AM,110,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",10,"CDISCPILOT01","ADAE","701","1383","VERBATIM_0653","CHEST DISCOMFORT","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,6/24/2013 0:00:00 AM,,141,141,6/24/2013 0:00:00 AM,141,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0441","HLT_0593","CHEST PRESSURE",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",11,"CDISCPILOT01","ADAE","701","1383","VERBATIM_1739","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,6/24/2013 0:00:00 AM,,141,141,6/24/2013 0:00:00 AM,141,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","FULLNESS HEAD",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1383",12,"CDISCPILOT01","ADAE","701","1383","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,7/17/2013 0:00:00 AM,,164,164,7/26/2013 0:00:00 AM,173,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",8/6/2013 0:00:00 AM,184,2/4/2013 0:00:00 AM
"01-701-1387",1,"CDISCPILOT01","ADAE","701","1387","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,3/18/2014 0:00:00 AM,,7,7,3/18/2014 0:00:00 AM,7,"Placebo","Pbo",0,87,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",3/25/2014 0:00:00 AM,14,3/12/2014 0:00:00 AM
"01-701-1387",2,"CDISCPILOT01","ADAE","701","1387","VERBATIM_1343","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,3/18/2014 0:00:00 AM,,7,7,3/18/2014 0:00:00 AM,7,"Placebo","Pbo",0,87,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING",3/25/2014 0:00:00 AM,14,3/12/2014 0:00:00 AM
"01-701-1392",1,"CDISCPILOT01","ADAE","701","1392","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,3/16/2013 0:00:00 AM,,140,140,3/21/2013 0:00:00 AM,145,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",4/28/2013 0:00:00 AM,183,10/28/2012 0:00:00 AM
"01-701-1392",2,"CDISCPILOT01","ADAE","701","1392","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,3/16/2013 0:00:00 AM,,140,140,3/21/2013 0:00:00 AM,145,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",4/28/2013 0:00:00 AM,183,10/28/2012 0:00:00 AM
"01-701-1415",1,"CDISCPILOT01","ADAE","701","1415","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,10/21/2013 0:00:00 AM,,29,29,11/4/2013 0:00:00 AM,43,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/24/2014 0:00:00 AM,183,9/23/2013 0:00:00 AM
"01-701-1415",2,"CDISCPILOT01","ADAE","701","1415","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,10/21/2013 0:00:00 AM,,29,29,11/4/2013 0:00:00 AM,43,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/24/2014 0:00:00 AM,183,9/23/2013 0:00:00 AM
"01-701-1415",3,"CDISCPILOT01","ADAE","701","1415","VERBATIM_1179","MICTURITION URGENCY","RENAL AND URINARY DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,12/2/2013 0:00:00 AM,,71,71,,,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0483","HLT_0294","URINARY URGENCY",3/24/2014 0:00:00 AM,183,9/23/2013 0:00:00 AM
"01-701-1415",4,"CDISCPILOT01","ADAE","701","1415","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,1/21/2014 0:00:00 AM,,121,121,2/10/2014 0:00:00 AM,141,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/24/2014 0:00:00 AM,183,9/23/2013 0:00:00 AM
"01-701-1415",5,"CDISCPILOT01","ADAE","701","1415","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,1/21/2014 0:00:00 AM,,121,121,2/10/2014 0:00:00 AM,141,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/24/2014 0:00:00 AM,183,9/23/2013 0:00:00 AM
"01-701-1415",6,"CDISCPILOT01","ADAE","701","1415","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/9/2014 0:00:00 AM,,168,168,3/9/2014 0:00:00 AM,168,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",3/24/2014 0:00:00 AM,183,9/23/2013 0:00:00 AM
"01-701-1442",1,"CDISCPILOT01","ADAE","701","1442","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,1/10/2014 0:00:00 AM,,77,77,,,"Xanomeline Low Dose","Xan_Lo",1,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/26/2014 0:00:00 AM,183,10/26/2013 0:00:00 AM
"01-701-1444",1,"CDISCPILOT01","ADAE","701","1444","VERBATIM_0349","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",2,"CDISCPILOT01","ADAE","701","1444","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",3,"CDISCPILOT01","ADAE","701","1444","VERBATIM_1572","SALIVARY HYPERSECRETION","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0488","HLT_0374","HYPERSALIVATION",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",4,"CDISCPILOT01","ADAE","701","1444","VERBATIM_0349","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",5,"CDISCPILOT01","ADAE","701","1444","VERBATIM_0578","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,1/19/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",6,"CDISCPILOT01","ADAE","701","1444","VERBATIM_1067","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,2/4/2013 0:00:00 AM,,31,31,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",7,"CDISCPILOT01","ADAE","701","1444","VERBATIM_0880","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,2/4/2013 0:00:00 AM,,31,31,,,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-701-1444",8,"CDISCPILOT01","ADAE","701","1444","VERBATIM_0365","PARAESTHESIA","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,2/8/2013 0:00:00 AM,,35,35,2/8/2013 0:00:00 AM,35,"Xanomeline High Dose","Xan_Hi",2,63,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0534","HLT_0481","TINGLING",2/12/2013 0:00:00 AM,39,1/5/2013 0:00:00 AM
"01-702-1082",1,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0795","WHITE BLOOD CELL COUNT INCREASED","INVESTIGATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,7/7/2013 0:00:00 AM,,-19,-18,7/26/2013 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0465","HLT_0417","WBC INCREASED",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",2,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0831","NEUTROPHIL COUNT INCREASED","INVESTIGATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,7/7/2013 0:00:00 AM,,-19,-18,7/26/2013 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0625","HLT_0326","NEUTROPHIL COUNT INCREASED",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",3,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0459","URINE ANALYSIS ABNORMAL","INVESTIGATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,7/7/2013 0:00:00 AM,,-19,-18,7/24/2013 0:00:00 AM,-2,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0295","HLT_0783","URINE ANALYSIS ABNORMAL",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",4,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0459","URINE ANALYSIS ABNORMAL","INVESTIGATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,7/7/2013 0:00:00 AM,,-19,-18,7/24/2013 0:00:00 AM,-2,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0295","HLT_0783","URINE ANALYSIS ABNORMAL",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",5,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0795","WHITE BLOOD CELL COUNT INCREASED","INVESTIGATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,7/7/2013 0:00:00 AM,,-19,-18,7/26/2013 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0465","HLT_0417","WBC INCREASED",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",6,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0831","NEUTROPHIL COUNT INCREASED","INVESTIGATIONS","MILD","N",0,"NONE",,"N","N",,,,,,,,7/7/2013 0:00:00 AM,,-19,-18,7/26/2013 0:00:00 AM,1,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0625","HLT_0326","NEUTROPHIL COUNT INCREASED",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",7,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0250","RECTAL HAEMORRHAGE","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,9/2/2013 0:00:00 AM,,39,39,9/6/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0755","HLT_0353","RECTAL BLEEDING",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",8,"CDISCPILOT01","ADAE","702","1082","VERBATIM_0250","RECTAL HAEMORRHAGE","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,9/2/2013 0:00:00 AM,,39,39,9/6/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0755","HLT_0353","RECTAL BLEEDING",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",9,"CDISCPILOT01","ADAE","702","1082","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,9/9/2013 0:00:00 AM,,46,46,9/24/2013 0:00:00 AM,61,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-702-1082",10,"CDISCPILOT01","ADAE","702","1082","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,10/12/2013 0:00:00 AM,,79,79,10/31/2013 0:00:00 AM,98,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",10/13/2013 0:00:00 AM,80,7/26/2013 0:00:00 AM
"01-703-1042",1,"CDISCPILOT01","ADAE","703","1042","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,3/4/2013 0:00:00 AM,,3,3,3/5/2013 0:00:00 AM,4,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",8/31/2013 0:00:00 AM,183,3/2/2013 0:00:00 AM
"01-703-1042",2,"CDISCPILOT01","ADAE","703","1042","VERBATIM_0377","INSOMNIA","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,3/5/2013 0:00:00 AM,,4,4,3/6/2013 0:00:00 AM,5,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0469","HLT_0297","INSOMNIA",8/31/2013 0:00:00 AM,183,3/2/2013 0:00:00 AM
"01-703-1076",1,"CDISCPILOT01","ADAE","703","1076","VERBATIM_1681","BIOPSY PROSTATE","INVESTIGATIONS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,11/16/2013 0:00:00 AM,,23,23,11/16/2013 0:00:00 AM,23,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0725","HLT_0553","BIOPSY OF PROSTATE",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1076",2,"CDISCPILOT01","ADAE","703","1076","VERBATIM_0138","BENIGN PROSTATIC HYPERPLASIA","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,11/20/2013 0:00:00 AM,,27,27,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0568","HLT_0215","BENIGN PROSTATIC HYPERTROPHY",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1076",3,"CDISCPILOT01","ADAE","703","1076","VERBATIM_0164","HYPERCHOLESTEROLAEMIA","METABOLISM AND NUTRITION DISORDERS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,,,,,,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0703","HLT_0025","HYPERCHOLESTEROLEMIA",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1076",4,"CDISCPILOT01","ADAE","703","1076","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,11/23/2013 0:00:00 AM,,30,30,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1076",5,"CDISCPILOT01","ADAE","703","1076","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/23/2013 0:00:00 AM,,30,30,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1076",6,"CDISCPILOT01","ADAE","703","1076","VERBATIM_1343","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,11/25/2013 0:00:00 AM,,32,32,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1076",7,"CDISCPILOT01","ADAE","703","1076","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,11/23/2013 0:00:00 AM,,30,30,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/24/2013 0:00:00 AM,61,10/25/2013 0:00:00 AM
"01-703-1086",1,"CDISCPILOT01","ADAE","703","1086","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,9/13/2012 0:00:00 AM,,12,12,1/2/2013 0:00:00 AM,123,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",12/4/2012 0:00:00 AM,94,9/2/2012 0:00:00 AM
"01-703-1086",2,"CDISCPILOT01","ADAE","703","1086","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/13/2012 0:00:00 AM,,12,12,1/2/2013 0:00:00 AM,123,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",12/4/2012 0:00:00 AM,94,9/2/2012 0:00:00 AM
"01-703-1086",3,"CDISCPILOT01","ADAE","703","1086","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/13/2012 0:00:00 AM,,12,12,1/2/2013 0:00:00 AM,123,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",12/4/2012 0:00:00 AM,94,9/2/2012 0:00:00 AM
"01-703-1086",4,"CDISCPILOT01","ADAE","703","1086","VERBATIM_1398","CHILLS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,10/9/2012 0:00:00 AM,,38,38,10/15/2012 0:00:00 AM,44,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0161","HLT_0586","CHILLS",12/4/2012 0:00:00 AM,94,9/2/2012 0:00:00 AM
"01-703-1086",5,"CDISCPILOT01","ADAE","703","1086","VERBATIM_1398","CHILLS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/9/2012 0:00:00 AM,,38,38,10/15/2012 0:00:00 AM,44,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0161","HLT_0586","CHILLS",12/4/2012 0:00:00 AM,94,9/2/2012 0:00:00 AM
"01-703-1086",6,"CDISCPILOT01","ADAE","703","1086","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/13/2012 0:00:00 AM,,12,12,1/2/2013 0:00:00 AM,123,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",12/4/2012 0:00:00 AM,94,9/2/2012 0:00:00 AM
"01-703-1100",1,"CDISCPILOT01","ADAE","703","1100","VERBATIM_0583","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,4/5/2013 0:00:00 AM,,24,24,4/16/2013 0:00:00 AM,35,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",2,"CDISCPILOT01","ADAE","703","1100","VERBATIM_0583","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/5/2013 0:00:00 AM,,24,24,4/16/2013 0:00:00 AM,35,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",3,"CDISCPILOT01","ADAE","703","1100","VERBATIM_0583","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/5/2013 0:00:00 AM,,24,24,4/16/2013 0:00:00 AM,35,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",4,"CDISCPILOT01","ADAE","703","1100","VERBATIM_1581","CATARACT OPERATION","SURGICAL AND MEDICAL PROCEDURES","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,4/25/2013 0:00:00 AM,,44,44,4/25/2013 0:00:00 AM,44,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0058","HLT_0432","CATARACT EXTRACTION",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",5,"CDISCPILOT01","ADAE","703","1100","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,5/27/2013 0:00:00 AM,,76,76,6/3/2013 0:00:00 AM,83,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",6,"CDISCPILOT01","ADAE","703","1100","VERBATIM_1652","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE",,"N","N",,,,,,,,2/28/2013 0:00:00 AM,,-13,-12,9/14/2013 0:00:00 AM,186,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","LEG EDEMA",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",7,"CDISCPILOT01","ADAE","703","1100","VERBATIM_0098","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,7/17/2013 0:00:00 AM,,127,127,9/14/2013 0:00:00 AM,186,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","LEG EDEMA",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",8,"CDISCPILOT01","ADAE","703","1100","VERBATIM_1652","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE",,"N","N",,,,,,,,2/28/2013 0:00:00 AM,,-13,-12,9/14/2013 0:00:00 AM,186,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","LEG EDEMA",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1100",9,"CDISCPILOT01","ADAE","703","1100","VERBATIM_0098","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,7/17/2013 0:00:00 AM,,127,127,9/14/2013 0:00:00 AM,186,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","LEG EDEMA",9/14/2013 0:00:00 AM,186,3/13/2013 0:00:00 AM
"01-703-1119",1,"CDISCPILOT01","ADAE","703","1119","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,3/16/2013 0:00:00 AM,,25,25,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",6/13/2013 0:00:00 AM,114,2/20/2013 0:00:00 AM
"01-703-1119",2,"CDISCPILOT01","ADAE","703","1119","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,3/16/2013 0:00:00 AM,,25,25,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",6/13/2013 0:00:00 AM,114,2/20/2013 0:00:00 AM
"01-703-1119",3,"CDISCPILOT01","ADAE","703","1119","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,5/4/2013 0:00:00 AM,,74,74,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/13/2013 0:00:00 AM,114,2/20/2013 0:00:00 AM
"01-703-1119",4,"CDISCPILOT01","ADAE","703","1119","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,5/4/2013 0:00:00 AM,,74,74,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/13/2013 0:00:00 AM,114,2/20/2013 0:00:00 AM
"01-703-1175",1,"CDISCPILOT01","ADAE","703","1175","VERBATIM_0077","ATRIOVENTRICULAR BLOCK SECOND DEGREE","CARDIAC DISORDERS","SEVERE","N",0,"NONE",,"N","N",,,,,,,,12/18/2013 0:00:00 AM,,-2,-1,,,"Placebo","Pbo",0,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0086","HLT_0415","HEART BLOCK SECOND DEGREE",12/26/2013 0:00:00 AM,7,12/20/2013 0:00:00 AM
"01-703-1182",1,"CDISCPILOT01","ADAE","703","1182","VERBATIM_1489","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,10/31/2013 0:00:00 AM,,15,15,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",12/11/2013 0:00:00 AM,56,10/17/2013 0:00:00 AM
"01-703-1182",2,"CDISCPILOT01","ADAE","703","1182","VERBATIM_1489","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,10/31/2013 0:00:00 AM,,15,15,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",12/11/2013 0:00:00 AM,56,10/17/2013 0:00:00 AM
"01-703-1182",3,"CDISCPILOT01","ADAE","703","1182","VERBATIM_0485","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,11/22/2013 0:00:00 AM,,37,37,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","DROWSINESS",12/11/2013 0:00:00 AM,56,10/17/2013 0:00:00 AM
"01-703-1182",4,"CDISCPILOT01","ADAE","703","1182","VERBATIM_0485","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"REMOTE","Y","Y","Y",,,,,,,,11/22/2013 0:00:00 AM,,37,37,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","DROWSINESS",12/11/2013 0:00:00 AM,56,10/17/2013 0:00:00 AM
"01-703-1210",1,"CDISCPILOT01","ADAE","703","1210","VERBATIM_0787","DISORIENTATION","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,4/2/2013 0:00:00 AM,,18,18,,,"Placebo","Pbo",0,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0307","HLT_0299","DISORIENTATION",9/6/2013 0:00:00 AM,175,3/16/2013 0:00:00 AM
"01-703-1210",2,"CDISCPILOT01","ADAE","703","1210","VERBATIM_0965","DECREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,5/4/2013 0:00:00 AM,,50,50,,,"Placebo","Pbo",0,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0231","HLT_0574","DECREASED APPETITE",9/6/2013 0:00:00 AM,175,3/16/2013 0:00:00 AM
"01-703-1210",3,"CDISCPILOT01","ADAE","703","1210","VERBATIM_0965","DECREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/4/2013 0:00:00 AM,,50,50,,,"Placebo","Pbo",0,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0231","HLT_0574","DECREASED APPETITE",9/6/2013 0:00:00 AM,175,3/16/2013 0:00:00 AM
"01-703-1258",1,"CDISCPILOT01","ADAE","703","1258","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,8/11/2012 0:00:00 AM,,23,23,8/19/2012 0:00:00 AM,31,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1258",2,"CDISCPILOT01","ADAE","703","1258","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,,,,,,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1258",3,"CDISCPILOT01","ADAE","703","1258","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,8/11/2012 0:00:00 AM,,23,23,8/19/2012 0:00:00 AM,31,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1258",4,"CDISCPILOT01","ADAE","703","1258","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,9/4/2012 0:00:00 AM,,47,47,1/25/2013 0:00:00 AM,190,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1258",5,"CDISCPILOT01","ADAE","703","1258","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,,,,,,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1258",6,"CDISCPILOT01","ADAE","703","1258","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/4/2012 0:00:00 AM,,47,47,1/25/2013 0:00:00 AM,190,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1258",7,"CDISCPILOT01","ADAE","703","1258","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/4/2012 0:00:00 AM,,47,47,1/25/2013 0:00:00 AM,190,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",1/11/2013 0:00:00 AM,176,7/20/2012 0:00:00 AM
"01-703-1295",1,"CDISCPILOT01","ADAE","703","1295","VERBATIM_0065","ARTHRITIS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,,12/28/2013 0:00:00 AM,,38,38,,,"Xanomeline High Dose","Xan_Hi",2,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0587","HLT_0019","ARTHRITIS",4/19/2014 0:00:00 AM,150,11/21/2013 0:00:00 AM
"01-703-1299",1,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,9/27/2012 0:00:00 AM,,16,16,10/6/2012 0:00:00 AM,25,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",2,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,9/27/2012 0:00:00 AM,,16,16,10/6/2012 0:00:00 AM,25,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",3,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0308","GLAUCOMA","EYE DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,,,,,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0734","HLT_0556","GLAUCOMA",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",4,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0677","HYPOTENSION","VASCULAR DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,3/1/2013 0:00:00 AM,,171,171,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0412","HLT_0761","HYPOTENSION",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",5,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0231","TACHYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,3/1/2013 0:00:00 AM,,171,171,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0574","HLT_0082","TACHYCARDIA",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",6,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0677","HYPOTENSION","VASCULAR DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,3/1/2013 0:00:00 AM,,171,171,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0412","HLT_0761","HYPOTENSION",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",7,"CDISCPILOT01","ADAE","703","1299","VERBATIM_0231","TACHYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,3/1/2013 0:00:00 AM,,171,171,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0574","HLT_0082","TACHYCARDIA",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1299",8,"CDISCPILOT01","ADAE","703","1299","VERBATIM_1262","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,1,,,,,3/13/2013 0:00:00 AM,,183,183,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","MYOCARDIAL INFARCTION",3/13/2013 0:00:00 AM,183,9/12/2012 0:00:00 AM
"01-703-1335",1,"CDISCPILOT01","ADAE","703","1335","VERBATIM_1650","ATRIOVENTRICULAR BLOCK SECOND DEGREE","CARDIAC DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,3/15/2014 0:00:00 AM,,-2,-1,3/30/2014 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0086","HLT_0415","AV BLOCK SECOND DEGREE",5/7/2014 0:00:00 AM,52,3/17/2014 0:00:00 AM
"01-703-1335",2,"CDISCPILOT01","ADAE","703","1335","VERBATIM_1650","ATRIOVENTRICULAR BLOCK SECOND DEGREE","CARDIAC DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,3/15/2014 0:00:00 AM,,-2,-1,3/30/2014 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0086","HLT_0415","AV BLOCK SECOND DEGREE",5/7/2014 0:00:00 AM,52,3/17/2014 0:00:00 AM
"01-703-1403",1,"CDISCPILOT01","ADAE","703","1403","VERBATIM_0293","WEIGHT DECREASED","INVESTIGATIONS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,12/12/2012 0:00:00 AM,,1,1,12/19/2012 0:00:00 AM,8,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0778","HLT_0158","WEIGHT LOSS",12/13/2012 0:00:00 AM,2,12/12/2012 0:00:00 AM
"01-703-1403",2,"CDISCPILOT01","ADAE","703","1403","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,,12/13/2012 0:00:00 AM,,2,2,12/14/2012 0:00:00 AM,3,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",12/13/2012 0:00:00 AM,2,12/12/2012 0:00:00 AM
"01-703-1403",3,"CDISCPILOT01","ADAE","703","1403","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,,12/13/2012 0:00:00 AM,,2,2,12/14/2012 0:00:00 AM,3,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",12/13/2012 0:00:00 AM,2,12/12/2012 0:00:00 AM
"01-703-1403",4,"CDISCPILOT01","ADAE","703","1403","VERBATIM_1293","CHEST DISCOMFORT","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","N","Y",,1,1,,,,,12/15/2012 0:00:00 AM,,4,4,12/16/2012 0:00:00 AM,5,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0441","HLT_0593","CHEST TIGHTNESS",12/13/2012 0:00:00 AM,2,12/12/2012 0:00:00 AM
"01-703-1403",5,"CDISCPILOT01","ADAE","703","1403","VERBATIM_0293","WEIGHT DECREASED","INVESTIGATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,,12/12/2012 0:00:00 AM,,1,1,12/19/2012 0:00:00 AM,8,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0778","HLT_0158","WEIGHT LOSS",12/13/2012 0:00:00 AM,2,12/12/2012 0:00:00 AM
"01-703-1439",1,"CDISCPILOT01","ADAE","703","1439","VERBATIM_0583","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,4/24/2014 0:00:00 AM,,44,44,,,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",9/11/2014 0:00:00 AM,184,3/12/2014 0:00:00 AM
"01-703-1439",2,"CDISCPILOT01","ADAE","703","1439","VERBATIM_0583","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/24/2014 0:00:00 AM,,44,44,,,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",9/11/2014 0:00:00 AM,184,3/12/2014 0:00:00 AM
"01-704-1008",1,"CDISCPILOT01","ADAE","704","1008","VERBATIM_0895","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,1/30/2013 0:00:00 AM,,18,18,,,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING INCREASED",2/21/2013 0:00:00 AM,40,1/13/2013 0:00:00 AM
"01-704-1008",2,"CDISCPILOT01","ADAE","704","1008","VERBATIM_1299","TRANSIENT ISCHAEMIC ATTACK","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"NONE","Y","Y","Y",,1,1,,,,,2/21/2013 0:00:00 AM,,40,40,2/21/2013 0:00:00 AM,40,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0433","HLT_0041","TRANSIENT ISCHEMIC ATTACKS",2/21/2013 0:00:00 AM,40,1/13/2013 0:00:00 AM
"01-704-1008",3,"CDISCPILOT01","ADAE","704","1008","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"NONE","Y","N","Y",,1,1,,,,,2/25/2013 0:00:00 AM,,44,44,,,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",2/21/2013 0:00:00 AM,40,1/13/2013 0:00:00 AM
"01-704-1009",1,"CDISCPILOT01","ADAE","704","1009","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,9/5/2013 0:00:00 AM,,10,10,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",9/25/2013 0:00:00 AM,30,8/27/2013 0:00:00 AM
"01-704-1009",2,"CDISCPILOT01","ADAE","704","1009","VERBATIM_1562","MALAISE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,9/5/2013 0:00:00 AM,,10,10,9/27/2013 0:00:00 AM,32,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0178","HLT_0456","MALAISE",9/25/2013 0:00:00 AM,30,8/27/2013 0:00:00 AM
"01-704-1009",3,"CDISCPILOT01","ADAE","704","1009","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,9/14/2013 0:00:00 AM,,19,19,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",9/25/2013 0:00:00 AM,30,8/27/2013 0:00:00 AM
"01-704-1009",4,"CDISCPILOT01","ADAE","704","1009","VERBATIM_1562","MALAISE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,9/5/2013 0:00:00 AM,,10,10,9/27/2013 0:00:00 AM,32,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0178","HLT_0456","MALAISE",9/25/2013 0:00:00 AM,30,8/27/2013 0:00:00 AM
"01-704-1009",5,"CDISCPILOT01","ADAE","704","1009","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,9/17/2013 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",9/25/2013 0:00:00 AM,30,8/27/2013 0:00:00 AM
"01-704-1009",6,"CDISCPILOT01","ADAE","704","1009","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,9/22/2013 0:00:00 AM,,27,27,9/23/2013 0:00:00 AM,28,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",9/25/2013 0:00:00 AM,30,8/27/2013 0:00:00 AM
"01-704-1010",1,"CDISCPILOT01","ADAE","704","1010","VERBATIM_0822","CYSTITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,2/27/2014 0:00:00 AM,,7,7,3/6/2014 0:00:00 AM,14,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0129","HLT_0739","BLADDER INFECTION",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1010",2,"CDISCPILOT01","ADAE","704","1010","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/5/2014 0:00:00 AM,,135,135,7/6/2014 0:00:00 AM,136,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1010",3,"CDISCPILOT01","ADAE","704","1010","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,7/5/2014 0:00:00 AM,,135,135,7/6/2014 0:00:00 AM,136,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1010",4,"CDISCPILOT01","ADAE","704","1010","VERBATIM_0274","EXCORIATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/6/2014 0:00:00 AM,,136,136,,,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0511","HLT_0738","ABRASION NOS",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1010",5,"CDISCPILOT01","ADAE","704","1010","VERBATIM_1710","SKIN LACERATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,7/6/2014 0:00:00 AM,,136,136,,,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0118","HLT_0075","SKIN TEAR",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1010",6,"CDISCPILOT01","ADAE","704","1010","VERBATIM_1396","ARTHRALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/6/2014 0:00:00 AM,,136,136,,,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0610","HLT_0375","KNEE PAIN",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1010",7,"CDISCPILOT01","ADAE","704","1010","VERBATIM_0689","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,7/6/2014 0:00:00 AM,,136,136,,,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISE OF HEAD",7/8/2014 0:00:00 AM,138,2/21/2014 0:00:00 AM
"01-704-1017",1,"CDISCPILOT01","ADAE","704","1017","VERBATIM_1635","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,10/19/2013 0:00:00 AM,,14,14,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","MYOCARDIAL INFARCTION",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",2,"CDISCPILOT01","ADAE","704","1017","VERBATIM_0888","VENTRICULAR SEPTAL DEFECT","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,10/19/2013 0:00:00 AM,,14,14,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0747","HLT_0589","VENTRICULAR SEPTAL DEFECT",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",3,"CDISCPILOT01","ADAE","704","1017","VERBATIM_1543","INFLUENZA","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,11/1/2013 0:00:00 AM,,27,27,11/8/2013 0:00:00 AM,34,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0081","HLT_0125","FLU",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",4,"CDISCPILOT01","ADAE","704","1017","VERBATIM_1744","CARDIAC DISORDER","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,11/1/2013 0:00:00 AM,,27,27,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0126","HLT_0507","CARDIAC DISORDER",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",5,"CDISCPILOT01","ADAE","704","1017","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,11/5/2013 0:00:00 AM,,31,31,11/22/2013 0:00:00 AM,48,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",6,"CDISCPILOT01","ADAE","704","1017","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/5/2013 0:00:00 AM,,31,31,11/22/2013 0:00:00 AM,48,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",7,"CDISCPILOT01","ADAE","704","1017","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,11/5/2013 0:00:00 AM,,31,31,11/22/2013 0:00:00 AM,48,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1017",8,"CDISCPILOT01","ADAE","704","1017","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,11/5/2013 0:00:00 AM,,31,31,11/22/2013 0:00:00 AM,48,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",11/18/2013 0:00:00 AM,44,10/6/2013 0:00:00 AM
"01-704-1025",1,"CDISCPILOT01","ADAE","704","1025","VERBATIM_1703","VERTIGO","EAR AND LABYRINTH DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,9/28/2013 0:00:00 AM,,2,2,9/30/2013 0:00:00 AM,4,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0147","HLT_0255","VERTIGO",10/24/2013 0:00:00 AM,28,9/27/2013 0:00:00 AM
"01-704-1025",2,"CDISCPILOT01","ADAE","704","1025","VERBATIM_0266","PALPITATIONS","CARDIAC DISORDERS","MODERATE","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,9/28/2013 0:00:00 AM,,2,2,9/30/2013 0:00:00 AM,4,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0593","HLT_0493","PALPITATIONS",10/24/2013 0:00:00 AM,28,9/27/2013 0:00:00 AM
"01-704-1025",3,"CDISCPILOT01","ADAE","704","1025","VERBATIM_1153","ELECTROCARDIOGRAM ST SEGMENT DEPRESSION","INVESTIGATIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,10/11/2013 0:00:00 AM,,15,15,10/25/2013 0:00:00 AM,29,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0220","HLT_0610","ST SEGMENT DEPRESSED",10/24/2013 0:00:00 AM,28,9/27/2013 0:00:00 AM
"01-704-1025",4,"CDISCPILOT01","ADAE","704","1025","VERBATIM_1601","WOLFF-PARKINSON-WHITE SYNDROME","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","N","Y",,,1,,,,,10/25/2013 0:00:00 AM,,29,29,11/29/2013 0:00:00 AM,64,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0218","HLT_0612","WOLFF-PARKINSON-WHITE SYNDROME",10/24/2013 0:00:00 AM,28,9/27/2013 0:00:00 AM
"01-704-1025",5,"CDISCPILOT01","ADAE","704","1025","VERBATIM_1153","ELECTROCARDIOGRAM ST SEGMENT DEPRESSION","INVESTIGATIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/11/2013 0:00:00 AM,,15,15,10/25/2013 0:00:00 AM,29,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0220","HLT_0610","ST SEGMENT DEPRESSED",10/24/2013 0:00:00 AM,28,9/27/2013 0:00:00 AM
"01-704-1025",6,"CDISCPILOT01","ADAE","704","1025","VERBATIM_1601","WOLFF-PARKINSON-WHITE SYNDROME","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","N","Y",,,,,,,,10/25/2013 0:00:00 AM,,29,29,11/29/2013 0:00:00 AM,64,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0218","HLT_0612","WOLFF-PARKINSON-WHITE SYNDROME",10/24/2013 0:00:00 AM,28,9/27/2013 0:00:00 AM
"01-704-1065",1,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1040","ABDOMINAL DISCOMFORT","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,10/26/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0332","HLT_0012","ABDOMINAL DISCOMFORT",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",2,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,10/27/2013 0:00:00 AM,,4,4,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",3,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,10/27/2013 0:00:00 AM,,4,4,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",4,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1335","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/9/2013 0:00:00 AM,,17,17,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",5,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1562","MALAISE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,11/9/2013 0:00:00 AM,,17,17,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0178","HLT_0456","MALAISE",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",6,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1115","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,11/9/2013 0:00:00 AM,,17,17,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",7,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1398","CHILLS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE","Y","Y","Y",,,1,,,,,11/17/2013 0:00:00 AM,,25,25,11/17/2013 0:00:00 AM,25,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0161","HLT_0586","CHILLS",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",8,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,11/17/2013 0:00:00 AM,,25,25,11/17/2013 0:00:00 AM,25,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",9,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,1,,,,,12/15/2013 0:00:00 AM,,53,53,12/15/2013 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1065",10,"CDISCPILOT01","ADAE","704","1065","VERBATIM_1422","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","N","Y",,1,1,,,,,12/24/2013 0:00:00 AM,,62,62,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","BRADYCARDIA SINUS",12/22/2013 0:00:00 AM,60,10/24/2013 0:00:00 AM
"01-704-1074",1,"CDISCPILOT01","ADAE","704","1074","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,1/22/2014 0:00:00 AM,,1,1,,,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",3/20/2014 0:00:00 AM,58,1/22/2014 0:00:00 AM
"01-704-1074",2,"CDISCPILOT01","ADAE","704","1074","VERBATIM_0027","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,2/9/2014 0:00:00 AM,,19,19,,,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","SKIN RED",3/20/2014 0:00:00 AM,58,1/22/2014 0:00:00 AM
"01-704-1093",1,"CDISCPILOT01","ADAE","704","1093","VERBATIM_0814","BLOOD GLUCOSE INCREASED","INVESTIGATIONS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,3/30/2013 0:00:00 AM,,16,16,4/13/2013 0:00:00 AM,30,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0188","HLT_0450","GLUCOSE INCREASED",6/17/2013 0:00:00 AM,95,3/15/2013 0:00:00 AM
"01-704-1093",2,"CDISCPILOT01","ADAE","704","1093","VERBATIM_0814","BLOOD GLUCOSE INCREASED","INVESTIGATIONS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,3/30/2013 0:00:00 AM,,16,16,4/13/2013 0:00:00 AM,30,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0188","HLT_0450","GLUCOSE INCREASED",6/17/2013 0:00:00 AM,95,3/15/2013 0:00:00 AM
"01-704-1093",3,"CDISCPILOT01","ADAE","704","1093","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,5/4/2013 0:00:00 AM,,51,51,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/17/2013 0:00:00 AM,95,3/15/2013 0:00:00 AM
"01-704-1093",4,"CDISCPILOT01","ADAE","704","1093","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,5/4/2013 0:00:00 AM,,51,51,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/17/2013 0:00:00 AM,95,3/15/2013 0:00:00 AM
"01-704-1114",1,"CDISCPILOT01","ADAE","704","1114","VERBATIM_1639","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,2/21/2013 0:00:00 AM,,30,30,2/23/2013 0:00:00 AM,32,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","REDNESS",7/7/2013 0:00:00 AM,166,1/23/2013 0:00:00 AM
"01-704-1114",2,"CDISCPILOT01","ADAE","704","1114","VERBATIM_1138","OEDEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,,2/23/2013 0:00:00 AM,,32,32,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0036","HLT_0656","EDEMA",7/7/2013 0:00:00 AM,166,1/23/2013 0:00:00 AM
"01-704-1114",3,"CDISCPILOT01","ADAE","704","1114","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,3/23/2013 0:00:00 AM,,60,60,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/7/2013 0:00:00 AM,166,1/23/2013 0:00:00 AM
"01-704-1114",4,"CDISCPILOT01","ADAE","704","1114","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,3/23/2013 0:00:00 AM,,60,60,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/7/2013 0:00:00 AM,166,1/23/2013 0:00:00 AM
"01-704-1114",5,"CDISCPILOT01","ADAE","704","1114","VERBATIM_1543","INFLUENZA","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,6/7/2013 0:00:00 AM,,136,136,6/13/2013 0:00:00 AM,142,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0081","HLT_0125","FLU",7/7/2013 0:00:00 AM,166,1/23/2013 0:00:00 AM
"01-704-1120",1,"CDISCPILOT01","ADAE","704","1120","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,12/23/2013 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/1/2014 0:00:00 AM,62,12/2/2013 0:00:00 AM
"01-704-1120",2,"CDISCPILOT01","ADAE","704","1120","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,12/28/2013 0:00:00 AM,,27,27,2/3/2014 0:00:00 AM,64,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",2/1/2014 0:00:00 AM,62,12/2/2013 0:00:00 AM
"01-704-1120",3,"CDISCPILOT01","ADAE","704","1120","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/23/2013 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/1/2014 0:00:00 AM,62,12/2/2013 0:00:00 AM
"01-704-1120",4,"CDISCPILOT01","ADAE","704","1120","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,1/27/2014 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/1/2014 0:00:00 AM,62,12/2/2013 0:00:00 AM
"01-704-1120",5,"CDISCPILOT01","ADAE","704","1120","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,1/27/2014 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/1/2014 0:00:00 AM,62,12/2/2013 0:00:00 AM
"01-704-1120",6,"CDISCPILOT01","ADAE","704","1120","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,12/28/2013 0:00:00 AM,,27,27,2/3/2014 0:00:00 AM,64,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",2/1/2014 0:00:00 AM,62,12/2/2013 0:00:00 AM
"01-704-1135",1,"CDISCPILOT01","ADAE","704","1135","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,,,"Y","Y",1,1,1,,,,1,12/8/2013 0:00:00 AM,,39,39,,,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",5/16/2014 0:00:00 AM,198,10/31/2013 0:00:00 AM
"01-704-1135",2,"CDISCPILOT01","ADAE","704","1135","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","SEVERE","N",0,,,"Y","Y",,,,,,,1,12/8/2013 0:00:00 AM,,39,39,,,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",5/16/2014 0:00:00 AM,198,10/31/2013 0:00:00 AM
"01-704-1164",1,"CDISCPILOT01","ADAE","704","1164","VERBATIM_1543","INFLUENZA","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,9/27/2012 0:00:00 AM,,9,9,10/7/2012 0:00:00 AM,19,"Placebo","Pbo",0,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0081","HLT_0125","FLU",4/4/2013 0:00:00 AM,198,9/19/2012 0:00:00 AM
"01-704-1164",2,"CDISCPILOT01","ADAE","704","1164","VERBATIM_1543","INFLUENZA","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,9/27/2012 0:00:00 AM,,9,9,10/7/2012 0:00:00 AM,19,"Placebo","Pbo",0,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0081","HLT_0125","FLU",4/4/2013 0:00:00 AM,198,9/19/2012 0:00:00 AM
"01-704-1164",3,"CDISCPILOT01","ADAE","704","1164","VERBATIM_0304","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,2/4/2013 0:00:00 AM,,139,139,2/13/2013 0:00:00 AM,148,"Placebo","Pbo",0,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","SWELLING OF FEET",4/4/2013 0:00:00 AM,198,9/19/2012 0:00:00 AM
"01-704-1218",1,"CDISCPILOT01","ADAE","704","1218","VERBATIM_0814","BLOOD GLUCOSE INCREASED","INVESTIGATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,12/30/2012 0:00:00 AM,,42,42,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0188","HLT_0450","GLUCOSE INCREASED",5/27/2013 0:00:00 AM,190,11/19/2012 0:00:00 AM
"01-704-1241",1,"CDISCPILOT01","ADAE","704","1241","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,1,8/14/2013 0:00:00 AM,,-11,-10,,,"Xanomeline High Dose","Xan_Hi",2,86,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",10/9/2013 0:00:00 AM,46,8/25/2013 0:00:00 AM
"01-704-1241",2,"CDISCPILOT01","ADAE","704","1241","VERBATIM_0785","DYSPNOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,9/28/2013 0:00:00 AM,,35,35,,,"Xanomeline High Dose","Xan_Hi",2,86,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0255","HLT_0296","RESPIRATION LABORED",10/9/2013 0:00:00 AM,46,8/25/2013 0:00:00 AM
"01-704-1266",1,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0396","SEASONAL ALLERGY","IMMUNE SYSTEM DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,,10/6/2013 0:00:00 AM,,-7,-6,,,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0782","HLT_0714","HAY FEVER",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",2,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,10/17/2013 0:00:00 AM,,5,5,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",3,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0096","ATRIAL FLUTTER","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,10/27/2013 0:00:00 AM,,15,15,11/8/2013 0:00:00 AM,27,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0627","HLT_0477","ATRIAL FLUTTER",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",4,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0402","ATRIAL FIBRILLATION","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,11/8/2013 0:00:00 AM,,27,27,12/6/2013 0:00:00 AM,55,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0012","HLT_0365","ATRIAL FIBRILLATION",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",5,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0096","ATRIAL FLUTTER","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,10/27/2013 0:00:00 AM,,15,15,11/8/2013 0:00:00 AM,27,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0627","HLT_0477","ATRIAL FLUTTER",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",6,"CDISCPILOT01","ADAE","704","1266","VERBATIM_1115","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,11/9/2013 0:00:00 AM,,28,28,12/4/2013 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",7,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0408","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/15/2013 0:00:00 AM,,34,34,12/14/2013 0:00:00 AM,63,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERING",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",8,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/15/2013 0:00:00 AM,,34,34,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",9,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,10/17/2013 0:00:00 AM,,5,5,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",10,"CDISCPILOT01","ADAE","704","1266","VERBATIM_1115","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,11/9/2013 0:00:00 AM,,28,28,12/4/2013 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",11,"CDISCPILOT01","ADAE","704","1266","VERBATIM_1287","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/6/2013 0:00:00 AM,,55,55,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","REDNESS",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",12,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,10/17/2013 0:00:00 AM,,5,5,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",13,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0402","ATRIAL FIBRILLATION","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,11/8/2013 0:00:00 AM,,27,27,12/6/2013 0:00:00 AM,55,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0012","HLT_0365","ATRIAL FIBRILLATION",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",14,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0408","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,11/15/2013 0:00:00 AM,,34,34,12/14/2013 0:00:00 AM,63,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERING",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",15,"CDISCPILOT01","ADAE","704","1266","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,11/15/2013 0:00:00 AM,,34,34,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1266",16,"CDISCPILOT01","ADAE","704","1266","VERBATIM_1287","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/6/2013 0:00:00 AM,,55,55,12/23/2013 0:00:00 AM,72,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","REDNESS",12/6/2013 0:00:00 AM,55,10/13/2013 0:00:00 AM
"01-704-1323",1,"CDISCPILOT01","ADAE","704","1323","VERBATIM_0002","VIRAL INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,7/30/2013 0:00:00 AM,,23,23,8/3/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0408","HLT_0733","VIRAL INFECTION",8/5/2013 0:00:00 AM,29,7/8/2013 0:00:00 AM
"01-704-1323",2,"CDISCPILOT01","ADAE","704","1323","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,8/4/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",8/5/2013 0:00:00 AM,29,7/8/2013 0:00:00 AM
"01-704-1323",3,"CDISCPILOT01","ADAE","704","1323","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,8/4/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",8/5/2013 0:00:00 AM,29,7/8/2013 0:00:00 AM
"01-704-1323",4,"CDISCPILOT01","ADAE","704","1323","VERBATIM_0248","OEDEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,,8/4/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0036","HLT_0656","EDEMA",8/5/2013 0:00:00 AM,29,7/8/2013 0:00:00 AM
"01-704-1325",1,"CDISCPILOT01","ADAE","704","1325","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/23/2014 0:00:00 AM,,31,31,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/4/2014 0:00:00 AM,73,4/23/2014 0:00:00 AM
"01-704-1325",2,"CDISCPILOT01","ADAE","704","1325","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,7/4/2014 0:00:00 AM,,73,73,,,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/4/2014 0:00:00 AM,73,4/23/2014 0:00:00 AM
"01-704-1332",1,"CDISCPILOT01","ADAE","704","1332","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,1,12/10/2013 0:00:00 AM,,2,2,2/24/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/14/2014 0:00:00 AM,68,12/9/2013 0:00:00 AM
"01-704-1332",2,"CDISCPILOT01","ADAE","704","1332","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,1/18/2014 0:00:00 AM,,41,41,2/24/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/14/2014 0:00:00 AM,68,12/9/2013 0:00:00 AM
"01-704-1332",3,"CDISCPILOT01","ADAE","704","1332","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,1,12/10/2013 0:00:00 AM,,2,2,2/24/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/14/2014 0:00:00 AM,68,12/9/2013 0:00:00 AM
"01-704-1332",4,"CDISCPILOT01","ADAE","704","1332","VERBATIM_1128","BURNING SENSATION","NERVOUS SYSTEM DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,,2/3/2014 0:00:00 AM,,57,57,,,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0456","HLT_0775","BURNING SENSATION",2/14/2014 0:00:00 AM,68,12/9/2013 0:00:00 AM
"01-704-1332",5,"CDISCPILOT01","ADAE","704","1332","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,1,12/10/2013 0:00:00 AM,,2,2,2/24/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/14/2014 0:00:00 AM,68,12/9/2013 0:00:00 AM
"01-704-1332",6,"CDISCPILOT01","ADAE","704","1332","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,1/18/2014 0:00:00 AM,,41,41,2/24/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/14/2014 0:00:00 AM,68,12/9/2013 0:00:00 AM
"01-704-1351",1,"CDISCPILOT01","ADAE","704","1351","VERBATIM_1701","POLLAKIURIA","RENAL AND URINARY DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,10/27/2013 0:00:00 AM,,16,16,4/4/2014 0:00:00 AM,175,"Placebo","Pbo",0,70,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0560","HLT_0393","URINARY FREQUENCY",4/18/2014 0:00:00 AM,189,10/12/2013 0:00:00 AM
"01-704-1351",2,"CDISCPILOT01","ADAE","704","1351","VERBATIM_0867","FLATULENCE","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,10/27/2013 0:00:00 AM,,16,16,4/4/2014 0:00:00 AM,175,"Placebo","Pbo",0,70,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0504","HLT_0356","GAS",4/18/2014 0:00:00 AM,189,10/12/2013 0:00:00 AM
"01-704-1351",3,"CDISCPILOT01","ADAE","704","1351","VERBATIM_1701","POLLAKIURIA","RENAL AND URINARY DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,10/27/2013 0:00:00 AM,,16,16,4/4/2014 0:00:00 AM,175,"Placebo","Pbo",0,70,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0560","HLT_0393","URINARY FREQUENCY",4/18/2014 0:00:00 AM,189,10/12/2013 0:00:00 AM
"01-704-1351",4,"CDISCPILOT01","ADAE","704","1351","VERBATIM_0867","FLATULENCE","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,10/27/2013 0:00:00 AM,,16,16,4/4/2014 0:00:00 AM,175,"Placebo","Pbo",0,70,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0504","HLT_0356","GAS",4/18/2014 0:00:00 AM,189,10/12/2013 0:00:00 AM
"01-704-1388",1,"CDISCPILOT01","ADAE","704","1388","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,8/23/2012 0:00:00 AM,,-106,-105,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",6/11/2013 0:00:00 AM,187,12/7/2012 0:00:00 AM
"01-704-1435",1,"CDISCPILOT01","ADAE","704","1435","VERBATIM_1127","PARKINSON'S DISEASE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,1/6/2013 0:00:00 AM,,51,51,,,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0313","HLT_0279","DISEASE PARKINSON'S",1/9/2013 0:00:00 AM,54,11/17/2012 0:00:00 AM
"01-704-1445",1,"CDISCPILOT01","ADAE","704","1445","VERBATIM_0276","COMPLETED SUICIDE","PSYCHIATRIC DISORDERS","SEVERE","N",0,"NONE",,"Y","Y",1,1,1,,,,,10/31/2014 0:00:00 AM,,174,174,10/31/2014 0:00:00 AM,174,"Placebo","Pbo",0,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","Y","N","N","HLGT_0013","HLT_0625","SUICIDE",11/1/2014 0:00:00 AM,175,5/11/2014 0:00:00 AM
"01-705-1031",1,"CDISCPILOT01","ADAE","705","1031","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,12/25/2013 0:00:00 AM,,29,29,,,"Xanomeline Low Dose","Xan_Lo",1,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",5/11/2014 0:00:00 AM,166,11/27/2013 0:00:00 AM
"01-705-1059",1,"CDISCPILOT01","ADAE","705","1059","VERBATIM_0314","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,11/2/2013 0:00:00 AM,,90,90,,,"Placebo","Pbo",0,66,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",12/5/2013 0:00:00 AM,123,8/5/2013 0:00:00 AM
"01-705-1186",1,"CDISCPILOT01","ADAE","705","1186","VERBATIM_0669","HYPERBILIRUBINAEMIA","HEPATOBILIARY DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,1/26/2014 0:00:00 AM,,19,19,,,"Placebo","Pbo",0,84,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0087","HLT_0478","HYPERBILIRUBINEMIA",1/26/2014 0:00:00 AM,19,1/8/2014 0:00:00 AM
"01-705-1199",1,"CDISCPILOT01","ADAE","705","1199","VERBATIM_0697","DYSPEPSIA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,9/17/2013 0:00:00 AM,,2,2,9/29/2013 0:00:00 AM,14,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0716","HLT_0244","PYROSIS",9/28/2013 0:00:00 AM,13,9/16/2013 0:00:00 AM
"01-705-1199",2,"CDISCPILOT01","ADAE","705","1199","VERBATIM_0697","DYSPEPSIA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,9/17/2013 0:00:00 AM,,2,2,9/29/2013 0:00:00 AM,14,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0716","HLT_0244","PYROSIS",9/28/2013 0:00:00 AM,13,9/16/2013 0:00:00 AM
"01-705-1280",1,"CDISCPILOT01","ADAE","705","1280","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,4/20/2014 0:00:00 AM,,94,94,,,"Xanomeline High Dose","Xan_Hi",2,56,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",7/25/2014 0:00:00 AM,190,1/17/2014 0:00:00 AM
"01-705-1281",1,"CDISCPILOT01","ADAE","705","1281","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,1/30/2014 0:00:00 AM,,64,64,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",2/27/2014 0:00:00 AM,92,11/28/2013 0:00:00 AM
"01-705-1281",2,"CDISCPILOT01","ADAE","705","1281","VERBATIM_1755","EXCORIATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,,1/30/2014 0:00:00 AM,,64,64,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0511","HLT_0738","ABRASIONS",2/27/2014 0:00:00 AM,92,11/28/2013 0:00:00 AM
"01-705-1281",3,"CDISCPILOT01","ADAE","705","1281","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,1/30/2014 0:00:00 AM,,64,64,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",2/27/2014 0:00:00 AM,92,11/28/2013 0:00:00 AM
"01-705-1292",1,"CDISCPILOT01","ADAE","705","1292","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,10/28/2013 0:00:00 AM,,15,15,,,"Xanomeline Low Dose","Xan_Lo",1,60,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",5/13/2014 0:00:00 AM,212,10/14/2013 0:00:00 AM
"01-705-1292",2,"CDISCPILOT01","ADAE","705","1292","VERBATIM_0314","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,2/13/2014 0:00:00 AM,,123,123,,,"Xanomeline Low Dose","Xan_Lo",1,60,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",5/13/2014 0:00:00 AM,212,10/14/2013 0:00:00 AM
"01-705-1303",1,"CDISCPILOT01","ADAE","705","1303","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,2/5/2014 0:00:00 AM,,52,52,3/3/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",6/2/2014 0:00:00 AM,169,12/16/2013 0:00:00 AM
"01-705-1303",2,"CDISCPILOT01","ADAE","705","1303","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,2/5/2014 0:00:00 AM,,52,52,3/3/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/2/2014 0:00:00 AM,169,12/16/2013 0:00:00 AM
"01-705-1303",3,"CDISCPILOT01","ADAE","705","1303","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,2/5/2014 0:00:00 AM,,52,52,3/3/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",6/2/2014 0:00:00 AM,169,12/16/2013 0:00:00 AM
"01-705-1303",4,"CDISCPILOT01","ADAE","705","1303","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,2/5/2014 0:00:00 AM,,52,52,3/3/2014 0:00:00 AM,78,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/2/2014 0:00:00 AM,169,12/16/2013 0:00:00 AM
"01-705-1310",1,"CDISCPILOT01","ADAE","705","1310","VERBATIM_0158","RASH PRURITIC","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,11/14/2013 0:00:00 AM,,13,13,,,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0753","HLT_0127","PRURITIC RASH",1/23/2014 0:00:00 AM,83,11/2/2013 0:00:00 AM
"01-705-1310",2,"CDISCPILOT01","ADAE","705","1310","VERBATIM_1798","WOUND HAEMORRHAGE","VASCULAR DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,1/9/2014 0:00:00 AM,,69,69,,,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0162","HLT_0154","WOUND BLEEDING",1/23/2014 0:00:00 AM,83,11/2/2013 0:00:00 AM
"01-705-1349",1,"CDISCPILOT01","ADAE","705","1349","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,4/8/2013 0:00:00 AM,,30,30,4/8/2013 0:00:00 AM,30,"Placebo","Pbo",0,86,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",9/8/2013 0:00:00 AM,183,3/10/2013 0:00:00 AM
"01-705-1349",2,"CDISCPILOT01","ADAE","705","1349","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,4/11/2013 0:00:00 AM,,33,33,4/11/2013 0:00:00 AM,33,"Placebo","Pbo",0,86,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",9/8/2013 0:00:00 AM,183,3/10/2013 0:00:00 AM
"01-705-1349",3,"CDISCPILOT01","ADAE","705","1349","VERBATIM_1214","VENTRICULAR HYPERTROPHY","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,8/25/2013 0:00:00 AM,,169,169,,,"Placebo","Pbo",0,86,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0259","HLT_0104","LEFT VENTRICULAR HYPERTROPHY",9/8/2013 0:00:00 AM,183,3/10/2013 0:00:00 AM
"01-705-1349",4,"CDISCPILOT01","ADAE","705","1349","VERBATIM_1153","ELECTROCARDIOGRAM ST SEGMENT DEPRESSION","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,8/25/2013 0:00:00 AM,,169,169,,,"Placebo","Pbo",0,86,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0220","HLT_0610","ST SEGMENT DEPRESSED",9/8/2013 0:00:00 AM,183,3/10/2013 0:00:00 AM
"01-705-1393",1,"CDISCPILOT01","ADAE","705","1393","VERBATIM_1719","ABDOMINAL PAIN","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,9/19/2012 0:00:00 AM,,13,13,9/24/2012 0:00:00 AM,18,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0419","HLT_0217","ABDOMINAL CRAMPS",2/1/2013 0:00:00 AM,148,9/7/2012 0:00:00 AM
"01-705-1393",2,"CDISCPILOT01","ADAE","705","1393","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","N","N",,,,,,,1,12/5/2011 0:00:00 AM,,-277,-276,2/20/2013 0:00:00 AM,167,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",2/1/2013 0:00:00 AM,148,9/7/2012 0:00:00 AM
"01-705-1393",3,"CDISCPILOT01","ADAE","705","1393","VERBATIM_0544","COLON CANCER","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","SEVERE","N",0,"NONE","Y","Y","Y",,1,1,,,,,1/21/2013 0:00:00 AM,,137,137,1/24/2013 0:00:00 AM,140,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","Y","N","N","N","Y","N","HLGT_0339","HLT_0597","COLON CANCER",2/1/2013 0:00:00 AM,148,9/7/2012 0:00:00 AM
"01-705-1393",4,"CDISCPILOT01","ADAE","705","1393","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","N","N",,,,,,,1,12/5/2011 0:00:00 AM,,-277,-276,2/20/2013 0:00:00 AM,167,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",2/1/2013 0:00:00 AM,148,9/7/2012 0:00:00 AM
"01-705-1431",1,"CDISCPILOT01","ADAE","705","1431","VERBATIM_0188","RASH ERYTHEMATOUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"N","N",,,,,,,1,6/22/2013 0:00:00 AM,,-1,0,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0701","HLT_0336","ERYTHEMATOUS RASH",12/19/2013 0:00:00 AM,180,6/23/2013 0:00:00 AM
"01-705-1431",2,"CDISCPILOT01","ADAE","705","1431","VERBATIM_0363","ANXIETY","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,7/4/2013 0:00:00 AM,,12,12,7/6/2013 0:00:00 AM,14,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0570","HLT_0559","FEELING ANXIOUS",12/19/2013 0:00:00 AM,180,6/23/2013 0:00:00 AM
"01-706-1041",1,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1033","ANXIETY","PSYCHIATRIC DISORDERS","MODERATE","N",0,"REMOTE",,"N","N",,,,,,,,5/1/2012 0:00:00 AM,"D",-609,-608,,,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0570","HLT_0559","ANXIETY ATTACK",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",2,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,1/7/2014 0:00:00 AM,,8,8,1/8/2014 0:00:00 AM,9,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",3,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1679","EXCORIATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/14/2014 0:00:00 AM,,15,15,1/28/2014 0:00:00 AM,29,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0511","HLT_0738","ABRASIONS",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",4,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1106","IRRITABILITY","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,1/15/2014 0:00:00 AM,,16,16,7/29/2014 0:00:00 AM,211,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0461","HLT_0627","IRRITABILITY",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",5,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1679","EXCORIATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,1/14/2014 0:00:00 AM,,15,15,1/28/2014 0:00:00 AM,29,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0511","HLT_0738","ABRASIONS",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",6,"CDISCPILOT01","ADAE","706","1041","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,3/4/2014 0:00:00 AM,,64,64,7/29/2014 0:00:00 AM,211,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",7,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1033","ANXIETY","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"N","N",,,,,,,,5/1/2012 0:00:00 AM,"D",-609,-608,,,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0570","HLT_0559","ANXIETY ATTACK",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",8,"CDISCPILOT01","ADAE","706","1041","VERBATIM_1106","IRRITABILITY","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,1/15/2014 0:00:00 AM,,16,16,7/29/2014 0:00:00 AM,211,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0461","HLT_0627","IRRITABILITY",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1041",9,"CDISCPILOT01","ADAE","706","1041","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,3/4/2014 0:00:00 AM,,64,64,7/29/2014 0:00:00 AM,211,"Placebo","Pbo",0,64,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/28/2014 0:00:00 AM,210,12/31/2013 0:00:00 AM
"01-706-1049",1,"CDISCPILOT01","ADAE","706","1049","VERBATIM_1235","SYNCOPE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,6/3/2013 0:00:00 AM,,21,21,6/3/2013 0:00:00 AM,21,"Xanomeline High Dose","Xan_Hi",2,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0310","HLT_0440","FAINTING",6/18/2013 0:00:00 AM,36,5/14/2013 0:00:00 AM
"01-706-1049",2,"CDISCPILOT01","ADAE","706","1049","VERBATIM_0436","SYNCOPE","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,,6/18/2013 0:00:00 AM,,36,36,6/18/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0310","HLT_0440","SYNCOPAL ATTACK",6/18/2013 0:00:00 AM,36,5/14/2013 0:00:00 AM
"01-706-1384",1,"CDISCPILOT01","ADAE","706","1384","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,1,9/15/2012 0:00:00 AM,,1,1,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",2,"CDISCPILOT01","ADAE","706","1384","VERBATIM_1586","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,1,,,,1,9/15/2012 0:00:00 AM,,1,1,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITIS",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",3,"CDISCPILOT01","ADAE","706","1384","VERBATIM_0354","EXCORIATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,9/15/2012 0:00:00 AM,,1,1,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0511","HLT_0738","ABRASIONS",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",4,"CDISCPILOT01","ADAE","706","1384","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/23/2012 0:00:00 AM,,9,9,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",5,"CDISCPILOT01","ADAE","706","1384","VERBATIM_1586","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/23/2012 0:00:00 AM,,9,9,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITIS",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",6,"CDISCPILOT01","ADAE","706","1384","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,1,9/15/2012 0:00:00 AM,,1,1,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",7,"CDISCPILOT01","ADAE","706","1384","VERBATIM_1586","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,1,9/15/2012 0:00:00 AM,,1,1,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITIS",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",8,"CDISCPILOT01","ADAE","706","1384","VERBATIM_0354","EXCORIATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,,9/15/2012 0:00:00 AM,,1,1,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0511","HLT_0738","ABRASIONS",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",9,"CDISCPILOT01","ADAE","706","1384","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/23/2012 0:00:00 AM,,9,9,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-706-1384",10,"CDISCPILOT01","ADAE","706","1384","VERBATIM_1586","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/23/2012 0:00:00 AM,,9,9,9/29/2012 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITIS",9/24/2012 0:00:00 AM,10,9/15/2012 0:00:00 AM
"01-707-1206",1,"CDISCPILOT01","ADAE","707","1206","VERBATIM_1645","SINUS ARRHYTHMIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,11/25/2013 0:00:00 AM,,29,29,12/23/2013 0:00:00 AM,57,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0630","HLT_0094","SINUS ARRHYTHMIA",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",2,"CDISCPILOT01","ADAE","707","1206","VERBATIM_1741","BLOOD CREATINE PHOSPHOKINASE INCREASED","INVESTIGATIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,11/26/2013 0:00:00 AM,,30,30,12/9/2013 0:00:00 AM,43,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0008","HLT_0404","CPK INCREASE",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",3,"CDISCPILOT01","ADAE","707","1206","VERBATIM_1588","POSTNASAL DRIP","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,12/3/2013 0:00:00 AM,,37,37,12/10/2013 0:00:00 AM,44,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0032","HLT_0172","POSTNASAL DRIP",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",4,"CDISCPILOT01","ADAE","707","1206","VERBATIM_1741","BLOOD CREATINE PHOSPHOKINASE INCREASED","INVESTIGATIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,11/26/2013 0:00:00 AM,,30,30,12/9/2013 0:00:00 AM,43,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0008","HLT_0404","CPK INCREASE",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",5,"CDISCPILOT01","ADAE","707","1206","VERBATIM_1588","POSTNASAL DRIP","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,12/3/2013 0:00:00 AM,,37,37,12/10/2013 0:00:00 AM,44,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0032","HLT_0172","POSTNASAL DRIP",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",6,"CDISCPILOT01","ADAE","707","1206","VERBATIM_1645","SINUS ARRHYTHMIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,11/25/2013 0:00:00 AM,,29,29,12/23/2013 0:00:00 AM,57,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0630","HLT_0094","SINUS ARRHYTHMIA",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",7,"CDISCPILOT01","ADAE","707","1206","VERBATIM_0757","CONJUNCTIVITIS","EYE DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,2/8/2014 0:00:00 AM,,104,104,2/22/2014 0:00:00 AM,118,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0335","HLT_0584","CONJUNCTIVITIS",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-707-1206",8,"CDISCPILOT01","ADAE","707","1206","VERBATIM_0757","CONJUNCTIVITIS","EYE DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,2/8/2014 0:00:00 AM,,104,104,2/22/2014 0:00:00 AM,118,"Placebo","Pbo",0,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0335","HLT_0584","CONJUNCTIVITIS",4/26/2014 0:00:00 AM,181,10/28/2013 0:00:00 AM
"01-708-1019",1,"CDISCPILOT01","ADAE","708","1019","VERBATIM_0520","HEADACHE","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,12/31/2013 0:00:00 AM,,12,12,12/31/2013 0:00:00 AM,12,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","FRONTAL HEADACHE",1/1/2014 0:00:00 AM,13,12/20/2013 0:00:00 AM
"01-708-1019",2,"CDISCPILOT01","ADAE","708","1019","VERBATIM_0442","STUPOR","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,1/1/2014 0:00:00 AM,,13,13,1/1/2014 0:00:00 AM,13,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0513","HLT_0595","STUPOR",1/1/2014 0:00:00 AM,13,12/20/2013 0:00:00 AM
"01-708-1019",3,"CDISCPILOT01","ADAE","708","1019","VERBATIM_1021","TRANSIENT ISCHAEMIC ATTACK","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,1/1/2014 0:00:00 AM,,13,13,1/1/2014 0:00:00 AM,13,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0433","HLT_0041","TRANSIENT ISCHEMIC ATTACKS",1/1/2014 0:00:00 AM,13,12/20/2013 0:00:00 AM
"01-708-1019",4,"CDISCPILOT01","ADAE","708","1019","VERBATIM_0911","VISION BLURRED","EYE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,1/1/2014 0:00:00 AM,,13,13,1/1/2014 0:00:00 AM,13,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0598","HLT_0120","BLURRED VISION",1/1/2014 0:00:00 AM,13,12/20/2013 0:00:00 AM
"01-708-1019",5,"CDISCPILOT01","ADAE","708","1019","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,1/1/2014 0:00:00 AM,,13,13,1/1/2014 0:00:00 AM,13,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",1/1/2014 0:00:00 AM,13,12/20/2013 0:00:00 AM
"01-708-1032",1,"CDISCPILOT01","ADAE","708","1032","VERBATIM_0318","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,2/26/2013 0:00:00 AM,,18,18,3/9/2013 0:00:00 AM,29,"Xanomeline Low Dose","Xan_Lo",1,62,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",3/1/2013 0:00:00 AM,21,2/9/2013 0:00:00 AM
"01-708-1084",1,"CDISCPILOT01","ADAE","708","1084","VERBATIM_0279","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,5/23/2013 0:00:00 AM,,15,15,5/23/2013 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",11/11/2013 0:00:00 AM,187,5/9/2013 0:00:00 AM
"01-708-1084",2,"CDISCPILOT01","ADAE","708","1084","VERBATIM_0279","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/23/2013 0:00:00 AM,,15,15,5/23/2013 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",11/11/2013 0:00:00 AM,187,5/9/2013 0:00:00 AM
"01-708-1084",3,"CDISCPILOT01","ADAE","708","1084","VERBATIM_1635","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,6/9/2013 0:00:00 AM,,32,32,6/9/2013 0:00:00 AM,32,"Xanomeline Low Dose","Xan_Lo",1,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","MYOCARDIAL INFARCTION",11/11/2013 0:00:00 AM,187,5/9/2013 0:00:00 AM
"01-708-1084",4,"CDISCPILOT01","ADAE","708","1084","VERBATIM_1635","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,6/9/2013 0:00:00 AM,,32,32,6/9/2013 0:00:00 AM,32,"Xanomeline Low Dose","Xan_Lo",1,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","MYOCARDIAL INFARCTION",11/11/2013 0:00:00 AM,187,5/9/2013 0:00:00 AM
"01-708-1084",5,"CDISCPILOT01","ADAE","708","1084","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,6/23/2013 0:00:00 AM,,46,46,6/23/2013 0:00:00 AM,46,"Xanomeline Low Dose","Xan_Lo",1,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",11/11/2013 0:00:00 AM,187,5/9/2013 0:00:00 AM
"01-708-1084",6,"CDISCPILOT01","ADAE","708","1084","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,6/23/2013 0:00:00 AM,,46,46,6/23/2013 0:00:00 AM,46,"Xanomeline Low Dose","Xan_Lo",1,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",11/11/2013 0:00:00 AM,187,5/9/2013 0:00:00 AM
"01-708-1087",1,"CDISCPILOT01","ADAE","708","1087","VERBATIM_0160","HEART RATE IRREGULAR","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,1/19/2013 0:00:00 AM,,90,90,1/19/2013 0:00:00 AM,90,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0140","HLT_0765","HEARTBEATS IRREGULAR",4/28/2013 0:00:00 AM,189,10/22/2012 0:00:00 AM
"01-708-1087",2,"CDISCPILOT01","ADAE","708","1087","VERBATIM_0160","HEART RATE IRREGULAR","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,1/19/2013 0:00:00 AM,,90,90,1/19/2013 0:00:00 AM,90,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0140","HLT_0765","HEARTBEATS IRREGULAR",4/28/2013 0:00:00 AM,189,10/22/2012 0:00:00 AM
"01-708-1087",3,"CDISCPILOT01","ADAE","708","1087","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,2/4/2013 0:00:00 AM,,106,106,2/8/2013 0:00:00 AM,110,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",4/28/2013 0:00:00 AM,189,10/22/2012 0:00:00 AM
"01-708-1087",4,"CDISCPILOT01","ADAE","708","1087","VERBATIM_1743","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,2/16/2013 0:00:00 AM,,118,118,,,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",4/28/2013 0:00:00 AM,189,10/22/2012 0:00:00 AM
"01-708-1087",5,"CDISCPILOT01","ADAE","708","1087","VERBATIM_0160","HEART RATE IRREGULAR","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,3/16/2013 0:00:00 AM,,146,146,3/16/2013 0:00:00 AM,146,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0140","HLT_0765","HEARTBEATS IRREGULAR",4/28/2013 0:00:00 AM,189,10/22/2012 0:00:00 AM
"01-708-1087",6,"CDISCPILOT01","ADAE","708","1087","VERBATIM_0160","HEART RATE IRREGULAR","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,3/16/2013 0:00:00 AM,,146,146,3/16/2013 0:00:00 AM,146,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0140","HLT_0765","HEARTBEATS IRREGULAR",4/28/2013 0:00:00 AM,189,10/22/2012 0:00:00 AM
"01-708-1158",1,"CDISCPILOT01","ADAE","708","1158","VERBATIM_0499","AGITATION","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,2/25/2014 0:00:00 AM,,18,18,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0170","HLT_0140","AGITATION",3/21/2014 0:00:00 AM,42,2/8/2014 0:00:00 AM
"01-708-1158",2,"CDISCPILOT01","ADAE","708","1158","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","N","Y",,1,1,,,,1,3/22/2014 0:00:00 AM,,43,43,3/22/2014 0:00:00 AM,43,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",3/21/2014 0:00:00 AM,42,2/8/2014 0:00:00 AM
"01-708-1178",1,"CDISCPILOT01","ADAE","708","1178","VERBATIM_1110","FLANK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,12/19/2013 0:00:00 AM,,-10,-9,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0543","HLT_0484","FLANK PAIN",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",2,"CDISCPILOT01","ADAE","708","1178","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,3/1/2014 0:00:00 AM,,63,63,3/8/2014 0:00:00 AM,70,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",3,"CDISCPILOT01","ADAE","708","1178","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,3/9/2014 0:00:00 AM,,71,71,4/6/2014 0:00:00 AM,99,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",4,"CDISCPILOT01","ADAE","708","1178","VERBATIM_1611","VENTRICULAR SEPTAL DEFECT","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/9/2014 0:00:00 AM,,71,71,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0747","HLT_0589","VENTRICULAR SEPTAL DEFECT",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",5,"CDISCPILOT01","ADAE","708","1178","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,3/9/2014 0:00:00 AM,,71,71,4/6/2014 0:00:00 AM,99,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",6,"CDISCPILOT01","ADAE","708","1178","VERBATIM_0278","DIZZINESS","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,3/24/2014 0:00:00 AM,,86,86,3/26/2014 0:00:00 AM,88,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0751","HLT_0619","LIGHT-HEADED",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",7,"CDISCPILOT01","ADAE","708","1178","VERBATIM_0402","ATRIAL FIBRILLATION","CARDIAC DISORDERS","SEVERE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,3/24/2014 0:00:00 AM,,86,86,3/26/2014 0:00:00 AM,88,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0012","HLT_0365","ATRIAL FIBRILLATION",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",8,"CDISCPILOT01","ADAE","708","1178","VERBATIM_0361","CYSTITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,3/24/2014 0:00:00 AM,,86,86,3/28/2014 0:00:00 AM,90,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0129","HLT_0739","BLADDER INFECTION",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1178",9,"CDISCPILOT01","ADAE","708","1178","VERBATIM_0340","ALCOHOL USE","SOCIAL CIRCUMSTANCES","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/24/2014 0:00:00 AM,,86,86,3/24/2014 0:00:00 AM,86,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0182","HLT_0138","ALCOHOL USE",4/6/2014 0:00:00 AM,99,12/29/2013 0:00:00 AM
"01-708-1213",1,"CDISCPILOT01","ADAE","708","1213","VERBATIM_0402","ATRIAL FIBRILLATION","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,2/22/2013 0:00:00 AM,,14,14,2/22/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0012","HLT_0365","ATRIAL FIBRILLATION",2/22/2013 0:00:00 AM,14,2/9/2013 0:00:00 AM
"01-708-1213",2,"CDISCPILOT01","ADAE","708","1213","VERBATIM_0402","ATRIAL FIBRILLATION","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,2/22/2013 0:00:00 AM,,14,14,2/22/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0012","HLT_0365","ATRIAL FIBRILLATION",2/22/2013 0:00:00 AM,14,2/9/2013 0:00:00 AM
"01-708-1216",1,"CDISCPILOT01","ADAE","708","1216","VERBATIM_0953","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,11/6/2012 0:00:00 AM,,14,14,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",11/29/2012 0:00:00 AM,37,10/24/2012 0:00:00 AM
"01-708-1216",2,"CDISCPILOT01","ADAE","708","1216","VERBATIM_0798","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/6/2012 0:00:00 AM,,14,14,12/13/2012 0:00:00 AM,51,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",11/29/2012 0:00:00 AM,37,10/24/2012 0:00:00 AM
"01-708-1216",3,"CDISCPILOT01","ADAE","708","1216","VERBATIM_0246","APPLICATION SITE SWELLING","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,11/22/2012 0:00:00 AM,,30,30,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0236","HLT_0105","APPLICATION SITE SWELLING",11/29/2012 0:00:00 AM,37,10/24/2012 0:00:00 AM
"01-708-1216",4,"CDISCPILOT01","ADAE","708","1216","VERBATIM_0798","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,11/6/2012 0:00:00 AM,,14,14,12/13/2012 0:00:00 AM,51,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",11/29/2012 0:00:00 AM,37,10/24/2012 0:00:00 AM
"01-708-1253",1,"CDISCPILOT01","ADAE","708","1253","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,5/6/2013 0:00:00 AM,,-1,0,5/16/2013 0:00:00 AM,10,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",2,"CDISCPILOT01","ADAE","708","1253","VERBATIM_0757","CONJUNCTIVITIS","EYE DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,5/6/2013 0:00:00 AM,,-1,0,5/16/2013 0:00:00 AM,10,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0335","HLT_0584","CONJUNCTIVITIS",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",3,"CDISCPILOT01","ADAE","708","1253","VERBATIM_0756","HEART RATE INCREASED","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,5/7/2013 0:00:00 AM,,1,1,5/10/2013 0:00:00 AM,4,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0673","HLT_0646","HEART RATE INCREASED",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",4,"CDISCPILOT01","ADAE","708","1253","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,5/6/2013 0:00:00 AM,,-1,0,5/16/2013 0:00:00 AM,10,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",5,"CDISCPILOT01","ADAE","708","1253","VERBATIM_0757","CONJUNCTIVITIS","EYE DISORDERS","MILD","N",0,"NONE",,"N","N",,,,,,,,5/6/2013 0:00:00 AM,,-1,0,5/16/2013 0:00:00 AM,10,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0335","HLT_0584","CONJUNCTIVITIS",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",6,"CDISCPILOT01","ADAE","708","1253","VERBATIM_0756","HEART RATE INCREASED","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/7/2013 0:00:00 AM,,1,1,5/10/2013 0:00:00 AM,4,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0673","HLT_0646","HEART RATE INCREASED",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",7,"CDISCPILOT01","ADAE","708","1253","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,6/7/2013 0:00:00 AM,,32,32,6/7/2013 0:00:00 AM,32,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1253",8,"CDISCPILOT01","ADAE","708","1253","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,6/7/2013 0:00:00 AM,,32,32,6/7/2013 0:00:00 AM,32,"Placebo","Pbo",0,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",11/5/2013 0:00:00 AM,183,5/7/2013 0:00:00 AM
"01-708-1272",1,"CDISCPILOT01","ADAE","708","1272","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,2/11/2013 0:00:00 AM,,6,6,2/11/2013 0:00:00 AM,6,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",2,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0534","MUSCLE SPASMS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","SEVERE","N",0,"NONE",,"Y","Y",,1,1,,,,,2/18/2013 0:00:00 AM,,13,13,2/18/2013 0:00:00 AM,13,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0750","HLT_0078","LEG CRAMPS",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",3,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0981","VENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,2/21/2013 0:00:00 AM,,16,16,3/20/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0594","HLT_0050","VENTRICULAR BIGEMINY",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",4,"CDISCPILOT01","ADAE","708","1272","VERBATIM_1621","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,2/27/2013 0:00:00 AM,,22,22,2/27/2013 0:00:00 AM,22,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",5,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/1/2013 0:00:00 AM,,24,24,3/7/2013 0:00:00 AM,30,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",6,"CDISCPILOT01","ADAE","708","1272","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/1/2013 0:00:00 AM,,24,24,3/7/2013 0:00:00 AM,30,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",7,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/7/2013 0:00:00 AM,,30,30,3/7/2013 0:00:00 AM,30,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",8,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/1/2013 0:00:00 AM,,24,24,3/7/2013 0:00:00 AM,30,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",9,"CDISCPILOT01","ADAE","708","1272","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/1/2013 0:00:00 AM,,24,24,3/7/2013 0:00:00 AM,30,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",10,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/7/2013 0:00:00 AM,,30,30,3/7/2013 0:00:00 AM,30,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",11,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0490","HOT FLUSH","VASCULAR DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/19/2013 0:00:00 AM,,42,42,3/19/2013 0:00:00 AM,42,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0773","HLT_0737","HOT FLASHES",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1272",12,"CDISCPILOT01","ADAE","708","1272","VERBATIM_0981","VENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,2/21/2013 0:00:00 AM,,16,16,3/20/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0594","HLT_0050","VENTRICULAR BIGEMINY",3/22/2013 0:00:00 AM,45,2/6/2013 0:00:00 AM
"01-708-1286",1,"CDISCPILOT01","ADAE","708","1286","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,9/12/2013 0:00:00 AM,,3,3,,,"Placebo","Pbo",0,80,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",3/8/2014 0:00:00 AM,180,9/10/2013 0:00:00 AM
"01-708-1286",2,"CDISCPILOT01","ADAE","708","1286","VERBATIM_0284","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,9/23/2013 0:00:00 AM,,14,14,,,"Placebo","Pbo",0,80,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","INFERIOR MYOCARDIAL INFARCTION",3/8/2014 0:00:00 AM,180,9/10/2013 0:00:00 AM
"01-708-1286",3,"CDISCPILOT01","ADAE","708","1286","VERBATIM_0554","ABDOMINAL PAIN","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,2/18/2014 0:00:00 AM,,162,162,2/18/2014 0:00:00 AM,162,"Placebo","Pbo",0,80,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0419","HLT_0217","ABDOMINAL PAIN",3/8/2014 0:00:00 AM,180,9/10/2013 0:00:00 AM
"01-708-1286",4,"CDISCPILOT01","ADAE","708","1286","VERBATIM_0443","CONSTIPATION","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,2/18/2014 0:00:00 AM,,162,162,2/18/2014 0:00:00 AM,162,"Placebo","Pbo",0,80,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0635","HLT_0402","CONSTIPATION",3/8/2014 0:00:00 AM,180,9/10/2013 0:00:00 AM
"01-708-1296",1,"CDISCPILOT01","ADAE","708","1296","VERBATIM_1263","ATRIAL HYPERTROPHY","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,6/27/2013 0:00:00 AM,,14,14,6/27/2013 0:00:00 AM,14,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0067","HLT_0271","LEFT ATRIAL HYPERTROPHY",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1296",2,"CDISCPILOT01","ADAE","708","1296","VERBATIM_1263","ATRIAL HYPERTROPHY","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,6/27/2013 0:00:00 AM,,14,14,6/27/2013 0:00:00 AM,14,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0067","HLT_0271","LEFT ATRIAL HYPERTROPHY",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1296",3,"CDISCPILOT01","ADAE","708","1296","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,9/4/2013 0:00:00 AM,,83,83,9/18/2013 0:00:00 AM,97,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1296",4,"CDISCPILOT01","ADAE","708","1296","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,9/4/2013 0:00:00 AM,,83,83,9/18/2013 0:00:00 AM,97,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1296",5,"CDISCPILOT01","ADAE","708","1296","VERBATIM_0133","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,10/4/2013 0:00:00 AM,,113,113,10/30/2013 0:00:00 AM,139,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1296",6,"CDISCPILOT01","ADAE","708","1296","VERBATIM_0133","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,10/4/2013 0:00:00 AM,,113,113,10/30/2013 0:00:00 AM,139,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1296",7,"CDISCPILOT01","ADAE","708","1296","VERBATIM_1008","PAIN IN EXTREMITY","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,12/7/2013 0:00:00 AM,,177,177,12/7/2013 0:00:00 AM,177,"Placebo","Pbo",0,57,"<65",1,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0764","HLT_0213","PAIN IN THIGH",12/12/2013 0:00:00 AM,182,6/14/2013 0:00:00 AM
"01-708-1297",1,"CDISCPILOT01","ADAE","708","1297","VERBATIM_1038","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,4/2/2013 0:00:00 AM,,68,68,,,"Xanomeline Low Dose","Xan_Lo",1,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",5/3/2013 0:00:00 AM,99,1/25/2013 0:00:00 AM
"01-708-1297",2,"CDISCPILOT01","ADAE","708","1297","VERBATIM_0246","APPLICATION SITE SWELLING","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,4/2/2013 0:00:00 AM,,68,68,,,"Xanomeline Low Dose","Xan_Lo",1,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0236","HLT_0105","APPLICATION SITE SWELLING",5/3/2013 0:00:00 AM,99,1/25/2013 0:00:00 AM
"01-708-1297",3,"CDISCPILOT01","ADAE","708","1297","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE","Y","N","Y",,1,1,,,,,5/8/2013 0:00:00 AM,,104,104,,,"Xanomeline Low Dose","Xan_Lo",1,61,"<65",1,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",5/3/2013 0:00:00 AM,99,1/25/2013 0:00:00 AM
"01-708-1316",1,"CDISCPILOT01","ADAE","708","1316","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,1/29/2014 0:00:00 AM,,160,160,,,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",3/1/2014 0:00:00 AM,191,8/23/2013 0:00:00 AM
"01-708-1316",2,"CDISCPILOT01","ADAE","708","1316","VERBATIM_0178","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,2/15/2014 0:00:00 AM,,177,177,,,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",3/1/2014 0:00:00 AM,191,8/23/2013 0:00:00 AM
"01-708-1336",1,"CDISCPILOT01","ADAE","708","1336","VERBATIM_1049","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,12/18/2012 0:00:00 AM,,12,12,12/18/2012 0:00:00 AM,12,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","LIGHTHEADEDNESS",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1336",2,"CDISCPILOT01","ADAE","708","1336","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,1/12/2013 0:00:00 AM,,37,37,1/12/2013 0:00:00 AM,37,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1336",3,"CDISCPILOT01","ADAE","708","1336","VERBATIM_0005","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/2/2013 0:00:00 AM,,58,58,2/2/2013 0:00:00 AM,58,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","LIGHT HEADEDNESS",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1336",4,"CDISCPILOT01","ADAE","708","1336","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/10/2013 0:00:00 AM,,125,125,6/5/2013 0:00:00 AM,181,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1336",5,"CDISCPILOT01","ADAE","708","1336","VERBATIM_0798","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,4/10/2013 0:00:00 AM,,125,125,6/5/2013 0:00:00 AM,181,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1336",6,"CDISCPILOT01","ADAE","708","1336","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/10/2013 0:00:00 AM,,125,125,6/5/2013 0:00:00 AM,181,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1336",7,"CDISCPILOT01","ADAE","708","1336","VERBATIM_0798","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/10/2013 0:00:00 AM,,125,125,6/5/2013 0:00:00 AM,181,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/5/2013 0:00:00 AM,181,12/7/2012 0:00:00 AM
"01-708-1347",1,"CDISCPILOT01","ADAE","708","1347","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",2,"CDISCPILOT01","ADAE","708","1347","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",3,"CDISCPILOT01","ADAE","708","1347","VERBATIM_1011","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",4,"CDISCPILOT01","ADAE","708","1347","VERBATIM_1691","APPLICATION SITE SWELLING","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0236","HLT_0105","APPLICATION SITE SWELLING",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",5,"CDISCPILOT01","ADAE","708","1347","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",6,"CDISCPILOT01","ADAE","708","1347","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",7,"CDISCPILOT01","ADAE","708","1347","VERBATIM_1011","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1347",8,"CDISCPILOT01","ADAE","708","1347","VERBATIM_1691","APPLICATION SITE SWELLING","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/13/2013 0:00:00 AM,,55,55,6/25/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,61,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0236","HLT_0105","APPLICATION SITE SWELLING",6/18/2013 0:00:00 AM,60,4/20/2013 0:00:00 AM
"01-708-1348",1,"CDISCPILOT01","ADAE","708","1348","VERBATIM_0335","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,8/18/2013 0:00:00 AM,,14,14,8/31/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","ANTEROSEPTAL INFARCTION",2/13/2014 0:00:00 AM,193,8/5/2013 0:00:00 AM
"01-708-1348",2,"CDISCPILOT01","ADAE","708","1348","VERBATIM_0335","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,8/18/2013 0:00:00 AM,,14,14,8/31/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","ANTEROSEPTAL INFARCTION",2/13/2014 0:00:00 AM,193,8/5/2013 0:00:00 AM
"01-708-1348",3,"CDISCPILOT01","ADAE","708","1348","VERBATIM_0445","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,12/1/2013 0:00:00 AM,,119,119,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",2/13/2014 0:00:00 AM,193,8/5/2013 0:00:00 AM
"01-708-1353",1,"CDISCPILOT01","ADAE","708","1353","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,8/18/2013 0:00:00 AM,,46,46,9/10/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",8/28/2013 0:00:00 AM,56,7/4/2013 0:00:00 AM
"01-708-1353",2,"CDISCPILOT01","ADAE","708","1353","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,,,,,,8/18/2013 0:00:00 AM,,46,46,9/10/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",8/28/2013 0:00:00 AM,56,7/4/2013 0:00:00 AM
"01-708-1353",3,"CDISCPILOT01","ADAE","708","1353","VERBATIM_0755","HYPOTENSION","VASCULAR DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,8/28/2013 0:00:00 AM,,56,56,9/10/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0412","HLT_0761","LOW BLOOD PRESSURE",8/28/2013 0:00:00 AM,56,7/4/2013 0:00:00 AM
"01-708-1372",1,"CDISCPILOT01","ADAE","708","1372","VERBATIM_1650","ATRIOVENTRICULAR BLOCK SECOND DEGREE","CARDIAC DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,4/10/2013 0:00:00 AM,,-2,-1,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0086","HLT_0415","AV BLOCK SECOND DEGREE",4/19/2013 0:00:00 AM,8,4/12/2013 0:00:00 AM
"01-708-1406",1,"CDISCPILOT01","ADAE","708","1406","VERBATIM_0397","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,6/16/2014 0:00:00 AM,,173,173,,,"Xanomeline High Dose","Xan_Hi",2,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","SWELLING OF LEGS",7/2/2014 0:00:00 AM,189,12/26/2013 0:00:00 AM
"01-708-1406",2,"CDISCPILOT01","ADAE","708","1406","VERBATIM_0896","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,6/16/2014 0:00:00 AM,,173,173,,,"Xanomeline High Dose","Xan_Hi",2,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","SWELLING OF LEGS",7/2/2014 0:00:00 AM,189,12/26/2013 0:00:00 AM
"01-708-1428",1,"CDISCPILOT01","ADAE","708","1428","VERBATIM_0847","EPISTAXIS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,11/22/2013 0:00:00 AM,,14,14,11/22/2013 0:00:00 AM,14,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0577","HLT_0386","NOSE BLEED",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-708-1428",2,"CDISCPILOT01","ADAE","708","1428","VERBATIM_1038","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,12/10/2013 0:00:00 AM,,32,32,12/21/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-708-1428",3,"CDISCPILOT01","ADAE","708","1428","VERBATIM_0798","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,12/10/2013 0:00:00 AM,,32,32,12/21/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-708-1428",4,"CDISCPILOT01","ADAE","708","1428","VERBATIM_0979","APPLICATION SITE WARMTH","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,12/10/2013 0:00:00 AM,,32,32,12/21/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0301","HLT_0260","APPLICATION SITE WARMTH",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-708-1428",5,"CDISCPILOT01","ADAE","708","1428","VERBATIM_1038","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/10/2013 0:00:00 AM,,32,32,12/21/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-708-1428",6,"CDISCPILOT01","ADAE","708","1428","VERBATIM_0798","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/10/2013 0:00:00 AM,,32,32,12/21/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-708-1428",7,"CDISCPILOT01","ADAE","708","1428","VERBATIM_0979","APPLICATION SITE WARMTH","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/10/2013 0:00:00 AM,,32,32,12/21/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0301","HLT_0260","APPLICATION SITE WARMTH",12/14/2013 0:00:00 AM,36,11/9/2013 0:00:00 AM
"01-709-1007",1,"CDISCPILOT01","ADAE","709","1007","VERBATIM_1481","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,8/16/2012 0:00:00 AM,,17,17,8/19/2012 0:00:00 AM,20,"Xanomeline Low Dose","Xan_Lo",1,54,"<65",1,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/28/2012 0:00:00 AM,29,7/31/2012 0:00:00 AM
"01-709-1007",2,"CDISCPILOT01","ADAE","709","1007","VERBATIM_1481","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,8/16/2012 0:00:00 AM,,17,17,8/19/2012 0:00:00 AM,20,"Xanomeline Low Dose","Xan_Lo",1,54,"<65",1,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/28/2012 0:00:00 AM,29,7/31/2012 0:00:00 AM
"01-709-1007",3,"CDISCPILOT01","ADAE","709","1007","VERBATIM_0008","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,8/21/2012 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,54,"<65",1,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/28/2012 0:00:00 AM,29,7/31/2012 0:00:00 AM
"01-709-1007",4,"CDISCPILOT01","ADAE","709","1007","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","N","Y",,1,1,,,,,8/30/2012 0:00:00 AM,,31,31,8/30/2012 0:00:00 AM,31,"Xanomeline Low Dose","Xan_Lo",1,54,"<65",1,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",8/28/2012 0:00:00 AM,29,7/31/2012 0:00:00 AM
"01-709-1020",1,"CDISCPILOT01","ADAE","709","1020","VERBATIM_0684","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,12/27/2012 0:00:00 AM,,27,27,,,"Xanomeline Low Dose","Xan_Lo",1,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",6/1/2013 0:00:00 AM,183,12/1/2012 0:00:00 AM
"01-709-1020",2,"CDISCPILOT01","ADAE","709","1020","VERBATIM_1107","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,1/3/2013 0:00:00 AM,,34,34,1/11/2013 0:00:00 AM,42,"Xanomeline Low Dose","Xan_Lo",1,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",6/1/2013 0:00:00 AM,183,12/1/2012 0:00:00 AM
"01-709-1020",3,"CDISCPILOT01","ADAE","709","1020","VERBATIM_0554","ABDOMINAL PAIN","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,1/3/2013 0:00:00 AM,,34,34,1/11/2013 0:00:00 AM,42,"Xanomeline Low Dose","Xan_Lo",1,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0419","HLT_0217","ABDOMINAL PAIN",6/1/2013 0:00:00 AM,183,12/1/2012 0:00:00 AM
"01-709-1020",4,"CDISCPILOT01","ADAE","709","1020","VERBATIM_0179","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,1/15/2013 0:00:00 AM,,46,46,,,"Xanomeline Low Dose","Xan_Lo",1,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/1/2013 0:00:00 AM,183,12/1/2012 0:00:00 AM
"01-709-1029",1,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0011","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,1/9/2013 0:00:00 AM,,16,16,2/19/2013 0:00:00 AM,57,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","SEPTAL MYOCARDIAL INFARCTION",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",2,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0716","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,1/17/2013 0:00:00 AM,,24,24,,,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",3,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0262","MUSCLE SPASMS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,1/24/2013 0:00:00 AM,,31,31,2/27/2013 0:00:00 AM,65,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0750","HLT_0078","CRAMP",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",4,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0011","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,1/9/2013 0:00:00 AM,,16,16,2/19/2013 0:00:00 AM,57,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","SEPTAL MYOCARDIAL INFARCTION",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",5,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0262","MUSCLE SPASMS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,1/24/2013 0:00:00 AM,,31,31,2/27/2013 0:00:00 AM,65,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0750","HLT_0078","CRAMP",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",6,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1150","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/20/2013 0:00:00 AM,,86,86,4/16/2013 0:00:00 AM,113,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","SEPTAL MYOCARDIAL INFARCTION",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",7,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,3/20/2013 0:00:00 AM,,86,86,4/16/2013 0:00:00 AM,113,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",8,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1150","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/20/2013 0:00:00 AM,,86,86,4/16/2013 0:00:00 AM,113,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","SEPTAL MYOCARDIAL INFARCTION",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",9,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,3/20/2013 0:00:00 AM,,86,86,4/16/2013 0:00:00 AM,113,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",10,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1421","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,5/12/2013 0:00:00 AM,,139,139,5/19/2013 0:00:00 AM,146,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",11,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1086","PHARYNGEAL ERYTHEMA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,1,5/12/2013 0:00:00 AM,,139,139,5/19/2013 0:00:00 AM,146,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0398","HLT_0591","RED THROAT",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",12,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1150","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,5/15/2013 0:00:00 AM,,142,142,,,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","SEPTAL MYOCARDIAL INFARCTION",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",13,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1421","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,5/12/2013 0:00:00 AM,,139,139,5/19/2013 0:00:00 AM,146,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",14,"CDISCPILOT01","ADAE","709","1029","VERBATIM_1086","PHARYNGEAL ERYTHEMA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,1,5/12/2013 0:00:00 AM,,139,139,5/19/2013 0:00:00 AM,146,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0398","HLT_0591","RED THROAT",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",15,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,6/12/2013 0:00:00 AM,,170,170,,,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1029",16,"CDISCPILOT01","ADAE","709","1029","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,6/19/2013 0:00:00 AM,,177,177,,,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/26/2013 0:00:00 AM,184,12/25/2012 0:00:00 AM
"01-709-1081",1,"CDISCPILOT01","ADAE","709","1081","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,4/7/2014 0:00:00 AM,,80,80,,,"Xanomeline Low Dose","Xan_Lo",1,86,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",4/27/2014 0:00:00 AM,100,1/18/2014 0:00:00 AM
"01-709-1081",2,"CDISCPILOT01","ADAE","709","1081","VERBATIM_1418","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE","Y","N","Y",,1,1,,,,,5/1/2014 0:00:00 AM,,104,104,,,"Xanomeline Low Dose","Xan_Lo",1,86,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","PERIPHERAL SWELLING",4/27/2014 0:00:00 AM,100,1/18/2014 0:00:00 AM
"01-709-1088",1,"CDISCPILOT01","ADAE","709","1088","VERBATIM_0968","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/8/2014 0:00:00 AM,,27,27,,,"Placebo","Pbo",0,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",10/9/2014 0:00:00 AM,181,4/12/2014 0:00:00 AM
"01-709-1088",2,"CDISCPILOT01","ADAE","709","1088","VERBATIM_0271","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,1,8/2/2014 0:00:00 AM,,113,113,,,"Placebo","Pbo",0,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",10/9/2014 0:00:00 AM,181,4/12/2014 0:00:00 AM
"01-709-1099",1,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,11/6/2013 0:00:00 AM,,13,13,11/17/2013 0:00:00 AM,24,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",2,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1069","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,11/12/2013 0:00:00 AM,,19,19,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",3,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1087","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,11/12/2013 0:00:00 AM,,19,19,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE VESICLES",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",4,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1663","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,11/12/2013 0:00:00 AM,,19,19,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",5,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,11/6/2013 0:00:00 AM,,13,13,11/17/2013 0:00:00 AM,24,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",6,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1069","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,11/12/2013 0:00:00 AM,,19,19,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",7,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1663","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,11/12/2013 0:00:00 AM,,19,19,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1099",8,"CDISCPILOT01","ADAE","709","1099","VERBATIM_1217","ACROCHORDON EXCISION","SURGICAL AND MEDICAL PROCEDURES","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/23/2014 0:00:00 AM,,150,150,3/23/2014 0:00:00 AM,150,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0103","HLT_0629","SKIN TAG REMOVAL",4/25/2014 0:00:00 AM,183,10/25/2013 0:00:00 AM
"01-709-1102",1,"CDISCPILOT01","ADAE","709","1102","VERBATIM_1069","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,2/11/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",3/27/2013 0:00:00 AM,72,1/15/2013 0:00:00 AM
"01-709-1102",2,"CDISCPILOT01","ADAE","709","1102","VERBATIM_1551","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,2/11/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",3/27/2013 0:00:00 AM,72,1/15/2013 0:00:00 AM
"01-709-1102",3,"CDISCPILOT01","ADAE","709","1102","VERBATIM_1069","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,2/11/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",3/27/2013 0:00:00 AM,72,1/15/2013 0:00:00 AM
"01-709-1102",4,"CDISCPILOT01","ADAE","709","1102","VERBATIM_1551","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,2/11/2013 0:00:00 AM,,28,28,,,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",3/27/2013 0:00:00 AM,72,1/15/2013 0:00:00 AM
"01-709-1102",5,"CDISCPILOT01","ADAE","709","1102","VERBATIM_0494","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,3/20/2013 0:00:00 AM,,65,65,3/26/2013 0:00:00 AM,71,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",3/27/2013 0:00:00 AM,72,1/15/2013 0:00:00 AM
"01-709-1102",6,"CDISCPILOT01","ADAE","709","1102","VERBATIM_0181","APPLICATION SITE VESICLES","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,3/26/2013 0:00:00 AM,,71,71,3/27/2013 0:00:00 AM,72,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0576","HLT_0180","APPLICATION SITE BLISTER",3/27/2013 0:00:00 AM,72,1/15/2013 0:00:00 AM
"01-709-1168",1,"CDISCPILOT01","ADAE","709","1168","VERBATIM_1165","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,8/17/2013 0:00:00 AM,,16,16,9/6/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","IRRITATION SKIN",9/26/2013 0:00:00 AM,56,8/2/2013 0:00:00 AM
"01-709-1168",2,"CDISCPILOT01","ADAE","709","1168","VERBATIM_1165","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,8/17/2013 0:00:00 AM,,16,16,9/6/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","IRRITATION SKIN",9/26/2013 0:00:00 AM,56,8/2/2013 0:00:00 AM
"01-709-1168",3,"CDISCPILOT01","ADAE","709","1168","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,9/6/2013 0:00:00 AM,,36,36,10/11/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",9/26/2013 0:00:00 AM,56,8/2/2013 0:00:00 AM
"01-709-1168",4,"CDISCPILOT01","ADAE","709","1168","VERBATIM_0324","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,9/6/2013 0:00:00 AM,,36,36,10/11/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",9/26/2013 0:00:00 AM,56,8/2/2013 0:00:00 AM
"01-709-1168",5,"CDISCPILOT01","ADAE","709","1168","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/6/2013 0:00:00 AM,,36,36,10/11/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",9/26/2013 0:00:00 AM,56,8/2/2013 0:00:00 AM
"01-709-1168",6,"CDISCPILOT01","ADAE","709","1168","VERBATIM_0324","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/6/2013 0:00:00 AM,,36,36,10/11/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",9/26/2013 0:00:00 AM,56,8/2/2013 0:00:00 AM
"01-709-1217",1,"CDISCPILOT01","ADAE","709","1217","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,3/6/2013 0:00:00 AM,,3,3,3/6/2013 0:00:00 AM,3,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",2,"CDISCPILOT01","ADAE","709","1217","VERBATIM_0620","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,3/20/2013 0:00:00 AM,,17,17,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",3,"CDISCPILOT01","ADAE","709","1217","VERBATIM_1036","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,3/26/2013 0:00:00 AM,,23,23,6/18/2013 0:00:00 AM,107,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",4,"CDISCPILOT01","ADAE","709","1217","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,3/27/2013 0:00:00 AM,,24,24,3/27/2013 0:00:00 AM,24,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",5,"CDISCPILOT01","ADAE","709","1217","VERBATIM_1077","ELECTROCARDIOGRAM T WAVE INVERSION","INVESTIGATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,3/30/2013 0:00:00 AM,,27,27,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0130","HLT_0289","T WAVE INVERTED",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",6,"CDISCPILOT01","ADAE","709","1217","VERBATIM_0494","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,4/1/2013 0:00:00 AM,,29,29,4/11/2013 0:00:00 AM,39,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",7,"CDISCPILOT01","ADAE","709","1217","VERBATIM_0494","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,4/1/2013 0:00:00 AM,,29,29,4/11/2013 0:00:00 AM,39,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",8,"CDISCPILOT01","ADAE","709","1217","VERBATIM_1036","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,3/26/2013 0:00:00 AM,,23,23,6/18/2013 0:00:00 AM,107,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",9,"CDISCPILOT01","ADAE","709","1217","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,1,,,,,5/17/2013 0:00:00 AM,,75,75,5/18/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",10,"CDISCPILOT01","ADAE","709","1217","VERBATIM_1036","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,3/26/2013 0:00:00 AM,,23,23,6/18/2013 0:00:00 AM,107,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1217",11,"CDISCPILOT01","ADAE","709","1217","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,5/27/2013 0:00:00 AM,,85,85,6/18/2013 0:00:00 AM,107,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/11/2013 0:00:00 AM,100,3/4/2013 0:00:00 AM
"01-709-1238",1,"CDISCPILOT01","ADAE","709","1238","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,5/28/2013 0:00:00 AM,,14,14,5/28/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",2,"CDISCPILOT01","ADAE","709","1238","VERBATIM_1069","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,5/30/2013 0:00:00 AM,,16,16,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",3,"CDISCPILOT01","ADAE","709","1238","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,5/30/2013 0:00:00 AM,,16,16,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",4,"CDISCPILOT01","ADAE","709","1238","VERBATIM_0012","APPLICATION SITE DISCHARGE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,5/30/2013 0:00:00 AM,,16,16,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0457","HLT_0200","APPLICATION SITE DISCHARGE",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",5,"CDISCPILOT01","ADAE","709","1238","VERBATIM_0163","HIP FRACTURE","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,5/31/2013 0:00:00 AM,,17,17,5/31/2013 0:00:00 AM,17,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0131","HLT_0097","HIP FRACTURE",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",6,"CDISCPILOT01","ADAE","709","1238","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,6/9/2013 0:00:00 AM,,26,26,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",7,"CDISCPILOT01","ADAE","709","1238","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,6/9/2013 0:00:00 AM,,26,26,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1238",8,"CDISCPILOT01","ADAE","709","1238","VERBATIM_0989","SKIN LESION EXCISION","SURGICAL AND MEDICAL PROCEDURES","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,6/28/2013 0:00:00 AM,,45,45,6/28/2013 0:00:00 AM,45,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0450","HLT_0498","SKIN LESION EXCISION",8/6/2013 0:00:00 AM,84,5/15/2013 0:00:00 AM
"01-709-1259",1,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0972","LOCALISED INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,2/5/2013 0:00:00 AM,,11,11,2/13/2013 0:00:00 AM,19,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0557","HLT_0435","INFECTED FINGER",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",2,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0972","LOCALISED INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,2/5/2013 0:00:00 AM,,11,11,2/13/2013 0:00:00 AM,19,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0557","HLT_0435","INFECTED FINGER",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",3,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0664","BLOOD URINE PRESENT","INVESTIGATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/14/2013 0:00:00 AM,,48,48,,,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0289","HLT_0458","BLOOD IN URINE",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",4,"CDISCPILOT01","ADAE","709","1259","VERBATIM_1792","CYSTOSCOPY","INVESTIGATIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,3/17/2013 0:00:00 AM,,51,51,3/17/2013 0:00:00 AM,51,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0041","HLT_0436","CYSTOSCOPY",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",5,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0255","BENIGN PROSTATIC HYPERPLASIA","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/17/2013 0:00:00 AM,,51,51,3/30/2013 0:00:00 AM,64,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0568","HLT_0215","ENLARGED PROSTATE",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",6,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0255","BENIGN PROSTATIC HYPERPLASIA","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","SEVERE","N",0,"NONE",,"Y","Y",,,,,,,,3/17/2013 0:00:00 AM,,51,51,3/30/2013 0:00:00 AM,64,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0568","HLT_0215","ENLARGED PROSTATE",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",7,"CDISCPILOT01","ADAE","709","1259","VERBATIM_1401","PYREXIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/13/2013 0:00:00 AM,,78,78,4/14/2013 0:00:00 AM,79,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0652","HLT_0310","FEVER",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",8,"CDISCPILOT01","ADAE","709","1259","VERBATIM_1538","DEHYDRATION","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/13/2013 0:00:00 AM,,78,78,4/14/2013 0:00:00 AM,79,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0011","HLT_0533","DEHYDRATION",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",9,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0755","HYPOTENSION","VASCULAR DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,4/13/2013 0:00:00 AM,,78,78,4/14/2013 0:00:00 AM,79,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0412","HLT_0761","LOW BLOOD PRESSURE",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",10,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0913","ORTHOSTATIC HYPOTENSION","VASCULAR DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,4/20/2013 0:00:00 AM,,85,85,6/13/2013 0:00:00 AM,139,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0111","HLT_0194","POSTURAL HYPOTENSION",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1259",11,"CDISCPILOT01","ADAE","709","1259","VERBATIM_0913","ORTHOSTATIC HYPOTENSION","VASCULAR DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,4/20/2013 0:00:00 AM,,85,85,6/13/2013 0:00:00 AM,139,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0111","HLT_0194","POSTURAL HYPOTENSION",6/13/2013 0:00:00 AM,139,1/26/2013 0:00:00 AM
"01-709-1285",1,"CDISCPILOT01","ADAE","709","1285","VERBATIM_1501","HEMIANOPIA HOMONYMOUS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,4/14/2013 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","Y","N","N","N","HLGT_0547","HLT_0639","HOMONYMOUS HEMIANOPSIA",5/23/2013 0:00:00 AM,61,3/24/2013 0:00:00 AM
"01-709-1285",2,"CDISCPILOT01","ADAE","709","1285","VERBATIM_1329","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,4/19/2013 0:00:00 AM,,27,27,5/31/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",5/23/2013 0:00:00 AM,61,3/24/2013 0:00:00 AM
"01-709-1285",3,"CDISCPILOT01","ADAE","709","1285","VERBATIM_0886","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,4/19/2013 0:00:00 AM,,27,27,5/31/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",5/23/2013 0:00:00 AM,61,3/24/2013 0:00:00 AM
"01-709-1285",4,"CDISCPILOT01","ADAE","709","1285","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,5/19/2013 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",5/23/2013 0:00:00 AM,61,3/24/2013 0:00:00 AM
"01-709-1285",5,"CDISCPILOT01","ADAE","709","1285","VERBATIM_1329","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/19/2013 0:00:00 AM,,27,27,5/31/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",5/23/2013 0:00:00 AM,61,3/24/2013 0:00:00 AM
"01-709-1285",6,"CDISCPILOT01","ADAE","709","1285","VERBATIM_0886","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/19/2013 0:00:00 AM,,27,27,5/31/2013 0:00:00 AM,69,"Xanomeline Low Dose","Xan_Lo",1,87,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",5/23/2013 0:00:00 AM,61,3/24/2013 0:00:00 AM
"01-709-1301",1,"CDISCPILOT01","ADAE","709","1301","VERBATIM_0875","DIABETES MELLITUS","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,8/30/2013 0:00:00 AM,,43,43,,,"Placebo","Pbo",0,62,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0572","HLT_0447","DIABETES",1/17/2014 0:00:00 AM,183,7/19/2013 0:00:00 AM
"01-709-1306",1,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1724","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,4/20/2014 0:00:00 AM,,77,77,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",2,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1492","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,4/20/2014 0:00:00 AM,,77,77,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",3,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1724","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/20/2014 0:00:00 AM,,77,77,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",4,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1492","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/20/2014 0:00:00 AM,,77,77,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",5,"CDISCPILOT01","ADAE","709","1306","VERBATIM_0132","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,5/4/2014 0:00:00 AM,,91,91,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",6,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1657","DRUG ERUPTION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,1,5/20/2014 0:00:00 AM,,107,107,5/23/2014 0:00:00 AM,110,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0253","HLT_0430","DRUG RASH",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",7,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1724","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/20/2014 0:00:00 AM,,77,77,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",8,"CDISCPILOT01","ADAE","709","1306","VERBATIM_1492","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/20/2014 0:00:00 AM,,77,77,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1306",9,"CDISCPILOT01","ADAE","709","1306","VERBATIM_0132","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,5/4/2014 0:00:00 AM,,91,91,6/23/2014 0:00:00 AM,141,"Placebo","Pbo",0,60,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",6/16/2014 0:00:00 AM,134,2/3/2014 0:00:00 AM
"01-709-1309",1,"CDISCPILOT01","ADAE","709","1309","VERBATIM_1060","RASH MACULO-PAPULAR","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,1,6/10/2013 0:00:00 AM,,-9,-8,7/1/2013 0:00:00 AM,13,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0097","HLT_0500","MACULOPAPULAR RASH",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",2,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0086","RASH PAPULAR","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,1,6/18/2013 0:00:00 AM,,-1,0,7/16/2013 0:00:00 AM,28,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0007","HLT_0549","PAPULAR RASH",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",3,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,6/19/2013 0:00:00 AM,,1,1,6/19/2013 0:00:00 AM,1,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",4,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,6/19/2013 0:00:00 AM,,1,1,6/19/2013 0:00:00 AM,1,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",5,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0615","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,6/19/2013 0:00:00 AM,,1,1,6/20/2013 0:00:00 AM,2,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",6,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0147","NIGHTMARE","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,6/19/2013 0:00:00 AM,,1,1,6/20/2013 0:00:00 AM,2,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0049","HLT_0186","NIGHTMARE",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",7,"CDISCPILOT01","ADAE","709","1309","VERBATIM_1060","RASH MACULO-PAPULAR","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,6/20/2013 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0097","HLT_0500","MACULOPAPULAR RASH",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",8,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0522","BIOPSY","INVESTIGATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,6/26/2013 0:00:00 AM,,8,8,6/26/2013 0:00:00 AM,8,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0076","HLT_0685","BIOPSY",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",9,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0712","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/1/2013 0:00:00 AM,,13,13,7/1/2013 0:00:00 AM,13,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",10,"CDISCPILOT01","ADAE","709","1309","VERBATIM_1060","RASH MACULO-PAPULAR","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,1,6/10/2013 0:00:00 AM,,-9,-8,7/1/2013 0:00:00 AM,13,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0097","HLT_0500","MACULOPAPULAR RASH",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",11,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0712","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,7/1/2013 0:00:00 AM,,13,13,7/1/2013 0:00:00 AM,13,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",12,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0906","ALLERGIC GRANULOMATOUS ANGIITIS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,7/4/2013 0:00:00 AM,,16,16,7/4/2013 0:00:00 AM,16,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0157","HLT_0114","ALLERGIC GRANULOMATOSIS",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",13,"CDISCPILOT01","ADAE","709","1309","VERBATIM_0086","RASH PAPULAR","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,1,6/18/2013 0:00:00 AM,,-1,0,7/16/2013 0:00:00 AM,28,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0007","HLT_0549","PAPULAR RASH",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",14,"CDISCPILOT01","ADAE","709","1309","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,7/28/2013 0:00:00 AM,,40,40,,,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1309",15,"CDISCPILOT01","ADAE","709","1309","VERBATIM_1770","FEELING COLD","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,9/6/2013 0:00:00 AM,,80,80,,,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0717","HLT_0340","FEELING COLD",12/19/2013 0:00:00 AM,184,6/19/2013 0:00:00 AM
"01-709-1312",1,"CDISCPILOT01","ADAE","709","1312","VERBATIM_0684","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/17/2014 0:00:00 AM,,28,28,,,"Placebo","Pbo",0,68,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",10/19/2014 0:00:00 AM,183,4/20/2014 0:00:00 AM
"01-709-1312",2,"CDISCPILOT01","ADAE","709","1312","VERBATIM_1095","ELECTROCARDIOGRAM ST SEGMENT DEPRESSION","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,10/19/2014 0:00:00 AM,,183,183,,,"Placebo","Pbo",0,68,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0220","HLT_0610","ST SEGMENT DEPRESSED",10/19/2014 0:00:00 AM,183,4/20/2014 0:00:00 AM
"01-709-1326",1,"CDISCPILOT01","ADAE","709","1326","VERBATIM_0684","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/1/2013 0:00:00 AM,,27,27,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",10/2/2013 0:00:00 AM,181,4/5/2013 0:00:00 AM
"01-709-1326",2,"CDISCPILOT01","ADAE","709","1326","VERBATIM_0179","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,5/1/2013 0:00:00 AM,,27,27,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",10/2/2013 0:00:00 AM,181,4/5/2013 0:00:00 AM
"01-709-1326",3,"CDISCPILOT01","ADAE","709","1326","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,5/21/2013 0:00:00 AM,,47,47,5/21/2013 0:00:00 AM,47,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",10/2/2013 0:00:00 AM,181,4/5/2013 0:00:00 AM
"01-709-1326",4,"CDISCPILOT01","ADAE","709","1326","VERBATIM_1537","SYNCOPE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,5/21/2013 0:00:00 AM,,47,47,5/21/2013 0:00:00 AM,47,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0310","HLT_0440","SYNCOPE",10/2/2013 0:00:00 AM,181,4/5/2013 0:00:00 AM
"01-709-1326",5,"CDISCPILOT01","ADAE","709","1326","VERBATIM_1413","APPLICATION SITE BLEEDING","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,6/7/2013 0:00:00 AM,,64,64,6/17/2013 0:00:00 AM,74,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0324","HLT_0718","APPLICATION SITE BLEEDING",10/2/2013 0:00:00 AM,181,4/5/2013 0:00:00 AM
"01-709-1326",6,"CDISCPILOT01","ADAE","709","1326","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/12/2013 0:00:00 AM,,99,99,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",10/2/2013 0:00:00 AM,181,4/5/2013 0:00:00 AM
"01-709-1329",1,"CDISCPILOT01","ADAE","709","1329","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,8/25/2013 0:00:00 AM,,11,11,8/25/2013 0:00:00 AM,11,"Xanomeline High Dose","Xan_Hi",2,70,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",8/25/2013 0:00:00 AM,11,8/15/2013 0:00:00 AM
"01-709-1329",2,"CDISCPILOT01","ADAE","709","1329","VERBATIM_1401","PYREXIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,8/25/2013 0:00:00 AM,,11,11,8/25/2013 0:00:00 AM,11,"Xanomeline High Dose","Xan_Hi",2,70,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0652","HLT_0310","FEVER",8/25/2013 0:00:00 AM,11,8/15/2013 0:00:00 AM
"01-709-1339",1,"CDISCPILOT01","ADAE","709","1339","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,11/1/2011 0:00:00 AM,"D",-418,-417,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",6/24/2013 0:00:00 AM,184,12/23/2012 0:00:00 AM
"01-709-1339",2,"CDISCPILOT01","ADAE","709","1339","VERBATIM_0037","BLOOD ALKALINE PHOSPHATASE INCREASED","INVESTIGATIONS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,,5/12/2013 0:00:00 AM,,141,141,,,"Placebo","Pbo",0,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0298","HLT_0615","ALK PHOS RAISED",6/24/2013 0:00:00 AM,184,12/23/2012 0:00:00 AM
"01-709-1424",1,"CDISCPILOT01","ADAE","709","1424","VERBATIM_1714","SYNCOPE","NERVOUS SYSTEM DISORDERS","MODERATE","Y",1,"POSSIBLE","Y","Y","Y",1,1,1,1,1,1,,3/7/2013 0:00:00 AM,,5,5,3/7/2013 0:00:00 AM,5,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0310","HLT_0440","SYNCOPE",3/7/2013 0:00:00 AM,5,3/3/2013 0:00:00 AM
"01-710-1002",1,"CDISCPILOT01","ADAE","710","1002","VERBATIM_1299","TRANSIENT ISCHAEMIC ATTACK","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,1/16/2014 0:00:00 AM,,3,3,1/20/2014 0:00:00 AM,7,"Xanomeline Low Dose","Xan_Lo",1,88,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0433","HLT_0041","TRANSIENT ISCHEMIC ATTACKS",1/18/2014 0:00:00 AM,5,1/14/2014 0:00:00 AM
"01-710-1002",2,"CDISCPILOT01","ADAE","710","1002","VERBATIM_1299","TRANSIENT ISCHAEMIC ATTACK","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,,,,,,1/16/2014 0:00:00 AM,,3,3,1/20/2014 0:00:00 AM,7,"Xanomeline Low Dose","Xan_Lo",1,88,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0433","HLT_0041","TRANSIENT ISCHEMIC ATTACKS",1/18/2014 0:00:00 AM,5,1/14/2014 0:00:00 AM
"01-710-1006",1,"CDISCPILOT01","ADAE","710","1006","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,2/18/2013 0:00:00 AM,,9,9,2/19/2013 0:00:00 AM,10,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",2,"CDISCPILOT01","ADAE","710","1006","VERBATIM_1130","SALIVARY HYPERSECRETION","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,3/1/2013 0:00:00 AM,,20,20,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0488","HLT_0374","SALIVATION",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",3,"CDISCPILOT01","ADAE","710","1006","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,3/1/2013 0:00:00 AM,,20,20,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",4,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0527","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,4/16/2013 0:00:00 AM,,66,66,4/16/2013 0:00:00 AM,66,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","FELT FAINT",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",5,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0575","URINARY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/17/2013 0:00:00 AM,,67,67,4/19/2013 0:00:00 AM,69,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0093","HLT_0161","URINARY INFECTION",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",6,"CDISCPILOT01","ADAE","710","1006","VERBATIM_1752","NEPHROLITHIASIS","RENAL AND URINARY DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,4/17/2013 0:00:00 AM,,67,67,4/17/2013 0:00:00 AM,67,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0546","HLT_0439","KIDNEY STONE",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",7,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,5/18/2013 0:00:00 AM,,98,98,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",8,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,6/29/2013 0:00:00 AM,,140,140,7/4/2013 0:00:00 AM,145,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",9,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,6/29/2013 0:00:00 AM,,140,140,7/4/2013 0:00:00 AM,145,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",10,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0364","FALL","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,8/8/2013 0:00:00 AM,,180,180,8/8/2013 0:00:00 AM,180,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0446","HLT_0168","FALL",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",11,"CDISCPILOT01","ADAE","710","1006","VERBATIM_0240","FACIAL BONES FRACTURE","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"NONE",,"Y","Y",,,1,,,,,8/8/2013 0:00:00 AM,,180,180,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0585","HLT_0305","FRACTURED NOSE",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1006",12,"CDISCPILOT01","ADAE","710","1006","VERBATIM_1622","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,8/8/2013 0:00:00 AM,,180,180,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISING OF FACE",8/9/2013 0:00:00 AM,181,2/10/2013 0:00:00 AM
"01-710-1021",1,"CDISCPILOT01","ADAE","710","1021","VERBATIM_0517","CHEST PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,10/10/2013 0:00:00 AM,,14,14,10/10/2013 0:00:00 AM,14,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0195","HLT_0717","CHEST PAIN",10/29/2013 0:00:00 AM,33,9/27/2013 0:00:00 AM
"01-710-1021",2,"CDISCPILOT01","ADAE","710","1021","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,10/21/2013 0:00:00 AM,,25,25,10/31/2013 0:00:00 AM,35,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",10/29/2013 0:00:00 AM,33,9/27/2013 0:00:00 AM
"01-710-1021",3,"CDISCPILOT01","ADAE","710","1021","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,10/21/2013 0:00:00 AM,,25,25,10/31/2013 0:00:00 AM,35,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",10/29/2013 0:00:00 AM,33,9/27/2013 0:00:00 AM
"01-710-1027",1,"CDISCPILOT01","ADAE","710","1027","VERBATIM_0334","HAEMOPTYSIS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,5/9/2014 0:00:00 AM,,71,71,6/1/2014 0:00:00 AM,94,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0680","HLT_0192","COUGHING BLOOD",8/29/2014 0:00:00 AM,183,2/28/2014 0:00:00 AM
"01-710-1027",2,"CDISCPILOT01","ADAE","710","1027","VERBATIM_1647","RALES","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,5/23/2014 0:00:00 AM,,85,85,6/20/2014 0:00:00 AM,113,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0410","HLT_0020","RALES",8/29/2014 0:00:00 AM,183,2/28/2014 0:00:00 AM
"01-710-1027",3,"CDISCPILOT01","ADAE","710","1027","VERBATIM_0334","HAEMOPTYSIS","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,5/9/2014 0:00:00 AM,,71,71,6/1/2014 0:00:00 AM,94,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0680","HLT_0192","COUGHING BLOOD",8/29/2014 0:00:00 AM,183,2/28/2014 0:00:00 AM
"01-710-1027",4,"CDISCPILOT01","ADAE","710","1027","VERBATIM_1647","RALES","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,5/23/2014 0:00:00 AM,,85,85,6/20/2014 0:00:00 AM,113,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0410","HLT_0020","RALES",8/29/2014 0:00:00 AM,183,2/28/2014 0:00:00 AM
"01-710-1045",1,"CDISCPILOT01","ADAE","710","1045","VERBATIM_0185","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,6/22/2013 0:00:00 AM,,20,20,6/22/2013 0:00:00 AM,20,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",2,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,7/2/2013 0:00:00 AM,,30,30,7/9/2013 0:00:00 AM,37,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",3,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,7/2/2013 0:00:00 AM,,30,30,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",4,"CDISCPILOT01","ADAE","710","1045","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,7/2/2013 0:00:00 AM,,30,30,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",5,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,7/2/2013 0:00:00 AM,,30,30,7/9/2013 0:00:00 AM,37,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",6,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,7/22/2013 0:00:00 AM,,50,50,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",7,"CDISCPILOT01","ADAE","710","1045","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,8/3/2013 0:00:00 AM,,62,62,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",8,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1321","SKIN EXFOLIATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,8/13/2013 0:00:00 AM,,72,72,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0726","HLT_0236","SKIN PEELING",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",9,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,7/2/2013 0:00:00 AM,,30,30,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",10,"CDISCPILOT01","ADAE","710","1045","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,7/2/2013 0:00:00 AM,,30,30,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",11,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,7/22/2013 0:00:00 AM,,50,50,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",12,"CDISCPILOT01","ADAE","710","1045","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,8/3/2013 0:00:00 AM,,62,62,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1045",13,"CDISCPILOT01","ADAE","710","1045","VERBATIM_1321","SKIN EXFOLIATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,8/13/2013 0:00:00 AM,,72,72,8/17/2013 0:00:00 AM,76,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0726","HLT_0236","SKIN PEELING",8/13/2013 0:00:00 AM,72,6/3/2013 0:00:00 AM
"01-710-1053",1,"CDISCPILOT01","ADAE","710","1053","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,1/28/2013 0:00:00 AM,,34,34,2/11/2013 0:00:00 AM,48,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/10/2013 0:00:00 AM,47,12/26/2012 0:00:00 AM
"01-710-1053",2,"CDISCPILOT01","ADAE","710","1053","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,1/28/2013 0:00:00 AM,,34,34,2/11/2013 0:00:00 AM,48,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/10/2013 0:00:00 AM,47,12/26/2012 0:00:00 AM
"01-710-1053",3,"CDISCPILOT01","ADAE","710","1053","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,1/28/2013 0:00:00 AM,,34,34,2/11/2013 0:00:00 AM,48,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/10/2013 0:00:00 AM,47,12/26/2012 0:00:00 AM
"01-710-1053",4,"CDISCPILOT01","ADAE","710","1053","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,1/28/2013 0:00:00 AM,,34,34,2/11/2013 0:00:00 AM,48,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/10/2013 0:00:00 AM,47,12/26/2012 0:00:00 AM
"01-710-1060",1,"CDISCPILOT01","ADAE","710","1060","VERBATIM_1612","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,1/2/2013 0:00:00 AM,,2,2,1/2/2013 0:00:00 AM,2,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NASAL CONGESTION",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",2,"CDISCPILOT01","ADAE","710","1060","VERBATIM_1504","INSOMNIA","PSYCHIATRIC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/4/2013 0:00:00 AM,,4,4,1/15/2013 0:00:00 AM,15,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0469","HLT_0297","DIFFICULTY SLEEPING",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",3,"CDISCPILOT01","ADAE","710","1060","VERBATIM_1504","INSOMNIA","PSYCHIATRIC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,1/4/2013 0:00:00 AM,,4,4,1/15/2013 0:00:00 AM,15,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0469","HLT_0297","DIFFICULTY SLEEPING",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",4,"CDISCPILOT01","ADAE","710","1060","VERBATIM_0685","APPLICATION SITE INDURATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,1/21/2013 0:00:00 AM,,21,21,1/21/2013 0:00:00 AM,21,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0715","HLT_0696","APPLICATION SITE INDURATION",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",5,"CDISCPILOT01","ADAE","710","1060","VERBATIM_0458","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,1/23/2013 0:00:00 AM,,23,23,1/23/2013 0:00:00 AM,23,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",6,"CDISCPILOT01","ADAE","710","1060","VERBATIM_0458","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,1/31/2013 0:00:00 AM,,31,31,1/31/2013 0:00:00 AM,31,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",7,"CDISCPILOT01","ADAE","710","1060","VERBATIM_1303","FALL","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,2/8/2013 0:00:00 AM,,39,39,2/8/2013 0:00:00 AM,39,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0446","HLT_0168","FALLING DOWN",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1060",8,"CDISCPILOT01","ADAE","710","1060","VERBATIM_1303","FALL","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,2/9/2013 0:00:00 AM,,40,40,2/9/2013 0:00:00 AM,40,"Placebo","Pbo",0,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0446","HLT_0168","FALLING DOWN",7/5/2013 0:00:00 AM,186,1/1/2013 0:00:00 AM
"01-710-1070",1,"CDISCPILOT01","ADAE","710","1070","VERBATIM_1717","SUPRAVENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,10/6/2012 0:00:00 AM,,29,29,,,"Xanomeline High Dose","Xan_Hi",2,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0279","HLT_0188","PREMATURE ATRIAL CONTRACTION",1/22/2013 0:00:00 AM,137,9/8/2012 0:00:00 AM
"01-710-1070",2,"CDISCPILOT01","ADAE","710","1070","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,12/12/2012 0:00:00 AM,,96,96,,,"Xanomeline High Dose","Xan_Hi",2,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",1/22/2013 0:00:00 AM,137,9/8/2012 0:00:00 AM
"01-710-1070",3,"CDISCPILOT01","ADAE","710","1070","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,12/12/2012 0:00:00 AM,,96,96,,,"Xanomeline High Dose","Xan_Hi",2,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",1/22/2013 0:00:00 AM,137,9/8/2012 0:00:00 AM
"01-710-1070",4,"CDISCPILOT01","ADAE","710","1070","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,12/12/2012 0:00:00 AM,,96,96,,,"Xanomeline High Dose","Xan_Hi",2,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",1/22/2013 0:00:00 AM,137,9/8/2012 0:00:00 AM
"01-710-1070",5,"CDISCPILOT01","ADAE","710","1070","VERBATIM_0985","HIP FRACTURE","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","SEVERE","N",0,"NONE","Y","Y","Y",,1,1,,,,,1/22/2013 0:00:00 AM,,137,137,1/25/2013 0:00:00 AM,140,"Xanomeline High Dose","Xan_Hi",2,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0131","HLT_0097","HIP FRACTURE",1/22/2013 0:00:00 AM,137,9/8/2012 0:00:00 AM
"01-710-1070",6,"CDISCPILOT01","ADAE","710","1070","VERBATIM_1577","GASTROINTESTINAL HAEMORRHAGE","GASTROINTESTINAL DISORDERS","SEVERE","N",0,"NONE","Y","N","Y",,1,1,,,,,2/5/2013 0:00:00 AM,,151,151,2/10/2013 0:00:00 AM,156,"Xanomeline High Dose","Xan_Hi",2,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0020","HLT_0354","GI BLEED",1/22/2013 0:00:00 AM,137,9/8/2012 0:00:00 AM
"01-710-1077",1,"CDISCPILOT01","ADAE","710","1077","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,12/12/2013 0:00:00 AM,,26,26,12/12/2013 0:00:00 AM,26,"Placebo","Pbo",0,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",5/18/2014 0:00:00 AM,183,11/17/2013 0:00:00 AM
"01-710-1077",2,"CDISCPILOT01","ADAE","710","1077","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,12/27/2013 0:00:00 AM,,41,41,,,"Placebo","Pbo",0,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",5/18/2014 0:00:00 AM,183,11/17/2013 0:00:00 AM
"01-710-1077",3,"CDISCPILOT01","ADAE","710","1077","VERBATIM_0499","AGITATION","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,1/12/2014 0:00:00 AM,,57,57,,,"Placebo","Pbo",0,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0170","HLT_0140","AGITATION",5/18/2014 0:00:00 AM,183,11/17/2013 0:00:00 AM
"01-710-1077",4,"CDISCPILOT01","ADAE","710","1077","VERBATIM_1309","ARTHRITIS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","SEVERE","N",0,"NONE",,"N","N",,,,,,,,,,,,,,"Placebo","Pbo",0,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0587","HLT_0019","ARTHRITIS",5/18/2014 0:00:00 AM,183,11/17/2013 0:00:00 AM
"01-710-1077",5,"CDISCPILOT01","ADAE","710","1077","VERBATIM_1309","ARTHRITIS","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,,,,,,,"Placebo","Pbo",0,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0587","HLT_0019","ARTHRITIS",5/18/2014 0:00:00 AM,183,11/17/2013 0:00:00 AM
"01-710-1083",1,"CDISCPILOT01","ADAE","710","1083","VERBATIM_0737","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","SEVERE","N",0,"POSSIBLE",,"N","Y",1,1,1,,,,,8/2/2013 0:00:00 AM,,12,12,8/2/2013 0:00:00 AM,12,"Placebo","Pbo",0,89,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","Y","Y","Y","HLGT_0688","HLT_0649","MYOCARDIAL INFARCT",8/1/2013 0:00:00 AM,11,7/22/2013 0:00:00 AM
"01-710-1137",1,"CDISCPILOT01","ADAE","710","1137","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,10/13/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",11/13/2013 0:00:00 AM,34,10/11/2013 0:00:00 AM
"01-710-1137",2,"CDISCPILOT01","ADAE","710","1137","VERBATIM_1639","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,10/13/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","REDNESS",11/13/2013 0:00:00 AM,34,10/11/2013 0:00:00 AM
"01-710-1137",3,"CDISCPILOT01","ADAE","710","1137","VERBATIM_1703","VERTIGO","EAR AND LABYRINTH DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,11/4/2013 0:00:00 AM,,25,25,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0147","HLT_0255","VERTIGO",11/13/2013 0:00:00 AM,34,10/11/2013 0:00:00 AM
"01-710-1137",4,"CDISCPILOT01","ADAE","710","1137","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,11/13/2013 0:00:00 AM,,34,34,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/13/2013 0:00:00 AM,34,10/11/2013 0:00:00 AM
"01-710-1142",1,"CDISCPILOT01","ADAE","710","1142","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,10/4/2012 0:00:00 AM,,3,3,10/6/2012 0:00:00 AM,5,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",10/20/2012 0:00:00 AM,19,10/2/2012 0:00:00 AM
"01-710-1142",2,"CDISCPILOT01","ADAE","710","1142","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,1,,,,,10/4/2012 0:00:00 AM,,3,3,10/6/2012 0:00:00 AM,5,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",10/20/2012 0:00:00 AM,19,10/2/2012 0:00:00 AM
"01-710-1142",3,"CDISCPILOT01","ADAE","710","1142","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,10/14/2012 0:00:00 AM,,13,13,10/14/2012 0:00:00 AM,13,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",10/20/2012 0:00:00 AM,19,10/2/2012 0:00:00 AM
"01-710-1142",4,"CDISCPILOT01","ADAE","710","1142","VERBATIM_0222","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,10/19/2012 0:00:00 AM,,18,18,10/19/2012 0:00:00 AM,18,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0688","HLT_0649","MYOCARDIAL INFARCTION",10/20/2012 0:00:00 AM,19,10/2/2012 0:00:00 AM
"01-710-1142",5,"CDISCPILOT01","ADAE","710","1142","VERBATIM_0210","SYNCOPE VASOVAGAL","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,10/19/2012 0:00:00 AM,,18,18,10/19/2012 0:00:00 AM,18,"Xanomeline High Dose","Xan_Hi",2,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0687","HLT_0003","SYNCOPE VASOVAGAL",10/20/2012 0:00:00 AM,19,10/2/2012 0:00:00 AM
"01-710-1154",1,"CDISCPILOT01","ADAE","710","1154","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,4/18/2014 0:00:00 AM,,21,21,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",4/27/2014 0:00:00 AM,30,3/29/2014 0:00:00 AM
"01-710-1154",2,"CDISCPILOT01","ADAE","710","1154","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","SEVERE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,4/18/2014 0:00:00 AM,,21,21,,,"Xanomeline Low Dose","Xan_Lo",1,84,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",4/27/2014 0:00:00 AM,30,3/29/2014 0:00:00 AM
"01-710-1166",1,"CDISCPILOT01","ADAE","710","1166","VERBATIM_0992","FALL","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,3/19/2013 0:00:00 AM,,110,110,3/19/2013 0:00:00 AM,110,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0446","HLT_0168","FALL",3/19/2013 0:00:00 AM,110,11/30/2012 0:00:00 AM
"01-710-1166",2,"CDISCPILOT01","ADAE","710","1166","VERBATIM_0587","SKIN LACERATION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,3/19/2013 0:00:00 AM,,110,110,3/19/2013 0:00:00 AM,110,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0118","HLT_0075","LACERATION OF HEAD",3/19/2013 0:00:00 AM,110,11/30/2012 0:00:00 AM
"01-710-1166",3,"CDISCPILOT01","ADAE","710","1166","VERBATIM_0455","SYNCOPE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,3/19/2013 0:00:00 AM,,110,110,3/19/2013 0:00:00 AM,110,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0310","HLT_0440","SYNCOPE",3/19/2013 0:00:00 AM,110,11/30/2012 0:00:00 AM
"01-710-1166",4,"CDISCPILOT01","ADAE","710","1166","VERBATIM_1135","COMPLEX PARTIAL SEIZURES","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,3/19/2013 0:00:00 AM,,110,110,3/20/2013 0:00:00 AM,111,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0656","HLT_0558","COMPLEX PARTIAL SEIZURES",3/19/2013 0:00:00 AM,110,11/30/2012 0:00:00 AM
"01-710-1166",5,"CDISCPILOT01","ADAE","710","1166","VERBATIM_0455","SYNCOPE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","N","Y",,,,,,,,3/20/2013 0:00:00 AM,,111,111,3/20/2013 0:00:00 AM,111,"Xanomeline Low Dose","Xan_Lo",1,81,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0310","HLT_0440","SYNCOPE",3/19/2013 0:00:00 AM,110,11/30/2012 0:00:00 AM
"01-710-1183",1,"CDISCPILOT01","ADAE","710","1183","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,3/10/2014 0:00:00 AM,,115,115,,,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",5/17/2014 0:00:00 AM,183,11/16/2013 0:00:00 AM
"01-710-1183",2,"CDISCPILOT01","ADAE","710","1183","VERBATIM_0166","ATRIOVENTRICULAR BLOCK FIRST DEGREE","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,3/10/2014 0:00:00 AM,,115,115,,,"Placebo","Pbo",0,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0464","HLT_0419","FIRST DEGREE ATRIOVENTRICULAR BLOCK",5/17/2014 0:00:00 AM,183,11/16/2013 0:00:00 AM
"01-710-1187",1,"CDISCPILOT01","ADAE","710","1187","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,12/23/2012 0:00:00 AM,,44,44,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",5/12/2013 0:00:00 AM,184,11/10/2012 0:00:00 AM
"01-710-1235",1,"CDISCPILOT01","ADAE","710","1235","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,,11/22/2012 0:00:00 AM,,58,58,12/14/2012 0:00:00 AM,80,"Xanomeline Low Dose","Xan_Lo",1,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",3/27/2013 0:00:00 AM,183,9/26/2012 0:00:00 AM
"01-710-1235",2,"CDISCPILOT01","ADAE","710","1235","VERBATIM_0634","SHOULDER PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/13/2013 0:00:00 AM,,110,110,,,"Xanomeline Low Dose","Xan_Lo",1,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0288","HLT_0527","SHOULDER PAIN",3/27/2013 0:00:00 AM,183,9/26/2012 0:00:00 AM
"01-710-1235",3,"CDISCPILOT01","ADAE","710","1235","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,1/29/2013 0:00:00 AM,,126,126,,,"Xanomeline Low Dose","Xan_Lo",1,56,"<65",1,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",3/27/2013 0:00:00 AM,183,9/26/2012 0:00:00 AM
"01-710-1249",1,"CDISCPILOT01","ADAE","710","1249","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,2/11/2014 0:00:00 AM,,46,46,2/11/2014 0:00:00 AM,46,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",6/28/2014 0:00:00 AM,183,12/28/2013 0:00:00 AM
"01-710-1249",2,"CDISCPILOT01","ADAE","710","1249","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,2/18/2014 0:00:00 AM,,53,53,2/18/2014 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",6/28/2014 0:00:00 AM,183,12/28/2013 0:00:00 AM
"01-710-1249",3,"CDISCPILOT01","ADAE","710","1249","VERBATIM_0254","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,2/23/2014 0:00:00 AM,,58,58,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/28/2014 0:00:00 AM,183,12/28/2013 0:00:00 AM
"01-710-1249",4,"CDISCPILOT01","ADAE","710","1249","VERBATIM_1202","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,4/24/2014 0:00:00 AM,,118,118,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",6/28/2014 0:00:00 AM,183,12/28/2013 0:00:00 AM
"01-710-1264",1,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,7/3/2013 0:00:00 AM,,21,21,7/5/2013 0:00:00 AM,23,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",2,"CDISCPILOT01","ADAE","710","1264","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,8/21/2013 0:00:00 AM,,70,70,,,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",3,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,8/21/2013 0:00:00 AM,,70,70,,,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",4,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1477","COLD SWEAT","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,9/29/2013 0:00:00 AM,,109,109,9/29/2013 0:00:00 AM,109,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0208","HLT_0124","COLD SWEAT",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",5,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1398","CHILLS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,9/29/2013 0:00:00 AM,,109,109,9/29/2013 0:00:00 AM,109,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0161","HLT_0586","CHILLS",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",6,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1477","COLD SWEAT","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/9/2013 0:00:00 AM,,119,119,10/9/2013 0:00:00 AM,119,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0208","HLT_0124","COLD SWEAT",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",7,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1398","CHILLS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/9/2013 0:00:00 AM,,119,119,10/9/2013 0:00:00 AM,119,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0161","HLT_0586","CHILLS",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",8,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1477","COLD SWEAT","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/11/2013 0:00:00 AM,,121,121,10/11/2013 0:00:00 AM,121,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0208","HLT_0124","COLD SWEAT",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1264",9,"CDISCPILOT01","ADAE","710","1264","VERBATIM_1398","CHILLS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/11/2013 0:00:00 AM,,121,121,10/11/2013 0:00:00 AM,121,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0161","HLT_0586","CHILLS",10/11/2013 0:00:00 AM,121,6/13/2013 0:00:00 AM
"01-710-1270",1,"CDISCPILOT01","ADAE","710","1270","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,2/23/2014 0:00:00 AM,,12,12,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",3/1/2014 0:00:00 AM,18,2/12/2014 0:00:00 AM
"01-710-1270",2,"CDISCPILOT01","ADAE","710","1270","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,2/23/2014 0:00:00 AM,,12,12,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",3/1/2014 0:00:00 AM,18,2/12/2014 0:00:00 AM
"01-710-1271",1,"CDISCPILOT01","ADAE","710","1271","VERBATIM_1509","DYSPNOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,11/21/2012 0:00:00 AM,,56,56,11/21/2012 0:00:00 AM,56,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0255","HLT_0296","SHORTNESS OF BREATH",11/21/2012 0:00:00 AM,56,9/27/2012 0:00:00 AM
"01-710-1271",2,"CDISCPILOT01","ADAE","710","1271","VERBATIM_0737","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","SEVERE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,11/21/2012 0:00:00 AM,,56,56,11/21/2012 0:00:00 AM,56,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","Y","HLGT_0688","HLT_0649","MYOCARDIAL INFARCT",11/21/2012 0:00:00 AM,56,9/27/2012 0:00:00 AM
"01-710-1271",3,"CDISCPILOT01","ADAE","710","1271","VERBATIM_0571","ATRIAL FIBRILLATION","CARDIAC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,11/21/2012 0:00:00 AM,,56,56,11/26/2012 0:00:00 AM,61,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","Y","HLGT_0012","HLT_0365","PAROXYSMAL ATRIAL FIBRILLATION",11/21/2012 0:00:00 AM,56,9/27/2012 0:00:00 AM
"01-710-1271",4,"CDISCPILOT01","ADAE","710","1271","VERBATIM_0411","CARDIAC FAILURE CONGESTIVE","CARDIAC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","N","Y",,,1,,,,,11/22/2012 0:00:00 AM,,57,57,,,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","Y","HLGT_0413","HLT_0511","CONGESTIVE HEART FAILURE",11/21/2012 0:00:00 AM,56,9/27/2012 0:00:00 AM
"01-710-1271",5,"CDISCPILOT01","ADAE","710","1271","VERBATIM_0078","HYPONATRAEMIA","METABOLISM AND NUTRITION DISORDERS","MODERATE","N",0,"REMOTE","Y","N","Y",,1,1,,,,,11/22/2012 0:00:00 AM,,57,57,11/26/2012 0:00:00 AM,61,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0102","HLT_0688","HYPONATREMIA",11/21/2012 0:00:00 AM,56,9/27/2012 0:00:00 AM
"01-710-1278",1,"CDISCPILOT01","ADAE","710","1278","VERBATIM_0485","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,1/13/2013 0:00:00 AM,,21,21,1/19/2013 0:00:00 AM,27,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","DROWSINESS",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1278",2,"CDISCPILOT01","ADAE","710","1278","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,2/7/2013 0:00:00 AM,,46,46,3/3/2013 0:00:00 AM,70,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1278",3,"CDISCPILOT01","ADAE","710","1278","VERBATIM_0159","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,2/24/2013 0:00:00 AM,,63,63,3/3/2013 0:00:00 AM,70,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1278",4,"CDISCPILOT01","ADAE","710","1278","VERBATIM_0152","BURNING SENSATION","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,2/24/2013 0:00:00 AM,,63,63,2/26/2013 0:00:00 AM,65,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0456","HLT_0775","BURNING SENSATION",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1278",5,"CDISCPILOT01","ADAE","710","1278","VERBATIM_0185","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","N","Y",,1,1,,,,,3/2/2013 0:00:00 AM,,69,69,3/2/2013 0:00:00 AM,69,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1278",6,"CDISCPILOT01","ADAE","710","1278","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,2/7/2013 0:00:00 AM,,46,46,3/3/2013 0:00:00 AM,70,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1278",7,"CDISCPILOT01","ADAE","710","1278","VERBATIM_0159","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,2/24/2013 0:00:00 AM,,63,63,3/3/2013 0:00:00 AM,70,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",2/26/2013 0:00:00 AM,65,12/24/2012 0:00:00 AM
"01-710-1300",1,"CDISCPILOT01","ADAE","710","1300","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,1/31/2013 0:00:00 AM,,48,48,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/15/2013 0:00:00 AM,63,12/15/2012 0:00:00 AM
"01-710-1300",2,"CDISCPILOT01","ADAE","710","1300","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,2/10/2013 0:00:00 AM,,58,58,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",2/15/2013 0:00:00 AM,63,12/15/2012 0:00:00 AM
"01-710-1300",3,"CDISCPILOT01","ADAE","710","1300","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,2/10/2013 0:00:00 AM,,58,58,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",2/15/2013 0:00:00 AM,63,12/15/2012 0:00:00 AM
"01-710-1300",4,"CDISCPILOT01","ADAE","710","1300","VERBATIM_1523","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,2/13/2013 0:00:00 AM,,61,61,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",2/15/2013 0:00:00 AM,63,12/15/2012 0:00:00 AM
"01-710-1314",1,"CDISCPILOT01","ADAE","710","1314","VERBATIM_0887","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,5/20/2013 0:00:00 AM,,27,27,5/24/2013 0:00:00 AM,31,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COMMON COLD",5/23/2013 0:00:00 AM,30,4/24/2013 0:00:00 AM
"01-710-1314",2,"CDISCPILOT01","ADAE","710","1314","VERBATIM_0887","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,5/20/2013 0:00:00 AM,,27,27,5/24/2013 0:00:00 AM,31,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COMMON COLD",5/23/2013 0:00:00 AM,30,4/24/2013 0:00:00 AM
"01-710-1315",1,"CDISCPILOT01","ADAE","710","1315","VERBATIM_0929","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE","Y","N","N",,,,,,,,2/26/2013 0:00:00 AM,,-1,0,2/26/2013 0:00:00 AM,-1,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1315",2,"CDISCPILOT01","ADAE","710","1315","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,1,5/14/2013 0:00:00 AM,,77,77,7/7/2013 0:00:00 AM,131,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1315",3,"CDISCPILOT01","ADAE","710","1315","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,6/18/2013 0:00:00 AM,,112,112,7/7/2013 0:00:00 AM,131,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1315",4,"CDISCPILOT01","ADAE","710","1315","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,6/18/2013 0:00:00 AM,,112,112,7/7/2013 0:00:00 AM,131,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1315",5,"CDISCPILOT01","ADAE","710","1315","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,5/14/2013 0:00:00 AM,,77,77,7/7/2013 0:00:00 AM,131,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1315",6,"CDISCPILOT01","ADAE","710","1315","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,6/18/2013 0:00:00 AM,,112,112,7/7/2013 0:00:00 AM,131,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1315",7,"CDISCPILOT01","ADAE","710","1315","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,,,,,1,6/18/2013 0:00:00 AM,,112,112,7/7/2013 0:00:00 AM,131,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/6/2013 0:00:00 AM,130,2/27/2013 0:00:00 AM
"01-710-1354",1,"CDISCPILOT01","ADAE","710","1354","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,12/30/2012 0:00:00 AM,,50,50,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",5/1/2013 0:00:00 AM,172,11/11/2012 0:00:00 AM
"01-710-1354",2,"CDISCPILOT01","ADAE","710","1354","VERBATIM_0215","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,2/14/2013 0:00:00 AM,,96,96,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITUS",5/1/2013 0:00:00 AM,172,11/11/2012 0:00:00 AM
"01-710-1358",1,"CDISCPILOT01","ADAE","710","1358","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,1,12/22/2012 0:00:00 AM,,97,97,,,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/9/2013 0:00:00 AM,146,9/17/2012 0:00:00 AM
"01-710-1358",2,"CDISCPILOT01","ADAE","710","1358","VERBATIM_0373","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,12/22/2012 0:00:00 AM,,97,97,,,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHY",2/9/2013 0:00:00 AM,146,9/17/2012 0:00:00 AM
"01-710-1358",3,"CDISCPILOT01","ADAE","710","1358","VERBATIM_1636","APPLICATION SITE DESQUAMATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,1/24/2013 0:00:00 AM,,130,130,,,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0193","HLT_0351","APPLICATION SITE DESQUAMATION",2/9/2013 0:00:00 AM,146,9/17/2012 0:00:00 AM
"01-710-1368",1,"CDISCPILOT01","ADAE","710","1368","VERBATIM_1155","HIP FRACTURE","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","SEVERE","N",0,"NONE",,"Y","Y",1,1,1,,,,,12/25/2013 0:00:00 AM,,64,64,4/24/2014 0:00:00 AM,184,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0131","HLT_0097","FRACTURED HIP",4/24/2014 0:00:00 AM,184,10/23/2013 0:00:00 AM
"01-710-1368",2,"CDISCPILOT01","ADAE","710","1368","VERBATIM_1218","DELUSION","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,3/26/2014 0:00:00 AM,,155,155,,,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0565","HLT_0198","DELUSIONS",4/24/2014 0:00:00 AM,184,10/23/2013 0:00:00 AM
"01-710-1368",3,"CDISCPILOT01","ADAE","710","1368","VERBATIM_1347","PSYCHOMOTOR HYPERACTIVITY","NERVOUS SYSTEM DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,3/26/2014 0:00:00 AM,,155,155,,,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0277","HLT_0383","INCREASED ACTIVITY",4/24/2014 0:00:00 AM,184,10/23/2013 0:00:00 AM
"01-710-1368",4,"CDISCPILOT01","ADAE","710","1368","VERBATIM_1155","HIP FRACTURE","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","SEVERE","N",0,"NONE",,"Y","Y",,,,,,,,12/25/2013 0:00:00 AM,,64,64,4/24/2014 0:00:00 AM,184,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0131","HLT_0097","FRACTURED HIP",4/24/2014 0:00:00 AM,184,10/23/2013 0:00:00 AM
"01-710-1385",1,"CDISCPILOT01","ADAE","710","1385","VERBATIM_1557","SUPRAVENTRICULAR TACHYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,11/12/2012 0:00:00 AM,,15,15,11/13/2012 0:00:00 AM,16,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0619","HLT_0692","SUPRAVENTRICULAR TACHYCARDIA",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",2,"CDISCPILOT01","ADAE","710","1385","VERBATIM_1557","SUPRAVENTRICULAR TACHYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,,,,,,11/12/2012 0:00:00 AM,,15,15,11/13/2012 0:00:00 AM,16,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0619","HLT_0692","SUPRAVENTRICULAR TACHYCARDIA",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",3,"CDISCPILOT01","ADAE","710","1385","VERBATIM_1564","ATRIOVENTRICULAR BLOCK FIRST DEGREE","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","Y","Y",,,1,,,,,11/26/2012 0:00:00 AM,,29,29,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0464","HLT_0419","FIRST DEGREE ATRIOVENTRICULAR BLOCK",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",4,"CDISCPILOT01","ADAE","710","1385","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,12/18/2012 0:00:00 AM,,51,51,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",5,"CDISCPILOT01","ADAE","710","1385","VERBATIM_1452","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,12/27/2012 0:00:00 AM,,60,60,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",6,"CDISCPILOT01","ADAE","710","1385","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,1,12/27/2012 0:00:00 AM,,60,60,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",7,"CDISCPILOT01","ADAE","710","1385","VERBATIM_0402","ATRIAL FIBRILLATION","CARDIAC DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,1,,,,,2/18/2013 0:00:00 AM,,113,113,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0012","HLT_0365","ATRIAL FIBRILLATION",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1385",8,"CDISCPILOT01","ADAE","710","1385","VERBATIM_1711","ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED","INVESTIGATIONS","MILD","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,2/18/2013 0:00:00 AM,,113,113,,,"Xanomeline Low Dose","Xan_Lo",1,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0030","HLT_0037","T WAVE FLATTENING OF",2/18/2013 0:00:00 AM,113,10/29/2012 0:00:00 AM
"01-710-1408",1,"CDISCPILOT01","ADAE","710","1408","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,1/31/2013 0:00:00 AM,,27,27,2/9/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",7/12/2013 0:00:00 AM,189,1/5/2013 0:00:00 AM
"01-710-1408",2,"CDISCPILOT01","ADAE","710","1408","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,1/31/2013 0:00:00 AM,,27,27,2/9/2013 0:00:00 AM,36,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",7/12/2013 0:00:00 AM,189,1/5/2013 0:00:00 AM
"01-710-1408",3,"CDISCPILOT01","ADAE","710","1408","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,2/24/2013 0:00:00 AM,,51,51,5/31/2013 0:00:00 AM,147,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/12/2013 0:00:00 AM,189,1/5/2013 0:00:00 AM
"01-710-1408",4,"CDISCPILOT01","ADAE","710","1408","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,1,2/24/2013 0:00:00 AM,,51,51,5/31/2013 0:00:00 AM,147,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/12/2013 0:00:00 AM,189,1/5/2013 0:00:00 AM
"01-711-1012",1,"CDISCPILOT01","ADAE","711","1012","VERBATIM_0950","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,4/16/2013 0:00:00 AM,,14,14,,,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1012",2,"CDISCPILOT01","ADAE","711","1012","VERBATIM_0905","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,4/16/2013 0:00:00 AM,,14,14,5/2/2013 0:00:00 AM,30,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1012",3,"CDISCPILOT01","ADAE","711","1012","VERBATIM_0950","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/16/2013 0:00:00 AM,,14,14,,,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1012",4,"CDISCPILOT01","ADAE","711","1012","VERBATIM_0905","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/16/2013 0:00:00 AM,,14,14,5/2/2013 0:00:00 AM,30,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1012",5,"CDISCPILOT01","ADAE","711","1012","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE","Y","Y","Y",,1,1,,,,,4/27/2013 0:00:00 AM,,25,25,,,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1012",6,"CDISCPILOT01","ADAE","711","1012","VERBATIM_0937","APPLICATION SITE URTICARIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,4/29/2013 0:00:00 AM,,27,27,5/1/2013 0:00:00 AM,29,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0233","HLT_0196","APPLICATION SITE URTICARIA",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1012",7,"CDISCPILOT01","ADAE","711","1012","VERBATIM_0905","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/16/2013 0:00:00 AM,,14,14,5/2/2013 0:00:00 AM,30,"Xanomeline High Dose","Xan_Hi",2,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",4/29/2013 0:00:00 AM,27,4/3/2013 0:00:00 AM
"01-711-1036",1,"CDISCPILOT01","ADAE","711","1036","VERBATIM_0292","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,7/29/2012 0:00:00 AM,,1,1,,,"Placebo","Pbo",0,70,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","INTERMITTENT HEADACHE",2/10/2013 0:00:00 AM,197,7/29/2012 0:00:00 AM
"01-711-1036",2,"CDISCPILOT01","ADAE","711","1036","VERBATIM_1034","EAR INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,8/4/2012 0:00:00 AM,,7,7,8/12/2012 0:00:00 AM,15,"Placebo","Pbo",0,70,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0760","HLT_0757","EAR INFECTION",2/10/2013 0:00:00 AM,197,7/29/2012 0:00:00 AM
"01-711-1036",3,"CDISCPILOT01","ADAE","711","1036","VERBATIM_0701","GLOSSITIS","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,8/12/2012 0:00:00 AM,,15,15,,,"Placebo","Pbo",0,70,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0427","HLT_0250","GLOSSITIS",2/10/2013 0:00:00 AM,197,7/29/2012 0:00:00 AM
"01-711-1036",4,"CDISCPILOT01","ADAE","711","1036","VERBATIM_1034","EAR INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,8/4/2012 0:00:00 AM,,7,7,8/12/2012 0:00:00 AM,15,"Placebo","Pbo",0,70,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0760","HLT_0757","EAR INFECTION",2/10/2013 0:00:00 AM,197,7/29/2012 0:00:00 AM
"01-711-1143",1,"CDISCPILOT01","ADAE","711","1143","VERBATIM_1065","TINNITUS","EAR AND LABYRINTH DISORDERS","MODERATE","N",0,"POSSIBLE","Y","N","N",,,,,,,,10/1/2007 0:00:00 AM,"D",-2011,-2010,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0180","HLT_0570","TINNITUS",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",2,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0872","PARAESTHESIA ORAL","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,4/11/2013 0:00:00 AM,,9,9,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0035","HLT_0727","TINGLING MOUTH",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",3,"CDISCPILOT01","ADAE","711","1143","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","SEVERE","N",0,"NONE","Y","Y","Y",,1,1,,,,,4/28/2013 0:00:00 AM,,26,26,5/11/2013 0:00:00 AM,39,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",4,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0401","SUPRAVENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,4/29/2013 0:00:00 AM,,27,27,5/15/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0279","HLT_0188","ECTOPIC ATRIAL BEATS",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",5,"CDISCPILOT01","ADAE","711","1143","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,4/28/2013 0:00:00 AM,,26,26,5/11/2013 0:00:00 AM,39,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",6,"CDISCPILOT01","ADAE","711","1143","VERBATIM_1698","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,4/28/2013 0:00:00 AM,,26,26,5/11/2013 0:00:00 AM,39,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",7,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0401","SUPRAVENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,4/29/2013 0:00:00 AM,,27,27,5/15/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0279","HLT_0188","ECTOPIC ATRIAL BEATS",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",8,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0950","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,5/18/2013 0:00:00 AM,,46,46,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",9,"CDISCPILOT01","ADAE","711","1143","VERBATIM_1328","RASH PRURITIC","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,5/27/2013 0:00:00 AM,,55,55,5/31/2013 0:00:00 AM,59,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0753","HLT_0127","ITCHY RASH",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",10,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0139","VENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,,5/28/2013 0:00:00 AM,,56,56,6/1/2013 0:00:00 AM,60,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0594","HLT_0050","PREMATURE VENTRICULAR CONTRACTIONS",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",11,"CDISCPILOT01","ADAE","711","1143","VERBATIM_1328","RASH PRURITIC","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,5/27/2013 0:00:00 AM,,55,55,5/31/2013 0:00:00 AM,59,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0753","HLT_0127","ITCHY RASH",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",12,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0600","CONJUNCTIVAL HAEMORRHAGE","EYE DISORDERS","MODERATE","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,5/30/2013 0:00:00 AM,,58,58,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0720","HLT_0013","SUBCONJUNCTIVAL HEMORRHAGE",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",13,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0856","CERUMEN IMPACTION","EAR AND LABYRINTH DISORDERS","MILD","N",0,"NONE","Y","N","Y",,1,1,,,,,6/1/2013 0:00:00 AM,,60,60,,,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0158","HLT_0018","CERUMEN IMPACTION",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1143",14,"CDISCPILOT01","ADAE","711","1143","VERBATIM_0139","VENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,,5/28/2013 0:00:00 AM,,56,56,6/1/2013 0:00:00 AM,60,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0594","HLT_0050","PREMATURE VENTRICULAR CONTRACTIONS",5/30/2013 0:00:00 AM,58,4/3/2013 0:00:00 AM
"01-711-1433",1,"CDISCPILOT01","ADAE","711","1433","VERBATIM_0342","HYPERTENSION","VASCULAR DISORDERS","MILD","N",0,"NONE","Y","N","N",,,,,,,,7/23/2012 0:00:00 AM,,-188,-187,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0476","HLT_0228","HYPERTENSION",2/5/2013 0:00:00 AM,10,1/27/2013 0:00:00 AM
"01-711-1433",2,"CDISCPILOT01","ADAE","711","1433","VERBATIM_0342","HYPERTENSION","VASCULAR DISORDERS","MODERATE","N",0,"NONE","Y","N","N",,,,,,,,7/23/2012 0:00:00 AM,,-188,-187,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0476","HLT_0228","HYPERTENSION",2/5/2013 0:00:00 AM,10,1/27/2013 0:00:00 AM
"01-711-1433",3,"CDISCPILOT01","ADAE","711","1433","VERBATIM_0281","ASTHENIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,2/5/2013 0:00:00 AM,,10,10,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"F","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0614","HLT_0205","WEAKNESS",2/5/2013 0:00:00 AM,10,1/27/2013 0:00:00 AM
"01-713-1043",1,"CDISCPILOT01","ADAE","713","1043","VERBATIM_0552","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,9/26/2013 0:00:00 AM,,12,12,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1043",2,"CDISCPILOT01","ADAE","713","1043","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,10/11/2013 0:00:00 AM,,27,27,10/11/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1043",3,"CDISCPILOT01","ADAE","713","1043","VERBATIM_0782","VOMITING","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,10/11/2013 0:00:00 AM,,27,27,10/11/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","EMESIS",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1043",4,"CDISCPILOT01","ADAE","713","1043","VERBATIM_0552","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,9/26/2013 0:00:00 AM,,12,12,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1043",5,"CDISCPILOT01","ADAE","713","1043","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,10/11/2013 0:00:00 AM,,27,27,10/11/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1043",6,"CDISCPILOT01","ADAE","713","1043","VERBATIM_0782","VOMITING","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,10/11/2013 0:00:00 AM,,27,27,10/11/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","EMESIS",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1043",7,"CDISCPILOT01","ADAE","713","1043","VERBATIM_1581","CATARACT OPERATION","SURGICAL AND MEDICAL PROCEDURES","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/8/2014 0:00:00 AM,,175,175,3/8/2014 0:00:00 AM,175,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0058","HLT_0432","CATARACT EXTRACTION",3/24/2014 0:00:00 AM,191,9/15/2013 0:00:00 AM
"01-713-1073",1,"CDISCPILOT01","ADAE","713","1073","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,7/14/2014 0:00:00 AM,,107,107,,,"Xanomeline Low Dose","Xan_Lo",1,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",10/5/2014 0:00:00 AM,190,3/30/2014 0:00:00 AM
"01-713-1141",1,"CDISCPILOT01","ADAE","713","1141","VERBATIM_1375","RASH PRURITIC","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,6/21/2013 0:00:00 AM,,22,22,7/15/2013 0:00:00 AM,46,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0753","HLT_0127","PRURITIC RASH",7/1/2013 0:00:00 AM,32,5/31/2013 0:00:00 AM
"01-713-1141",2,"CDISCPILOT01","ADAE","713","1141","VERBATIM_1375","RASH PRURITIC","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/21/2013 0:00:00 AM,,22,22,7/15/2013 0:00:00 AM,46,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0753","HLT_0127","PRURITIC RASH",7/1/2013 0:00:00 AM,32,5/31/2013 0:00:00 AM
"01-713-1141",3,"CDISCPILOT01","ADAE","713","1141","VERBATIM_1583","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,6/30/2013 0:00:00 AM,,31,31,,,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","BACK PAIN",7/1/2013 0:00:00 AM,32,5/31/2013 0:00:00 AM
"01-713-1141",4,"CDISCPILOT01","ADAE","713","1141","VERBATIM_0372","DELIRIUM","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,7/1/2013 0:00:00 AM,,32,32,7/15/2013 0:00:00 AM,46,"Xanomeline High Dose","Xan_Hi",2,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","N","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0176","HLT_0376","DELIRIUM",7/1/2013 0:00:00 AM,32,5/31/2013 0:00:00 AM
"01-713-1179",1,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1186","DYSURIA","RENAL AND URINARY DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,8/19/2013 0:00:00 AM,,11,11,8/23/2013 0:00:00 AM,15,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0210","HLT_0637","MICTURITION BURNING",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",2,"CDISCPILOT01","ADAE","713","1179","VERBATIM_0841","DYSPEPSIA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,8/22/2013 0:00:00 AM,,14,14,8/22/2013 0:00:00 AM,14,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0716","HLT_0244","HEARTBURN",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",3,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1682","URINARY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,8/28/2013 0:00:00 AM,,20,20,9/8/2013 0:00:00 AM,31,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0093","HLT_0161","URINARY TRACT INFECTION",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",4,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1430","ASTHENIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,9/5/2013 0:00:00 AM,,28,28,,,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0614","HLT_0205","LOWER EXTREMITIES WEAKNESS OF",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",5,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1682","URINARY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,8/28/2013 0:00:00 AM,,20,20,9/8/2013 0:00:00 AM,31,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0093","HLT_0161","URINARY TRACT INFECTION",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",6,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1430","ASTHENIA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,9/5/2013 0:00:00 AM,,28,28,,,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0614","HLT_0205","LOWER EXTREMITIES WEAKNESS OF",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",7,"CDISCPILOT01","ADAE","713","1179","VERBATIM_0800","DYSPEPSIA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,9/12/2013 0:00:00 AM,,35,35,,,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0716","HLT_0244","INDIGESTION",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",8,"CDISCPILOT01","ADAE","713","1179","VERBATIM_0230","PELVIC PAIN","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,10/10/2013 0:00:00 AM,,63,63,1/18/2014 0:00:00 AM,163,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0691","HLT_0189","PELVIC PAIN",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",9,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1024","GASTROENTERITIS VIRAL","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"REMOTE",,"Y","Y",,,1,,,,,10/10/2013 0:00:00 AM,,63,63,10/13/2013 0:00:00 AM,66,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0385","HLT_0211","STOMACH FLU",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",10,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1801","GASTROOESOPHAGEAL REFLUX DISEASE","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,10/10/2013 0:00:00 AM,,63,63,,,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0304","HLT_0407","GASTROOESOPHAGEAL REFLUX DISEASE",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",11,"CDISCPILOT01","ADAE","713","1179","VERBATIM_0207","VAGINAL MYCOSIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,11/23/2013 0:00:00 AM,,107,107,12/2/2013 0:00:00 AM,116,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0643","HLT_0508","VAGINAL YEAST INFECTION",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",12,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1707","CERVICITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,11/23/2013 0:00:00 AM,,107,107,12/2/2013 0:00:00 AM,116,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0282","HLT_0651","CERVICITIS",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",13,"CDISCPILOT01","ADAE","713","1179","VERBATIM_0207","VAGINAL MYCOSIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,11/23/2013 0:00:00 AM,,107,107,12/2/2013 0:00:00 AM,116,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0643","HLT_0508","VAGINAL YEAST INFECTION",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",14,"CDISCPILOT01","ADAE","713","1179","VERBATIM_1707","CERVICITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,11/23/2013 0:00:00 AM,,107,107,12/2/2013 0:00:00 AM,116,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0282","HLT_0651","CERVICITIS",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1179",15,"CDISCPILOT01","ADAE","713","1179","VERBATIM_0230","PELVIC PAIN","REPRODUCTIVE SYSTEM AND BREAST DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,10/10/2013 0:00:00 AM,,63,63,1/18/2014 0:00:00 AM,163,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0691","HLT_0189","PELVIC PAIN",2/5/2014 0:00:00 AM,181,8/9/2013 0:00:00 AM
"01-713-1209",1,"CDISCPILOT01","ADAE","713","1209","VERBATIM_0554","ABDOMINAL PAIN","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,5/30/2013 0:00:00 AM,,4,4,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0419","HLT_0217","ABDOMINAL PAIN",11/22/2013 0:00:00 AM,180,5/27/2013 0:00:00 AM
"01-713-1209",2,"CDISCPILOT01","ADAE","713","1209","VERBATIM_1219","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,6/2/2013 0:00:00 AM,,7,7,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",11/22/2013 0:00:00 AM,180,5/27/2013 0:00:00 AM
"01-713-1209",3,"CDISCPILOT01","ADAE","713","1209","VERBATIM_0554","ABDOMINAL PAIN","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/30/2013 0:00:00 AM,,4,4,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0419","HLT_0217","ABDOMINAL PAIN",11/22/2013 0:00:00 AM,180,5/27/2013 0:00:00 AM
"01-713-1209",4,"CDISCPILOT01","ADAE","713","1209","VERBATIM_1049","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,10/31/2013 0:00:00 AM,,158,158,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","LIGHTHEADEDNESS",11/22/2013 0:00:00 AM,180,5/27/2013 0:00:00 AM
"01-713-1256",1,"CDISCPILOT01","ADAE","713","1256","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,10/30/2012 0:00:00 AM,,42,42,10/31/2012 0:00:00 AM,43,"Placebo","Pbo",0,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",3/25/2013 0:00:00 AM,188,9/19/2012 0:00:00 AM
"01-713-1256",2,"CDISCPILOT01","ADAE","713","1256","VERBATIM_1298","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,10/30/2012 0:00:00 AM,,42,42,10/31/2012 0:00:00 AM,43,"Placebo","Pbo",0,71,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",3/25/2013 0:00:00 AM,188,9/19/2012 0:00:00 AM
"01-713-1269",1,"CDISCPILOT01","ADAE","713","1269","VERBATIM_0232","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,2/2/2014 0:00:00 AM,,7,7,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-713-1269",2,"CDISCPILOT01","ADAE","713","1269","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,4/18/2014 0:00:00 AM,,82,82,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-713-1269",3,"CDISCPILOT01","ADAE","713","1269","VERBATIM_0061","SHOULDER PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,6/1/2014 0:00:00 AM,,126,126,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0288","HLT_0527","SHOULDER PAIN",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-713-1269",4,"CDISCPILOT01","ADAE","713","1269","VERBATIM_0389","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,1,7/10/2014 0:00:00 AM,,165,165,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-713-1269",5,"CDISCPILOT01","ADAE","713","1269","VERBATIM_0061","SHOULDER PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,6/1/2014 0:00:00 AM,,126,126,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0288","HLT_0527","SHOULDER PAIN",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-713-1269",6,"CDISCPILOT01","ADAE","713","1269","VERBATIM_0389","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,1,7/10/2014 0:00:00 AM,,165,165,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-713-1448",1,"CDISCPILOT01","ADAE","713","1448","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,3/19/2014 0:00:00 AM,,60,60,5/23/2014 0:00:00 AM,125,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",5/16/2014 0:00:00 AM,118,1/19/2014 0:00:00 AM
"01-713-1448",2,"CDISCPILOT01","ADAE","713","1448","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,3/27/2014 0:00:00 AM,,68,68,5/23/2014 0:00:00 AM,125,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",5/16/2014 0:00:00 AM,118,1/19/2014 0:00:00 AM
"01-713-1448",3,"CDISCPILOT01","ADAE","713","1448","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,3/19/2014 0:00:00 AM,,60,60,5/23/2014 0:00:00 AM,125,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",5/16/2014 0:00:00 AM,118,1/19/2014 0:00:00 AM
"01-713-1448",4,"CDISCPILOT01","ADAE","713","1448","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,3/27/2014 0:00:00 AM,,68,68,5/23/2014 0:00:00 AM,125,"Xanomeline Low Dose","Xan_Lo",1,71,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",5/16/2014 0:00:00 AM,118,1/19/2014 0:00:00 AM
"01-714-1035",1,"CDISCPILOT01","ADAE","714","1035","VERBATIM_0319","BUNDLE BRANCH BLOCK RIGHT","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,5/26/2014 0:00:00 AM,,40,40,6/4/2014 0:00:00 AM,49,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0597","HLT_0751","INCOMPLETE RIGHT BUNDLE BRANCH BLOCK",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1035",2,"CDISCPILOT01","ADAE","714","1035","VERBATIM_0748","ELECTROCARDIOGRAM T WAVE INVERSION","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,5/26/2014 0:00:00 AM,,40,40,,,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0130","HLT_0289","T WAVE INVERSION",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1035",3,"CDISCPILOT01","ADAE","714","1035","VERBATIM_1420","SUPRAVENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,6/4/2014 0:00:00 AM,,49,49,6/17/2014 0:00:00 AM,62,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0279","HLT_0188","PREMATURE ATRIAL CONTRACTION",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1035",4,"CDISCPILOT01","ADAE","714","1035","VERBATIM_1153","ELECTROCARDIOGRAM ST SEGMENT DEPRESSION","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,6/4/2014 0:00:00 AM,,49,49,,,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0220","HLT_0610","ST SEGMENT DEPRESSED",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1035",5,"CDISCPILOT01","ADAE","714","1035","VERBATIM_0319","BUNDLE BRANCH BLOCK RIGHT","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,5/26/2014 0:00:00 AM,,40,40,6/4/2014 0:00:00 AM,49,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0597","HLT_0751","INCOMPLETE RIGHT BUNDLE BRANCH BLOCK",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1035",6,"CDISCPILOT01","ADAE","714","1035","VERBATIM_1420","SUPRAVENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,6/4/2014 0:00:00 AM,,49,49,6/17/2014 0:00:00 AM,62,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0279","HLT_0188","PREMATURE ATRIAL CONTRACTION",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1035",7,"CDISCPILOT01","ADAE","714","1035","VERBATIM_1176","BRONCHITIS","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,7/18/2014 0:00:00 AM,,93,93,7/24/2014 0:00:00 AM,99,"Placebo","Pbo",0,88,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0523","HLT_0634","BRONCHITIS",10/16/2014 0:00:00 AM,183,4/17/2014 0:00:00 AM
"01-714-1068",1,"CDISCPILOT01","ADAE","714","1068","VERBATIM_0019","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,8/12/2013 0:00:00 AM,,5,5,8/22/2013 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",10/8/2013 0:00:00 AM,62,8/8/2013 0:00:00 AM
"01-714-1068",2,"CDISCPILOT01","ADAE","714","1068","VERBATIM_0019","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,8/12/2013 0:00:00 AM,,5,5,8/22/2013 0:00:00 AM,15,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",10/8/2013 0:00:00 AM,62,8/8/2013 0:00:00 AM
"01-714-1068",3,"CDISCPILOT01","ADAE","714","1068","VERBATIM_0343","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,9/20/2013 0:00:00 AM,,44,44,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",10/8/2013 0:00:00 AM,62,8/8/2013 0:00:00 AM
"01-714-1068",4,"CDISCPILOT01","ADAE","714","1068","VERBATIM_1386","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,9/20/2013 0:00:00 AM,,44,44,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",10/8/2013 0:00:00 AM,62,8/8/2013 0:00:00 AM
"01-714-1068",5,"CDISCPILOT01","ADAE","714","1068","VERBATIM_0343","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/20/2013 0:00:00 AM,,44,44,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE ERYTHEMA",10/8/2013 0:00:00 AM,62,8/8/2013 0:00:00 AM
"01-714-1068",6,"CDISCPILOT01","ADAE","714","1068","VERBATIM_1386","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,9/20/2013 0:00:00 AM,,44,44,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",10/8/2013 0:00:00 AM,62,8/8/2013 0:00:00 AM
"01-714-1195",1,"CDISCPILOT01","ADAE","714","1195","VERBATIM_1274","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,5/12/2013 0:00:00 AM,,17,17,7/17/2013 0:00:00 AM,83,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","LOOSE STOOLS",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",2,"CDISCPILOT01","ADAE","714","1195","VERBATIM_1325","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,5/12/2013 0:00:00 AM,,17,17,7/17/2013 0:00:00 AM,83,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",3,"CDISCPILOT01","ADAE","714","1195","VERBATIM_0907","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,5/13/2013 0:00:00 AM,,18,18,7/17/2013 0:00:00 AM,83,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",4,"CDISCPILOT01","ADAE","714","1195","VERBATIM_0352","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,5/14/2013 0:00:00 AM,,19,19,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","DROWSINESS",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",5,"CDISCPILOT01","ADAE","714","1195","VERBATIM_1606","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,5/17/2013 0:00:00 AM,,22,22,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE PRURITUS",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",6,"CDISCPILOT01","ADAE","714","1195","VERBATIM_1274","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,5/12/2013 0:00:00 AM,,17,17,7/17/2013 0:00:00 AM,83,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","LOOSE STOOLS",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",7,"CDISCPILOT01","ADAE","714","1195","VERBATIM_1325","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/12/2013 0:00:00 AM,,17,17,7/17/2013 0:00:00 AM,83,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",8,"CDISCPILOT01","ADAE","714","1195","VERBATIM_0907","APPLICATION SITE ERYTHEMA","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/13/2013 0:00:00 AM,,18,18,7/17/2013 0:00:00 AM,83,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0152","HLT_0617","APPLICATION SITE REDNESS",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1195",9,"CDISCPILOT01","ADAE","714","1195","VERBATIM_1664","DYSURIA","RENAL AND URINARY DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,7/25/2013 0:00:00 AM,,91,91,8/6/2013 0:00:00 AM,103,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0210","HLT_0637","URINATION DIFFICULTY",10/23/2013 0:00:00 AM,181,4/26/2013 0:00:00 AM
"01-714-1288",1,"CDISCPILOT01","ADAE","714","1288","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,12/13/2013 0:00:00 AM,,10,10,12/13/2013 0:00:00 AM,10,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",2,"CDISCPILOT01","ADAE","714","1288","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,12/14/2013 0:00:00 AM,,11,11,12/15/2013 0:00:00 AM,12,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",3,"CDISCPILOT01","ADAE","714","1288","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,1/11/2014 0:00:00 AM,,39,39,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",4,"CDISCPILOT01","ADAE","714","1288","VERBATIM_0405","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/22/2014 0:00:00 AM,,50,50,1/25/2014 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","HEAD COLD",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",5,"CDISCPILOT01","ADAE","714","1288","VERBATIM_0910","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/22/2014 0:00:00 AM,,50,50,1/25/2014 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",6,"CDISCPILOT01","ADAE","714","1288","VERBATIM_0291","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,2/24/2014 0:00:00 AM,,83,83,4/8/2014 0:00:00 AM,126,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","LOW BACK PAIN",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",7,"CDISCPILOT01","ADAE","714","1288","VERBATIM_0672","ARTHRALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,,1,,,,,3/8/2014 0:00:00 AM,,95,95,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0610","HLT_0375","KNEE PAIN",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",8,"CDISCPILOT01","ADAE","714","1288","VERBATIM_0291","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,2/24/2014 0:00:00 AM,,83,83,4/8/2014 0:00:00 AM,126,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","LOW BACK PAIN",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1288",9,"CDISCPILOT01","ADAE","714","1288","VERBATIM_1595","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,5/27/2014 0:00:00 AM,,175,175,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","BRADYCARDIA SINUS",6/17/2014 0:00:00 AM,196,12/4/2013 0:00:00 AM
"01-714-1375",1,"CDISCPILOT01","ADAE","714","1375","VERBATIM_0290","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,1,3/30/2013 0:00:00 AM,,33,33,4/6/2013 0:00:00 AM,40,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","IRRITATION SKIN",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",2,"CDISCPILOT01","ADAE","714","1375","VERBATIM_1599","EAR PAIN","EAR AND LABYRINTH DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/4/2013 0:00:00 AM,,38,38,4/15/2013 0:00:00 AM,49,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0432","HLT_0631","EAR PAIN",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",3,"CDISCPILOT01","ADAE","714","1375","VERBATIM_0290","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,,,,,,1,3/30/2013 0:00:00 AM,,33,33,4/6/2013 0:00:00 AM,40,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","IRRITATION SKIN",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",4,"CDISCPILOT01","ADAE","714","1375","VERBATIM_1599","EAR PAIN","EAR AND LABYRINTH DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,4/4/2013 0:00:00 AM,,38,38,4/15/2013 0:00:00 AM,49,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0432","HLT_0631","EAR PAIN",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",5,"CDISCPILOT01","ADAE","714","1375","VERBATIM_1586","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,5/29/2013 0:00:00 AM,,93,93,,,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITIS",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",6,"CDISCPILOT01","ADAE","714","1375","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,6/16/2013 0:00:00 AM,,111,111,,,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",7,"CDISCPILOT01","ADAE","714","1375","VERBATIM_1586","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/29/2013 0:00:00 AM,,93,93,,,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","PRURITIS",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1375",8,"CDISCPILOT01","ADAE","714","1375","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,6/16/2013 0:00:00 AM,,111,111,,,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/7/2013 0:00:00 AM,194,2/26/2013 0:00:00 AM
"01-714-1425",1,"CDISCPILOT01","ADAE","714","1425","VERBATIM_1758","ATRIOVENTRICULAR BLOCK SECOND DEGREE","CARDIAC DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,8/13/2013 0:00:00 AM,,-2,-1,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0086","HLT_0415","AV BLOCK SECOND DEGREE",8/19/2013 0:00:00 AM,5,8/15/2013 0:00:00 AM
"01-715-1107",1,"CDISCPILOT01","ADAE","715","1107","VERBATIM_0387","DERMATITIS CONTACT","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,5/7/2013 0:00:00 AM,,71,71,5/21/2013 0:00:00 AM,85,"Xanomeline Low Dose","Xan_Lo",1,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0331","HLT_0056","CONTACT DERMATITIS",5/7/2013 0:00:00 AM,71,2/26/2013 0:00:00 AM
"01-715-1107",2,"CDISCPILOT01","ADAE","715","1107","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","N","Y",,1,1,,,,,5/13/2013 0:00:00 AM,,77,77,,,"Xanomeline Low Dose","Xan_Lo",1,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",5/7/2013 0:00:00 AM,71,2/26/2013 0:00:00 AM
"01-715-1107",3,"CDISCPILOT01","ADAE","715","1107","VERBATIM_0387","DERMATITIS CONTACT","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,5/7/2013 0:00:00 AM,,71,71,5/21/2013 0:00:00 AM,85,"Xanomeline Low Dose","Xan_Lo",1,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0331","HLT_0056","CONTACT DERMATITIS",5/7/2013 0:00:00 AM,71,2/26/2013 0:00:00 AM
"01-715-1207",1,"CDISCPILOT01","ADAE","715","1207","VERBATIM_0739","NEPHROLITHIASIS","RENAL AND URINARY DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,,1/10/2013 0:00:00 AM,,54,54,1/10/2013 0:00:00 AM,54,"Placebo","Pbo",0,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0546","HLT_0439","KIDNEY STONES",5/27/2013 0:00:00 AM,191,11/18/2012 0:00:00 AM
"01-715-1319",1,"CDISCPILOT01","ADAE","715","1319","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"NONE",,"N","Y",1,1,1,,,,,3/18/2013 0:00:00 AM,,30,30,3/18/2013 0:00:00 AM,30,"Xanomeline High Dose","Xan_Hi",2,65,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",3/5/2013 0:00:00 AM,17,2/17/2013 0:00:00 AM
"01-715-1321",1,"CDISCPILOT01","ADAE","715","1321","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",1,1,1,,,,,3/14/2014 0:00:00 AM,,32,32,3/14/2014 0:00:00 AM,32,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",4/21/2014 0:00:00 AM,70,2/11/2014 0:00:00 AM
"01-715-1321",2,"CDISCPILOT01","ADAE","715","1321","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE","Y","Y","Y",,,,,,,,3/14/2014 0:00:00 AM,,32,32,3/14/2014 0:00:00 AM,32,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",4/21/2014 0:00:00 AM,70,2/11/2014 0:00:00 AM
"01-715-1321",3,"CDISCPILOT01","ADAE","715","1321","VERBATIM_1688","APPLICATION SITE REACTION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,4/21/2014 0:00:00 AM,,70,70,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0668","HLT_0339","APPLICATION SITE REACTION",4/21/2014 0:00:00 AM,70,2/11/2014 0:00:00 AM
"01-715-1321",4,"CDISCPILOT01","ADAE","715","1321","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"NONE","Y","N","Y",,1,1,,,,,4/22/2014 0:00:00 AM,,71,71,,,"Xanomeline High Dose","Xan_Hi",2,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",4/21/2014 0:00:00 AM,70,2/11/2014 0:00:00 AM
"01-715-1405",1,"CDISCPILOT01","ADAE","715","1405","VERBATIM_0135","PALPITATIONS","CARDIAC DISORDERS","MODERATE","N",0,"PROBABLE","Y","N","Y",1,1,1,,,,,7/8/2013 0:00:00 AM,,3,3,7/8/2013 0:00:00 AM,3,"Xanomeline Low Dose","Xan_Lo",1,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0593","HLT_0493","PALPITATIONS",7/7/2013 0:00:00 AM,2,7/6/2013 0:00:00 AM
"01-715-1405",2,"CDISCPILOT01","ADAE","715","1405","VERBATIM_1343","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","N","Y",,1,1,,,,,7/8/2013 0:00:00 AM,,3,3,7/8/2013 0:00:00 AM,3,"Xanomeline Low Dose","Xan_Lo",1,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING",7/7/2013 0:00:00 AM,2,7/6/2013 0:00:00 AM
"01-715-1405",3,"CDISCPILOT01","ADAE","715","1405","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"PROBABLE","Y","N","Y",,1,1,,,,,7/8/2013 0:00:00 AM,,3,3,7/8/2013 0:00:00 AM,3,"Xanomeline Low Dose","Xan_Lo",1,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",7/7/2013 0:00:00 AM,2,7/6/2013 0:00:00 AM
"01-715-1405",4,"CDISCPILOT01","ADAE","715","1405","VERBATIM_1713","CONFUSIONAL STATE","PSYCHIATRIC DISORDERS","MODERATE","N",0,"PROBABLE","Y","N","Y",,1,1,,,,,7/8/2013 0:00:00 AM,,3,3,7/8/2013 0:00:00 AM,3,"Xanomeline Low Dose","Xan_Lo",1,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0329","HLT_0642","CONFUSION",7/7/2013 0:00:00 AM,2,7/6/2013 0:00:00 AM
"01-715-1405",5,"CDISCPILOT01","ADAE","715","1405","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"NONE","Y","N","Y",,,1,,,,,7/13/2013 0:00:00 AM,,8,8,7/13/2013 0:00:00 AM,8,"Xanomeline Low Dose","Xan_Lo",1,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",7/7/2013 0:00:00 AM,2,7/6/2013 0:00:00 AM
"01-715-1405",6,"CDISCPILOT01","ADAE","715","1405","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MODERATE","N",0,"NONE","Y","N","Y",,,,,,,,7/13/2013 0:00:00 AM,,8,8,7/13/2013 0:00:00 AM,8,"Xanomeline Low Dose","Xan_Lo",1,69,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",7/7/2013 0:00:00 AM,2,7/6/2013 0:00:00 AM
"01-716-1024",1,"CDISCPILOT01","ADAE","716","1024","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,,8/20/2012 0:00:00 AM,,43,43,9/27/2012 0:00:00 AM,81,"Placebo","Pbo",0,87,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",1/20/2013 0:00:00 AM,196,7/9/2012 0:00:00 AM
"01-716-1024",2,"CDISCPILOT01","ADAE","716","1024","VERBATIM_1552","NASOPHARYNGITIS","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,,,,,,,8/20/2012 0:00:00 AM,,43,43,9/27/2012 0:00:00 AM,81,"Placebo","Pbo",0,87,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0709","HLT_0036","COLD SYMPTOMS",1/20/2013 0:00:00 AM,196,7/9/2012 0:00:00 AM
"01-716-1024",3,"CDISCPILOT01","ADAE","716","1024","VERBATIM_0087","EMPHYSEMA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,,12/16/2012 0:00:00 AM,,161,161,,,"Placebo","Pbo",0,87,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0221","HLT_0698","EMPHYSEMA",1/20/2013 0:00:00 AM,196,7/9/2012 0:00:00 AM
"01-716-1026",1,"CDISCPILOT01","ADAE","716","1026","VERBATIM_1115","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,4/17/2014 0:00:00 AM,,16,16,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1026",2,"CDISCPILOT01","ADAE","716","1026","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,4/17/2014 0:00:00 AM,,16,16,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1026",3,"CDISCPILOT01","ADAE","716","1026","VERBATIM_1077","ELECTROCARDIOGRAM T WAVE INVERSION","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,4/18/2014 0:00:00 AM,,17,17,7/31/2014 0:00:00 AM,121,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0130","HLT_0289","T WAVE INVERTED",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1026",4,"CDISCPILOT01","ADAE","716","1026","VERBATIM_1034","EAR INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,7/16/2014 0:00:00 AM,,106,106,7/25/2014 0:00:00 AM,115,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0760","HLT_0757","EAR INFECTION",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1026",5,"CDISCPILOT01","ADAE","716","1026","VERBATIM_1711","ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,7/31/2014 0:00:00 AM,,121,121,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0030","HLT_0037","T WAVE FLATTENING OF",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1026",6,"CDISCPILOT01","ADAE","716","1026","VERBATIM_1077","ELECTROCARDIOGRAM T WAVE INVERSION","INVESTIGATIONS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,4/18/2014 0:00:00 AM,,17,17,7/31/2014 0:00:00 AM,121,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0130","HLT_0289","T WAVE INVERTED",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1026",7,"CDISCPILOT01","ADAE","716","1026","VERBATIM_1034","EAR INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,8/15/2014 0:00:00 AM,,136,136,8/27/2014 0:00:00 AM,148,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0760","HLT_0757","EAR INFECTION",10/16/2014 0:00:00 AM,198,4/2/2014 0:00:00 AM
"01-716-1044",1,"CDISCPILOT01","ADAE","716","1044","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,5/21/2013 0:00:00 AM,,25,25,5/26/2013 0:00:00 AM,30,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",11/3/2013 0:00:00 AM,191,4/27/2013 0:00:00 AM
"01-716-1044",2,"CDISCPILOT01","ADAE","716","1044","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/21/2013 0:00:00 AM,,25,25,5/26/2013 0:00:00 AM,30,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",11/3/2013 0:00:00 AM,191,4/27/2013 0:00:00 AM
"01-716-1044",3,"CDISCPILOT01","ADAE","716","1044","VERBATIM_1524","CONFUSIONAL STATE","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,10/15/2013 0:00:00 AM,,172,172,,,"Placebo","Pbo",0,74,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0329","HLT_0642","CONFUSION",11/3/2013 0:00:00 AM,191,4/27/2013 0:00:00 AM
"01-716-1063",1,"CDISCPILOT01","ADAE","716","1063","VERBATIM_0056","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","N","Y",,,1,,,,,5/9/2014 0:00:00 AM,,366,366,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1063",2,"CDISCPILOT01","ADAE","716","1063","VERBATIM_0885","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,7/1/2013 0:00:00 AM,,54,54,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","TIREDNESS",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1063",3,"CDISCPILOT01","ADAE","716","1063","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,7/4/2013 0:00:00 AM,,57,57,7/28/2013 0:00:00 AM,81,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1063",4,"CDISCPILOT01","ADAE","716","1063","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,7/4/2013 0:00:00 AM,,57,57,7/28/2013 0:00:00 AM,81,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1063",5,"CDISCPILOT01","ADAE","716","1063","VERBATIM_0749","RESTLESSNESS","PSYCHIATRIC DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,,7/28/2013 0:00:00 AM,,81,81,7/31/2013 0:00:00 AM,84,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0510","HLT_0427","RESTLESSNESS",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1063",6,"CDISCPILOT01","ADAE","716","1063","VERBATIM_1091","LETHARGY","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,,7/31/2013 0:00:00 AM,,84,84,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0448","HLT_0027","LETHARGY",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1063",7,"CDISCPILOT01","ADAE","716","1063","VERBATIM_0749","RESTLESSNESS","PSYCHIATRIC DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,,7/28/2013 0:00:00 AM,,81,81,7/31/2013 0:00:00 AM,84,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0510","HLT_0427","RESTLESSNESS",8/25/2013 0:00:00 AM,109,5/9/2013 0:00:00 AM
"01-716-1071",1,"CDISCPILOT01","ADAE","716","1071","VERBATIM_1251","HYPERSOMNIA","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,7/13/2013 0:00:00 AM,,36,36,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0628","HLT_0231","SLEEP EXCESSIVE",8/1/2013 0:00:00 AM,55,6/8/2013 0:00:00 AM
"01-716-1071",2,"CDISCPILOT01","ADAE","716","1071","VERBATIM_1745","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,7/13/2013 0:00:00 AM,,36,36,,,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","TIREDNESS",8/1/2013 0:00:00 AM,55,6/8/2013 0:00:00 AM
"01-716-1071",3,"CDISCPILOT01","ADAE","716","1071","VERBATIM_1714","SYNCOPE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,,7/31/2013 0:00:00 AM,,54,54,7/31/2013 0:00:00 AM,54,"Xanomeline High Dose","Xan_Hi",2,78,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0310","HLT_0440","SYNCOPE",8/1/2013 0:00:00 AM,55,6/8/2013 0:00:00 AM
"01-716-1094",1,"CDISCPILOT01","ADAE","716","1094","VERBATIM_0096","ATRIAL FLUTTER","CARDIAC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,1/19/2013 0:00:00 AM,,32,32,,,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0627","HLT_0477","ATRIAL FLUTTER",1/24/2013 0:00:00 AM,37,12/19/2012 0:00:00 AM
"01-716-1094",2,"CDISCPILOT01","ADAE","716","1094","VERBATIM_1728","BUNDLE BRANCH BLOCK RIGHT","CARDIAC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,1/19/2013 0:00:00 AM,,32,32,,,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0597","HLT_0751","INCOMPLETE RIGHT BUNDLE BRANCH BLOCK",1/24/2013 0:00:00 AM,37,12/19/2012 0:00:00 AM
"01-716-1094",3,"CDISCPILOT01","ADAE","716","1094","VERBATIM_1723","VENTRICULAR SEPTAL DEFECT","CONGENITAL, FAMILIAL AND GENETIC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,1/19/2013 0:00:00 AM,,32,32,,,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0747","HLT_0589","VENTRICULAR SEPTAL DEFECT",1/24/2013 0:00:00 AM,37,12/19/2012 0:00:00 AM
"01-716-1103",1,"CDISCPILOT01","ADAE","716","1103","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,7/9/2014 0:00:00 AM,,112,112,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",9/20/2014 0:00:00 AM,185,3/20/2014 0:00:00 AM
"01-716-1103",2,"CDISCPILOT01","ADAE","716","1103","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,7/9/2014 0:00:00 AM,,112,112,7/16/2014 0:00:00 AM,119,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",9/20/2014 0:00:00 AM,185,3/20/2014 0:00:00 AM
"01-716-1103",3,"CDISCPILOT01","ADAE","716","1103","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,7/9/2014 0:00:00 AM,,112,112,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/20/2014 0:00:00 AM,185,3/20/2014 0:00:00 AM
"01-716-1103",4,"CDISCPILOT01","ADAE","716","1103","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","SEVERE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,8/17/2014 0:00:00 AM,,151,151,8/24/2014 0:00:00 AM,158,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",9/20/2014 0:00:00 AM,185,3/20/2014 0:00:00 AM
"01-716-1103",5,"CDISCPILOT01","ADAE","716","1103","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","SEVERE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,8/17/2014 0:00:00 AM,,151,151,8/24/2014 0:00:00 AM,158,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",9/20/2014 0:00:00 AM,185,3/20/2014 0:00:00 AM
"01-716-1108",1,"CDISCPILOT01","ADAE","716","1108","VERBATIM_1095","ELECTROCARDIOGRAM ST SEGMENT DEPRESSION","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,4/12/2013 0:00:00 AM,,60,60,,,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0220","HLT_0610","ST SEGMENT DEPRESSED",8/10/2013 0:00:00 AM,180,2/12/2013 0:00:00 AM
"01-716-1108",2,"CDISCPILOT01","ADAE","716","1108","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,5/1/2013 0:00:00 AM,,79,79,,,"Placebo","Pbo",0,86,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",8/10/2013 0:00:00 AM,180,2/12/2013 0:00:00 AM
"01-716-1151",1,"CDISCPILOT01","ADAE","716","1151","VERBATIM_0742","MALIGNANT FIBROUS HISTIOCYTOMA","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,2/19/2013 0:00:00 AM,,19,19,3/22/2013 0:00:00 AM,50,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","Y","N","N","N","N","N","HLGT_0507","HLT_0245","MALIGNANT FIBROUS HISTIOCYTOMA",5/11/2013 0:00:00 AM,100,2/1/2013 0:00:00 AM
"01-716-1151",2,"CDISCPILOT01","ADAE","716","1151","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,3/15/2013 0:00:00 AM,,43,43,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",5/11/2013 0:00:00 AM,100,2/1/2013 0:00:00 AM
"01-716-1151",3,"CDISCPILOT01","ADAE","716","1151","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,3/15/2013 0:00:00 AM,,43,43,,,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",5/11/2013 0:00:00 AM,100,2/1/2013 0:00:00 AM
"01-716-1151",4,"CDISCPILOT01","ADAE","716","1151","VERBATIM_0742","MALIGNANT FIBROUS HISTIOCYTOMA","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","MILD","N",0,"NONE","Y","Y","Y",,,,,,,,2/19/2013 0:00:00 AM,,19,19,3/22/2013 0:00:00 AM,50,"Xanomeline Low Dose","Xan_Lo",1,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","Y","N","N","N","N","N","HLGT_0507","HLT_0245","MALIGNANT FIBROUS HISTIOCYTOMA",5/11/2013 0:00:00 AM,100,2/1/2013 0:00:00 AM
"01-716-1157",1,"CDISCPILOT01","ADAE","716","1157","VERBATIM_1539","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,10/17/2013 0:00:00 AM,,16,16,11/4/2013 0:00:00 AM,34,"Xanomeline Low Dose","Xan_Lo",1,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",4/4/2014 0:00:00 AM,185,10/2/2013 0:00:00 AM
"01-716-1157",2,"CDISCPILOT01","ADAE","716","1157","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,10/25/2013 0:00:00 AM,,24,24,,,"Xanomeline Low Dose","Xan_Lo",1,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",4/4/2014 0:00:00 AM,185,10/2/2013 0:00:00 AM
"01-716-1157",3,"CDISCPILOT01","ADAE","716","1157","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,10/25/2013 0:00:00 AM,,24,24,,,"Xanomeline Low Dose","Xan_Lo",1,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",4/4/2014 0:00:00 AM,185,10/2/2013 0:00:00 AM
"01-716-1157",4,"CDISCPILOT01","ADAE","716","1157","VERBATIM_1539","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,10/17/2013 0:00:00 AM,,16,16,11/4/2013 0:00:00 AM,34,"Xanomeline Low Dose","Xan_Lo",1,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",4/4/2014 0:00:00 AM,185,10/2/2013 0:00:00 AM
"01-716-1160",1,"CDISCPILOT01","ADAE","716","1160","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/9/2013 0:00:00 AM,,35,35,,,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",10/11/2013 0:00:00 AM,190,4/5/2013 0:00:00 AM
"01-716-1160",2,"CDISCPILOT01","ADAE","716","1160","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,5/9/2013 0:00:00 AM,,35,35,,,"Placebo","Pbo",0,83,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",10/11/2013 0:00:00 AM,190,4/5/2013 0:00:00 AM
"01-716-1167",1,"CDISCPILOT01","ADAE","716","1167","VERBATIM_0658","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,1,11/17/2012 0:00:00 AM,,41,41,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCH",4/12/2013 0:00:00 AM,187,10/8/2012 0:00:00 AM
"01-716-1167",2,"CDISCPILOT01","ADAE","716","1167","VERBATIM_1412","SWELLING","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,11/17/2012 0:00:00 AM,,41,41,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0484","HLT_0658","SWELLING",4/12/2013 0:00:00 AM,187,10/8/2012 0:00:00 AM
"01-716-1167",3,"CDISCPILOT01","ADAE","716","1167","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,1,,,,1,12/3/2012 0:00:00 AM,,57,57,,,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",4/12/2013 0:00:00 AM,187,10/8/2012 0:00:00 AM
"01-716-1167",4,"CDISCPILOT01","ADAE","716","1167","VERBATIM_1451","HYPERSENSITIVITY","IMMUNE SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,3/10/2013 0:00:00 AM,,154,154,4/10/2013 0:00:00 AM,185,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0765","HLT_0473","ALLERGY",4/12/2013 0:00:00 AM,187,10/8/2012 0:00:00 AM
"01-716-1167",5,"CDISCPILOT01","ADAE","716","1167","VERBATIM_1451","HYPERSENSITIVITY","IMMUNE SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,3/10/2013 0:00:00 AM,,154,154,4/10/2013 0:00:00 AM,185,"Xanomeline Low Dose","Xan_Lo",1,68,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0765","HLT_0473","ALLERGY",4/12/2013 0:00:00 AM,187,10/8/2012 0:00:00 AM
"01-716-1177",1,"CDISCPILOT01","ADAE","716","1177","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"N","N",,,,,,,1,8/24/2014 0:00:00 AM,,-9,-8,,,"Placebo","Pbo",0,72,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",3/5/2015 0:00:00 AM,185,9/2/2014 0:00:00 AM
"01-716-1189",1,"CDISCPILOT01","ADAE","716","1189","VERBATIM_0460","HALLUCINATION","PSYCHIATRIC DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",1,1,1,,,,,11/24/2012 0:00:00 AM,,47,47,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0649","HLT_0026","HALLUCINATION",2/27/2013 0:00:00 AM,142,10/9/2012 0:00:00 AM
"01-716-1189",2,"CDISCPILOT01","ADAE","716","1189","VERBATIM_1218","DELUSION","PSYCHIATRIC DISORDERS","MODERATE","N",0,"NONE","Y","Y","Y",,,1,,,,,11/24/2012 0:00:00 AM,,47,47,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0565","HLT_0198","DELUSIONS",2/27/2013 0:00:00 AM,142,10/9/2012 0:00:00 AM
"01-716-1189",3,"CDISCPILOT01","ADAE","716","1189","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,1,1/5/2013 0:00:00 AM,,89,89,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/27/2013 0:00:00 AM,142,10/9/2012 0:00:00 AM
"01-716-1189",4,"CDISCPILOT01","ADAE","716","1189","VERBATIM_0154","PROSTATE CANCER","NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)","SEVERE","N",0,"NONE","Y","Y","Y",,1,1,,,,,2/7/2013 0:00:00 AM,,122,122,,,"Xanomeline High Dose","Xan_Hi",2,81,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","Y","N","N","N","N","N","HLGT_0190","HLT_0412","PROSTATE CANCER",2/27/2013 0:00:00 AM,142,10/9/2012 0:00:00 AM
"01-716-1229",1,"CDISCPILOT01","ADAE","716","1229","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,2/20/2013 0:00:00 AM,,1,1,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",3/31/2013 0:00:00 AM,40,2/20/2013 0:00:00 AM
"01-716-1229",2,"CDISCPILOT01","ADAE","716","1229","VERBATIM_1044","BLOOD CHOLESTEROL INCREASED","INVESTIGATIONS","MILD","N",0,"NONE","Y","Y","Y",,1,1,,,,,3/6/2013 0:00:00 AM,,15,15,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0430","HLT_0210","HIGH CHOLESTEROL",3/31/2013 0:00:00 AM,40,2/20/2013 0:00:00 AM
"01-716-1298",1,"CDISCPILOT01","ADAE","716","1298","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",1,1,1,,,,1,4/22/2013 0:00:00 AM,,15,15,7/6/2013 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/28/2013 0:00:00 AM,82,4/8/2013 0:00:00 AM
"01-716-1298",2,"CDISCPILOT01","ADAE","716","1298","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,4/22/2013 0:00:00 AM,,15,15,7/6/2013 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/28/2013 0:00:00 AM,82,4/8/2013 0:00:00 AM
"01-716-1298",3,"CDISCPILOT01","ADAE","716","1298","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,6/8/2013 0:00:00 AM,,62,62,7/6/2013 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",6/28/2013 0:00:00 AM,82,4/8/2013 0:00:00 AM
"01-716-1298",4,"CDISCPILOT01","ADAE","716","1298","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/22/2013 0:00:00 AM,,15,15,7/6/2013 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/28/2013 0:00:00 AM,82,4/8/2013 0:00:00 AM
"01-716-1298",5,"CDISCPILOT01","ADAE","716","1298","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,4/22/2013 0:00:00 AM,,15,15,7/6/2013 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/28/2013 0:00:00 AM,82,4/8/2013 0:00:00 AM
"01-716-1298",6,"CDISCPILOT01","ADAE","716","1298","VERBATIM_1655","BLISTER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,6/8/2013 0:00:00 AM,,62,62,7/6/2013 0:00:00 AM,90,"Xanomeline Low Dose","Xan_Lo",1,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0267","HLT_0752","BLISTERS",6/28/2013 0:00:00 AM,82,4/8/2013 0:00:00 AM
"01-716-1308",1,"CDISCPILOT01","ADAE","716","1308","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,9/20/2013 0:00:00 AM,,24,24,,,"Placebo","Pbo",0,76,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",10/7/2013 0:00:00 AM,41,8/28/2013 0:00:00 AM
"01-716-1311",1,"CDISCPILOT01","ADAE","716","1311","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/28/2014 0:00:00 AM,,15,15,9/22/2014 0:00:00 AM,132,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/21/2014 0:00:00 AM,131,5/14/2014 0:00:00 AM
"01-716-1311",2,"CDISCPILOT01","ADAE","716","1311","VERBATIM_0554","ABDOMINAL PAIN","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,7/22/2014 0:00:00 AM,,70,70,8/2/2014 0:00:00 AM,81,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0419","HLT_0217","ABDOMINAL PAIN",9/21/2014 0:00:00 AM,131,5/14/2014 0:00:00 AM
"01-716-1311",3,"CDISCPILOT01","ADAE","716","1311","VERBATIM_1041","ULCER","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,8/2/2014 0:00:00 AM,,81,81,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0245","HLT_0040","ULCER",9/21/2014 0:00:00 AM,131,5/14/2014 0:00:00 AM
"01-716-1311",4,"CDISCPILOT01","ADAE","716","1311","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/28/2014 0:00:00 AM,,15,15,9/22/2014 0:00:00 AM,132,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",9/21/2014 0:00:00 AM,131,5/14/2014 0:00:00 AM
"01-716-1364",1,"CDISCPILOT01","ADAE","716","1364","VERBATIM_0658","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,8/18/2013 0:00:00 AM,,46,46,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCH",1/9/2014 0:00:00 AM,190,7/4/2013 0:00:00 AM
"01-716-1364",2,"CDISCPILOT01","ADAE","716","1364","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,9/2/2013 0:00:00 AM,,61,61,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",1/9/2014 0:00:00 AM,190,7/4/2013 0:00:00 AM
"01-716-1373",1,"CDISCPILOT01","ADAE","716","1373","VERBATIM_0384","COGNITIVE DISORDER","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE","Y","Y","Y",1,1,1,,,,,12/14/2012 0:00:00 AM,,1,1,,,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0506","HLT_0265","COGNITIVE IMPAIRMENT",2/27/2013 0:00:00 AM,76,12/14/2012 0:00:00 AM
"01-716-1373",2,"CDISCPILOT01","ADAE","716","1373","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,12/15/2012 0:00:00 AM,,2,2,,,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",2/27/2013 0:00:00 AM,76,12/14/2012 0:00:00 AM
"01-716-1418",1,"CDISCPILOT01","ADAE","716","1418","VERBATIM_1341","URTICARIA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/5/2013 0:00:00 AM,,1,1,5/7/2013 0:00:00 AM,3,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0705","HLT_0420","WELTS",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",2,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,5/5/2013 0:00:00 AM,,1,1,,,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",3,"CDISCPILOT01","ADAE","716","1418","VERBATIM_1341","URTICARIA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/5/2013 0:00:00 AM,,1,1,5/7/2013 0:00:00 AM,3,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0705","HLT_0420","WELTS",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",4,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,5/7/2013 0:00:00 AM,,3,3,,,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",5,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,7/1/2013 0:00:00 AM,"D",58,58,9/26/2013 0:00:00 AM,145,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",6,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0911","VISION BLURRED","EYE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,7/1/2013 0:00:00 AM,"D",58,58,10/4/2013 0:00:00 AM,153,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0598","HLT_0120","BLURRED VISION",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",7,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,7/1/2013 0:00:00 AM,"D",58,58,9/26/2013 0:00:00 AM,145,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",8,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0911","VISION BLURRED","EYE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,7/1/2013 0:00:00 AM,"D",58,58,10/4/2013 0:00:00 AM,153,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0598","HLT_0120","BLURRED VISION",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",9,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,9/26/2013 0:00:00 AM,,145,145,11/11/2013 0:00:00 AM,191,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1418",10,"CDISCPILOT01","ADAE","716","1418","VERBATIM_0301","HEADACHE","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,9/26/2013 0:00:00 AM,,145,145,11/11/2013 0:00:00 AM,191,"Xanomeline High Dose","Xan_Hi",2,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0344","HLT_0064","HEADACHE",11/20/2013 0:00:00 AM,200,5/5/2013 0:00:00 AM
"01-716-1441",1,"CDISCPILOT01","ADAE","716","1441","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/11/2014 0:00:00 AM,,110,110,,,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",7/22/2014 0:00:00 AM,182,1/22/2014 0:00:00 AM
"01-716-1447",1,"CDISCPILOT01","ADAE","716","1447","VERBATIM_0056","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,1/1/2014 0:00:00 AM,,17,17,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",6/17/2014 0:00:00 AM,184,12/16/2013 0:00:00 AM
"01-716-1447",2,"CDISCPILOT01","ADAE","716","1447","VERBATIM_0300","ERYTHEMA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,1/14/2014 0:00:00 AM,,30,30,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0192","HLT_0284","ERYTHEMA",6/17/2014 0:00:00 AM,184,12/16/2013 0:00:00 AM
"01-716-1447",3,"CDISCPILOT01","ADAE","716","1447","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,1/14/2014 0:00:00 AM,,30,30,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",6/17/2014 0:00:00 AM,184,12/16/2013 0:00:00 AM
"01-716-1447",4,"CDISCPILOT01","ADAE","716","1447","VERBATIM_0366","ELECTROCARDIOGRAM T WAVE INVERSION","INVESTIGATIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,3/14/2014 0:00:00 AM,,89,89,,,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0130","HLT_0289","T WAVE INVERTED",6/17/2014 0:00:00 AM,184,12/16/2013 0:00:00 AM
"01-716-1447",5,"CDISCPILOT01","ADAE","716","1447","VERBATIM_0517","CHEST PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,4/5/2014 0:00:00 AM,,111,111,4/9/2014 0:00:00 AM,115,"Xanomeline High Dose","Xan_Hi",2,72,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0195","HLT_0717","CHEST PAIN",6/17/2014 0:00:00 AM,184,12/16/2013 0:00:00 AM
"01-717-1004",1,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1678","ENURESIS","RENAL AND URINARY DISORDERS","MODERATE","N",0,"POSSIBLE",,"N","N",,,,,,,,5/1/2013 0:00:00 AM,"D",-258,-257,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0623","HLT_0107","BED WETTING",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",2,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1666","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,,1/13/2014 0:00:00 AM,,-1,0,2/10/2014 0:00:00 AM,28,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","SOFT STOOLS",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",3,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1357","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,1/15/2014 0:00:00 AM,,2,2,2/18/2014 0:00:00 AM,36,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",4,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0214","RHINORRHOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,1/15/2014 0:00:00 AM,,2,2,2/8/2014 0:00:00 AM,26,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0460","HLT_0635","RUNNY NOSE",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",5,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,1/15/2014 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",6,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,1/15/2014 0:00:00 AM,,2,2,2/9/2014 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",7,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1280","ANXIETY","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,1/15/2014 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0570","HLT_0559","ANXIETY",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",8,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0793","IRRITABILITY","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,1/15/2014 0:00:00 AM,,2,2,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0461","HLT_0627","IRRITABILITY",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",9,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0214","RHINORRHOEA","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,1/15/2014 0:00:00 AM,,2,2,2/8/2014 0:00:00 AM,26,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0460","HLT_0635","RUNNY NOSE",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",10,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1666","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE",,"N","N",,,,,,,,1/13/2014 0:00:00 AM,,-1,0,2/10/2014 0:00:00 AM,28,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","SOFT STOOLS",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",11,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,1/15/2014 0:00:00 AM,,2,2,2/9/2014 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",12,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1357","COUGH","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,1/15/2014 0:00:00 AM,,2,2,2/18/2014 0:00:00 AM,36,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0280","HLT_0701","COUGH",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",13,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,3/9/2014 0:00:00 AM,,55,55,3/15/2014 0:00:00 AM,61,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",14,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,3/9/2014 0:00:00 AM,,55,55,3/15/2014 0:00:00 AM,61,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",15,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,4/8/2014 0:00:00 AM,,85,85,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",16,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/21/2014 0:00:00 AM,,98,98,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",17,"CDISCPILOT01","ADAE","717","1004","VERBATIM_1583","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,5/21/2014 0:00:00 AM,,128,128,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","BACK PAIN",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",18,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0942","WOUND","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,,6/3/2014 0:00:00 AM,,141,141,6/10/2014 0:00:00 AM,148,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0540","HLT_0542","WOUND NOS",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1004",19,"CDISCPILOT01","ADAE","717","1004","VERBATIM_0942","WOUND","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,,6/3/2014 0:00:00 AM,,141,141,6/10/2014 0:00:00 AM,148,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0540","HLT_0542","WOUND NOS",7/16/2014 0:00:00 AM,184,1/14/2014 0:00:00 AM
"01-717-1109",1,"CDISCPILOT01","ADAE","717","1109","VERBATIM_0156","INCREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,1/29/2014 0:00:00 AM,,3,3,7/16/2014 0:00:00 AM,171,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0769","HLT_0566","INCREASED APPETITE",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",2,"CDISCPILOT01","ADAE","717","1109","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,2/15/2014 0:00:00 AM,,20,20,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",3,"CDISCPILOT01","ADAE","717","1109","VERBATIM_0895","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,2/15/2014 0:00:00 AM,,20,20,2/17/2014 0:00:00 AM,22,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","SWEATING INCREASED",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",4,"CDISCPILOT01","ADAE","717","1109","VERBATIM_1524","CONFUSIONAL STATE","PSYCHIATRIC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,2/20/2014 0:00:00 AM,,25,25,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0329","HLT_0642","CONFUSION",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",5,"CDISCPILOT01","ADAE","717","1109","VERBATIM_0377","INSOMNIA","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,2/22/2014 0:00:00 AM,,27,27,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0469","HLT_0297","INSOMNIA",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",6,"CDISCPILOT01","ADAE","717","1109","VERBATIM_0990","PRURITUS GENERALISED","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,3/4/2014 0:00:00 AM,,37,37,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0689","HLT_0123","GENERALIZED PRURITUS",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",7,"CDISCPILOT01","ADAE","717","1109","VERBATIM_0760","VENTRICULAR EXTRASYSTOLES","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/18/2014 0:00:00 AM,,82,82,,,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0594","HLT_0050","PREMATURE VENTRICULAR CONTRACTIONS",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1109",8,"CDISCPILOT01","ADAE","717","1109","VERBATIM_0156","INCREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,1/29/2014 0:00:00 AM,,3,3,7/16/2014 0:00:00 AM,171,"Xanomeline High Dose","Xan_Hi",2,84,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0769","HLT_0566","INCREASED APPETITE",7/28/2014 0:00:00 AM,183,1/27/2014 0:00:00 AM
"01-717-1174",1,"CDISCPILOT01","ADAE","717","1174","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,1/26/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/24/2013 0:00:00 AM,184,1/22/2013 0:00:00 AM
"01-717-1174",2,"CDISCPILOT01","ADAE","717","1174","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,2/3/2013 0:00:00 AM,,13,13,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/24/2013 0:00:00 AM,184,1/22/2013 0:00:00 AM
"01-717-1174",3,"CDISCPILOT01","ADAE","717","1174","VERBATIM_0377","INSOMNIA","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,4/17/2013 0:00:00 AM,,86,86,4/19/2013 0:00:00 AM,88,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0469","HLT_0297","INSOMNIA",7/24/2013 0:00:00 AM,184,1/22/2013 0:00:00 AM
"01-717-1174",4,"CDISCPILOT01","ADAE","717","1174","VERBATIM_0426","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","SEVERE","N",0,"REMOTE",,"Y","Y",,,1,,,,1,4/25/2013 0:00:00 AM,,94,94,4/26/2013 0:00:00 AM,95,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",7/24/2013 0:00:00 AM,184,1/22/2013 0:00:00 AM
"01-717-1174",5,"CDISCPILOT01","ADAE","717","1174","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,1/26/2013 0:00:00 AM,,5,5,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",7/24/2013 0:00:00 AM,184,1/22/2013 0:00:00 AM
"01-717-1174",6,"CDISCPILOT01","ADAE","717","1174","VERBATIM_0216","PRURITUS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,2/3/2013 0:00:00 AM,,13,13,,,"Xanomeline High Dose","Xan_Hi",2,73,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0695","HLT_0778","ITCHING",7/24/2013 0:00:00 AM,184,1/22/2013 0:00:00 AM
"01-717-1201",1,"CDISCPILOT01","ADAE","717","1201","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,12/19/2013 0:00:00 AM,,1,1,,,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",2/21/2014 0:00:00 AM,65,12/19/2013 0:00:00 AM
"01-717-1201",2,"CDISCPILOT01","ADAE","717","1201","VERBATIM_1197","ALOPECIA","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,1/15/2014 0:00:00 AM,,28,28,,,"Placebo","Pbo",0,85,">80",3,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0234","HLT_0077","HAIR LOSS",2/21/2014 0:00:00 AM,65,12/19/2013 0:00:00 AM
"01-717-1344",1,"CDISCPILOT01","ADAE","717","1344","VERBATIM_1164","NASAL CONGESTION","RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",1,1,1,,,,,2/1/2014 0:00:00 AM,,22,22,2/6/2014 0:00:00 AM,27,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0549","HLT_0118","NOSE CONGESTION",3/14/2014 0:00:00 AM,63,1/11/2014 0:00:00 AM
"01-717-1344",2,"CDISCPILOT01","ADAE","717","1344","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,2/1/2014 0:00:00 AM,,22,22,2/18/2014 0:00:00 AM,39,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",3/14/2014 0:00:00 AM,63,1/11/2014 0:00:00 AM
"01-717-1344",3,"CDISCPILOT01","ADAE","717","1344","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/1/2014 0:00:00 AM,,22,22,2/18/2014 0:00:00 AM,39,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",3/14/2014 0:00:00 AM,63,1/11/2014 0:00:00 AM
"01-717-1344",4,"CDISCPILOT01","ADAE","717","1344","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,2/28/2014 0:00:00 AM,,49,49,3/1/2014 0:00:00 AM,50,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",3/14/2014 0:00:00 AM,63,1/11/2014 0:00:00 AM
"01-717-1344",5,"CDISCPILOT01","ADAE","717","1344","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,1,,,,,2/28/2014 0:00:00 AM,,49,49,3/1/2014 0:00:00 AM,50,"Placebo","Pbo",0,64,"<65",1,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",3/14/2014 0:00:00 AM,63,1/11/2014 0:00:00 AM
"01-717-1357",1,"CDISCPILOT01","ADAE","717","1357","VERBATIM_0529","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,,4/1/1994 0:00:00 AM,"D",-6970,-6969,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",2,"CDISCPILOT01","ADAE","717","1357","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,5/23/2013 0:00:00 AM,,23,23,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",3,"CDISCPILOT01","ADAE","717","1357","VERBATIM_0286","OEDEMA PERIPHERAL","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,5/29/2013 0:00:00 AM,,29,29,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0137","HLT_0661","ANKLE EDEMA",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",4,"CDISCPILOT01","ADAE","717","1357","VERBATIM_0707","APPLICATION SITE PERSPIRATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,6/11/2013 0:00:00 AM,,42,42,10/15/2013 0:00:00 AM,168,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0403","HLT_0283","APPLICATION SITE PERSPIRATION",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",5,"CDISCPILOT01","ADAE","717","1357","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/23/2013 0:00:00 AM,,23,23,,,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",6,"CDISCPILOT01","ADAE","717","1357","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,7/7/2013 0:00:00 AM,,68,68,7/8/2013 0:00:00 AM,69,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",7,"CDISCPILOT01","ADAE","717","1357","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,,7/22/2013 0:00:00 AM,,83,83,7/22/2013 0:00:00 AM,83,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",8,"CDISCPILOT01","ADAE","717","1357","VERBATIM_1533","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,8/10/2013 0:00:00 AM,,102,102,8/10/2013 0:00:00 AM,102,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","DIZZINESS",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1357",9,"CDISCPILOT01","ADAE","717","1357","VERBATIM_0707","APPLICATION SITE PERSPIRATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,6/11/2013 0:00:00 AM,,42,42,10/15/2013 0:00:00 AM,168,"Xanomeline High Dose","Xan_Hi",2,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0403","HLT_0283","APPLICATION SITE PERSPIRATION",10/14/2013 0:00:00 AM,167,5/1/2013 0:00:00 AM
"01-717-1446",1,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1480","ANXIETY","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,9/15/2013 0:00:00 AM,,15,15,9/16/2013 0:00:00 AM,16,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0570","HLT_0559","ANXIETY AGGRAVATED",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",2,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1480","ANXIETY","PSYCHIATRIC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,9/15/2013 0:00:00 AM,,15,15,9/16/2013 0:00:00 AM,16,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0570","HLT_0559","ANXIETY AGGRAVATED",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",3,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1630","SKIN IRRITATION","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,1,9/19/2013 0:00:00 AM,,19,19,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0384","HLT_0583","SKIN IRRITATION",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",4,"CDISCPILOT01","ADAE","717","1446","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,1,1,,,,,10/6/2013 0:00:00 AM,,36,36,3/3/2014 0:00:00 AM,184,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",5,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1706","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,1,,,,1,10/7/2013 0:00:00 AM,,37,37,10/11/2013 0:00:00 AM,41,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",6,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1706","RASH","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,1,10/7/2013 0:00:00 AM,,37,37,10/11/2013 0:00:00 AM,41,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0198","HLT_0762","RASH",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",7,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1240","PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,1,1,,,,,1/13/2014 0:00:00 AM,,135,135,1/14/2014 0:00:00 AM,136,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0478","HLT_0314","STINGING",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",8,"CDISCPILOT01","ADAE","717","1446","VERBATIM_1240","PAIN","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,,1/28/2014 0:00:00 AM,,150,150,,,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0478","HLT_0314","STINGING",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-717-1446",9,"CDISCPILOT01","ADAE","717","1446","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"REMOTE",,"Y","Y",,,,,,,,10/6/2013 0:00:00 AM,,36,36,3/3/2014 0:00:00 AM,184,"Xanomeline Low Dose","Xan_Lo",1,75,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",3/3/2014 0:00:00 AM,184,9/1/2013 0:00:00 AM
"01-718-1066",1,"CDISCPILOT01","ADAE","718","1066","VERBATIM_1714","SYNCOPE","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,7/16/2013 0:00:00 AM,,10,10,7/20/2013 0:00:00 AM,14,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0310","HLT_0440","SYNCOPE",7/16/2013 0:00:00 AM,10,7/7/2013 0:00:00 AM
"01-718-1066",2,"CDISCPILOT01","ADAE","718","1066","VERBATIM_0499","AGITATION","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","N","Y",,1,1,,,,,7/18/2013 0:00:00 AM,,12,12,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0170","HLT_0140","AGITATION",7/16/2013 0:00:00 AM,10,7/7/2013 0:00:00 AM
"01-718-1066",3,"CDISCPILOT01","ADAE","718","1066","VERBATIM_1714","SYNCOPE","NERVOUS SYSTEM DISORDERS","SEVERE","N",0,"POSSIBLE","Y","N","Y",,,,,,,,7/30/2013 0:00:00 AM,,24,24,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0310","HLT_0440","SYNCOPE",7/16/2013 0:00:00 AM,10,7/7/2013 0:00:00 AM
"01-718-1066",4,"CDISCPILOT01","ADAE","718","1066","VERBATIM_1651","INFLAMMATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"REMOTE","Y","N","Y",,1,1,,,,,7/30/2013 0:00:00 AM,,24,24,,,"Xanomeline Low Dose","Xan_Lo",1,79,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0004","HLT_0582","INFLAMMATION LOCALIZED",7/16/2013 0:00:00 AM,10,7/7/2013 0:00:00 AM
"01-718-1079",1,"CDISCPILOT01","ADAE","718","1079","VERBATIM_1524","CONFUSIONAL STATE","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,10/5/2012 0:00:00 AM,,17,17,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0329","HLT_0642","CONFUSION",10/31/2012 0:00:00 AM,43,9/19/2012 0:00:00 AM
"01-718-1079",2,"CDISCPILOT01","ADAE","718","1079","VERBATIM_1567","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,10/5/2012 0:00:00 AM,,17,17,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",10/31/2012 0:00:00 AM,43,9/19/2012 0:00:00 AM
"01-718-1079",3,"CDISCPILOT01","ADAE","718","1079","VERBATIM_1567","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","SEVERE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,10/5/2012 0:00:00 AM,,17,17,,,"Xanomeline Low Dose","Xan_Lo",1,67,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",10/31/2012 0:00:00 AM,43,9/19/2012 0:00:00 AM
"01-718-1101",1,"CDISCPILOT01","ADAE","718","1101","VERBATIM_0897","VOMITING","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,3/6/2013 0:00:00 AM,,18,18,3/6/2013 0:00:00 AM,18,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0350","HLT_0016","VOMITING",7/31/2013 0:00:00 AM,165,2/17/2013 0:00:00 AM
"01-718-1101",2,"CDISCPILOT01","ADAE","718","1101","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,4/13/2013 0:00:00 AM,,56,56,5/12/2013 0:00:00 AM,85,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",7/31/2013 0:00:00 AM,165,2/17/2013 0:00:00 AM
"01-718-1101",3,"CDISCPILOT01","ADAE","718","1101","VERBATIM_0149","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,4/14/2013 0:00:00 AM,,57,57,7/6/2013 0:00:00 AM,140,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",7/31/2013 0:00:00 AM,165,2/17/2013 0:00:00 AM
"01-718-1101",4,"CDISCPILOT01","ADAE","718","1101","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,4/13/2013 0:00:00 AM,,56,56,5/12/2013 0:00:00 AM,85,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",7/31/2013 0:00:00 AM,165,2/17/2013 0:00:00 AM
"01-718-1101",5,"CDISCPILOT01","ADAE","718","1101","VERBATIM_0706","MYOCARDIAL INFARCTION","CARDIAC DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,1,,,,,7/6/2013 0:00:00 AM,,140,140,,,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0688","HLT_0649","INFERIOR MYOCARDIAL INFARCTION",7/31/2013 0:00:00 AM,165,2/17/2013 0:00:00 AM
"01-718-1101",6,"CDISCPILOT01","ADAE","718","1101","VERBATIM_0149","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,4/14/2013 0:00:00 AM,,57,57,7/6/2013 0:00:00 AM,140,"Xanomeline High Dose","Xan_Hi",2,82,">80",3,"AFRICAN DESCENT (NEGRO, BLACK)",2,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","PERSPIRATION EXCESSIVE",7/31/2013 0:00:00 AM,165,2/17/2013 0:00:00 AM
"01-718-1139",1,"CDISCPILOT01","ADAE","718","1139","VERBATIM_0731","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,6/3/2013 0:00:00 AM,,16,16,7/16/2013 0:00:00 AM,59,"Placebo","Pbo",0,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","SLEEPINESS",11/17/2013 0:00:00 AM,183,5/19/2013 0:00:00 AM
"01-718-1139",2,"CDISCPILOT01","ADAE","718","1139","VERBATIM_0731","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,6/3/2013 0:00:00 AM,,16,16,7/16/2013 0:00:00 AM,59,"Placebo","Pbo",0,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","SLEEPINESS",11/17/2013 0:00:00 AM,183,5/19/2013 0:00:00 AM
"01-718-1139",3,"CDISCPILOT01","ADAE","718","1139","VERBATIM_1126","DIARRHOEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,11/16/2013 0:00:00 AM,,182,182,11/16/2013 0:00:00 AM,182,"Placebo","Pbo",0,77,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0588","HLT_0148","DIARRHEA",11/17/2013 0:00:00 AM,183,5/19/2013 0:00:00 AM
"01-718-1150",1,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0125","BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",1,1,1,,,,,2/16/2013 0:00:00 AM,,29,29,3/17/2013 0:00:00 AM,58,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0294","HLT_0640","BRADYCARDIA",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",2,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,3/6/2013 0:00:00 AM,,47,47,3/26/2013 0:00:00 AM,67,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",3,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0479","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,3/15/2013 0:00:00 AM,,56,56,3/15/2013 0:00:00 AM,56,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",4,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0125","BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/16/2013 0:00:00 AM,,29,29,3/17/2013 0:00:00 AM,58,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0294","HLT_0640","BRADYCARDIA",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",5,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0579","UPPER RESPIRATORY TRACT INFECTION","INFECTIONS AND INFESTATIONS","MODERATE","N",0,"NONE",,"Y","Y",,,,,,,,3/6/2013 0:00:00 AM,,47,47,3/26/2013 0:00:00 AM,67,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0489","HLT_0520","UPPER RESPIRATORY INFECTION",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",6,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0125","BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/10/2013 0:00:00 AM,,112,112,7/7/2013 0:00:00 AM,170,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0294","HLT_0640","BRADYCARDIA",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",7,"CDISCPILOT01","ADAE","718","1150","VERBATIM_1319","FOOD CRAVING","METABOLISM AND NUTRITION DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,6/9/2013 0:00:00 AM,,142,142,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0376","HLT_0754","CARBOHYDRATE CRAVING",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",8,"CDISCPILOT01","ADAE","718","1150","VERBATIM_1031","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,6/16/2013 0:00:00 AM,,149,149,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",9,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0125","BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"Y","Y",,,,,,,,5/10/2013 0:00:00 AM,,112,112,7/7/2013 0:00:00 AM,170,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0294","HLT_0640","BRADYCARDIA",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1150",10,"CDISCPILOT01","ADAE","718","1150","VERBATIM_0796","SINUS BRADYCARDIA","CARDIAC DISORDERS","MILD","N",0,"POSSIBLE",,"N","Y",,,1,,,,,7/31/2013 0:00:00 AM,,194,194,,,"Placebo","Pbo",0,73,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0500","HLT_0644","SINUS BRADYCARDIA",7/29/2013 0:00:00 AM,192,1/19/2013 0:00:00 AM
"01-718-1170",1,"CDISCPILOT01","ADAE","718","1170","VERBATIM_1049","DIZZINESS","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,10/7/2013 0:00:00 AM,,22,22,10/7/2013 0:00:00 AM,22,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0751","HLT_0619","LIGHTHEADEDNESS",10/12/2013 0:00:00 AM,27,9/16/2013 0:00:00 AM
"01-718-1170",2,"CDISCPILOT01","ADAE","718","1170","VERBATIM_0889","HYPERHIDROSIS","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,10/11/2013 0:00:00 AM,,26,26,10/12/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0005","HLT_0587","DIAPHORESIS",10/12/2013 0:00:00 AM,27,9/16/2013 0:00:00 AM
"01-718-1170",3,"CDISCPILOT01","ADAE","718","1170","VERBATIM_1174","BODY TEMPERATURE INCREASED","INVESTIGATIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,10/11/2013 0:00:00 AM,,26,26,10/12/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0351","HLT_0734","TEMPERATURE ELEVATION",10/12/2013 0:00:00 AM,27,9/16/2013 0:00:00 AM
"01-718-1170",4,"CDISCPILOT01","ADAE","718","1170","VERBATIM_0342","HYPERTENSION","VASCULAR DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,10/11/2013 0:00:00 AM,,26,26,10/12/2013 0:00:00 AM,27,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0476","HLT_0228","HYPERTENSION",10/12/2013 0:00:00 AM,27,9/16/2013 0:00:00 AM
"01-718-1170",5,"CDISCPILOT01","ADAE","718","1170","VERBATIM_1714","SYNCOPE","NERVOUS SYSTEM DISORDERS","SEVERE","Y",1,"PROBABLE","Y","Y","Y",,,1,1,1,1,,10/12/2013 0:00:00 AM,,27,27,10/13/2013 0:00:00 AM,28,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0310","HLT_0440","SYNCOPE",10/12/2013 0:00:00 AM,27,9/16/2013 0:00:00 AM
"01-718-1170",6,"CDISCPILOT01","ADAE","718","1170","VERBATIM_0258","AGITATION","PSYCHIATRIC DISORDERS","SEVERE","N",0,"POSSIBLE","Y","N","Y",,1,1,,,,,10/16/2013 0:00:00 AM,,31,31,,,"Xanomeline Low Dose","Xan_Lo",1,80,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0170","HLT_0140","INCREASED AGITATION",10/12/2013 0:00:00 AM,27,9/16/2013 0:00:00 AM
"01-718-1250",1,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0272","BALANCE DISORDER","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,10/9/2013 0:00:00 AM,,19,19,11/15/2013 0:00:00 AM,56,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0101","HLT_0541","UNSTEADINESS",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",2,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0992","FALL","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"REMOTE","Y","Y","Y",,1,1,,,,,10/9/2013 0:00:00 AM,,19,19,10/9/2013 0:00:00 AM,19,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0446","HLT_0168","FALL",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",3,"CDISCPILOT01","ADAE","718","1250","VERBATIM_1794","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MODERATE","N",0,"REMOTE","Y","Y","Y",,,1,,,,,10/15/2013 0:00:00 AM,,25,25,11/2/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISING OF FACE",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",4,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0272","BALANCE DISORDER","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/9/2013 0:00:00 AM,,19,19,11/15/2013 0:00:00 AM,56,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0101","HLT_0541","UNSTEADINESS",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",5,"CDISCPILOT01","ADAE","718","1250","VERBATIM_1794","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"REMOTE","Y","Y","Y",,,,,,,,10/15/2013 0:00:00 AM,,25,25,11/2/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISING OF FACE",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",6,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0272","BALANCE DISORDER","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,,,,,,10/9/2013 0:00:00 AM,,19,19,11/15/2013 0:00:00 AM,56,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0101","HLT_0541","UNSTEADINESS",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",7,"CDISCPILOT01","ADAE","718","1250","VERBATIM_1794","CONTUSION","INJURY, POISONING AND PROCEDURAL COMPLICATIONS","MILD","N",0,"REMOTE","Y","Y","Y",,,,,,,,10/15/2013 0:00:00 AM,,25,25,11/2/2013 0:00:00 AM,43,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0381","HLT_0713","BRUISING OF FACE",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",8,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0425","COORDINATION ABNORMAL","NERVOUS SYSTEM DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,,1,,,,,11/15/2013 0:00:00 AM,,56,56,11/15/2013 0:00:00 AM,56,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0015","HLT_0315","INCOORDINATION",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",9,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0414","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,1,1,,,,1,12/29/2013 0:00:00 AM,,100,100,2/19/2014 0:00:00 AM,152,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",10,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0414","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/29/2013 0:00:00 AM,,100,100,2/19/2014 0:00:00 AM,152,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1250",11,"CDISCPILOT01","ADAE","718","1250","VERBATIM_0414","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,12/29/2013 0:00:00 AM,,100,100,2/19/2014 0:00:00 AM,152,"Xanomeline Low Dose","Xan_Lo",1,82,">80",3,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/31/2014 0:00:00 AM,133,9/21/2013 0:00:00 AM
"01-718-1254",1,"CDISCPILOT01","ADAE","718","1254","VERBATIM_1282","ARTHRALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",1,1,1,,,,,7/13/2013 0:00:00 AM,,4,4,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0610","HLT_0375","PAIN IN HIP",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",2,"CDISCPILOT01","ADAE","718","1254","VERBATIM_0209","ARTHRALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,7/25/2013 0:00:00 AM,,16,16,7/25/2013 0:00:00 AM,16,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0610","HLT_0375","KNEE PAIN",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",3,"CDISCPILOT01","ADAE","718","1254","VERBATIM_0209","ARTHRALGIA","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,7/25/2013 0:00:00 AM,,16,16,7/25/2013 0:00:00 AM,16,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0610","HLT_0375","KNEE PAIN",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",4,"CDISCPILOT01","ADAE","718","1254","VERBATIM_1032","APPLICATION SITE DISCOLOURATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,8/13/2013 0:00:00 AM,,35,35,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0273","HLT_0121","APPLICATION SITE DISCOLORATION",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",5,"CDISCPILOT01","ADAE","718","1254","VERBATIM_0777","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,8/13/2013 0:00:00 AM,,35,35,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",6,"CDISCPILOT01","ADAE","718","1254","VERBATIM_0118","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,9/3/2013 0:00:00 AM,,56,56,9/19/2013 0:00:00 AM,72,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","SOMNOLENCE",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",7,"CDISCPILOT01","ADAE","718","1254","VERBATIM_0118","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,9/3/2013 0:00:00 AM,,56,56,9/19/2013 0:00:00 AM,72,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","SOMNOLENCE",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",8,"CDISCPILOT01","ADAE","718","1254","VERBATIM_1319","FOOD CRAVING","METABOLISM AND NUTRITION DISORDERS","MODERATE","N",0,,,"Y","Y",,1,1,,,,,10/31/2013 0:00:00 AM,,114,114,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0376","HLT_0754","CARBOHYDRATE CRAVING",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1254",9,"CDISCPILOT01","ADAE","718","1254","VERBATIM_1056","DYSPHAGIA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,,,"Y","Y",,1,1,,,,,10/31/2013 0:00:00 AM,,114,114,,,"Xanomeline Low Dose","Xan_Lo",1,78,"65-80",2,"HISPANIC (MEXICAN - AMERICAN, MEXICO, CENTRAL AND SOUTH AMERICA)",5,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0405","HLT_0563","SWALLOWING DIFFICULT",1/9/2014 0:00:00 AM,184,7/10/2013 0:00:00 AM
"01-718-1328",1,"CDISCPILOT01","ADAE","718","1328","VERBATIM_1195","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,3/23/2013 0:00:00 AM,,51,51,3/25/2013 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,86,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",4/18/2013 0:00:00 AM,77,2/1/2013 0:00:00 AM
"01-718-1328",2,"CDISCPILOT01","ADAE","718","1328","VERBATIM_0504","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,3/23/2013 0:00:00 AM,,51,51,3/25/2013 0:00:00 AM,53,"Xanomeline High Dose","Xan_Hi",2,86,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE BURNING",4/18/2013 0:00:00 AM,77,2/1/2013 0:00:00 AM
"01-718-1328",3,"CDISCPILOT01","ADAE","718","1328","VERBATIM_1406","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/2/2013 0:00:00 AM,,61,61,4/21/2013 0:00:00 AM,80,"Xanomeline High Dose","Xan_Hi",2,86,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",4/18/2013 0:00:00 AM,77,2/1/2013 0:00:00 AM
"01-718-1328",4,"CDISCPILOT01","ADAE","718","1328","VERBATIM_1406","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,4/2/2013 0:00:00 AM,,61,61,4/21/2013 0:00:00 AM,80,"Xanomeline High Dose","Xan_Hi",2,86,">80",3,"CAUCASIAN",1,"M","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",4/18/2013 0:00:00 AM,77,2/1/2013 0:00:00 AM
"01-718-1355",1,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0931","SKIN ULCER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",1,1,1,,,,1,3/8/2013 0:00:00 AM,,9,9,3/22/2013 0:00:00 AM,23,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0017","HLT_0005","SKIN EROSION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",2,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0931","SKIN ULCER","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,3/8/2013 0:00:00 AM,,9,9,3/22/2013 0:00:00 AM,23,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0017","HLT_0005","SKIN EROSION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",3,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0331","DERMATITIS ATOPIC","SKIN AND SUBCUTANEOUS TISSUE DISORDERS","MODERATE","N",0,"NONE",,"N","N",,,,,,,1,,,,,,,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0257","HLT_0480","ATOPIC DERMATITIS",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",4,"CDISCPILOT01","ADAE","718","1355","VERBATIM_1524","CONFUSIONAL STATE","PSYCHIATRIC DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,4/17/2013 0:00:00 AM,,49,49,,,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0329","HLT_0642","CONFUSION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",5,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0873","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,4/27/2013 0:00:00 AM,,59,59,4/27/2013 0:00:00 AM,59,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",6,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0306","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/12/2013 0:00:00 AM,,74,74,5/12/2013 0:00:00 AM,74,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",7,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0622","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/16/2013 0:00:00 AM,,78,78,5/16/2013 0:00:00 AM,78,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",8,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0404","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,5/20/2013 0:00:00 AM,,82,82,5/20/2013 0:00:00 AM,82,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",9,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0066","SOMNOLENCE","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"NONE",,"Y","Y",,1,1,,,,,5/25/2013 0:00:00 AM,,87,87,,,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0254","HLT_0160","SLEEPINESS",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",10,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0592","APPLICATION SITE REACTION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,6/23/2013 0:00:00 AM,,116,116,8/13/2013 0:00:00 AM,167,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0668","HLT_0339","APPLICATION SITE REACTION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",11,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0592","APPLICATION SITE REACTION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,6/23/2013 0:00:00 AM,,116,116,8/13/2013 0:00:00 AM,167,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0668","HLT_0339","APPLICATION SITE REACTION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",12,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0342","HYPERTENSION","VASCULAR DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,8/15/2013 0:00:00 AM,,169,169,8/29/2013 0:00:00 AM,183,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0476","HLT_0228","HYPERTENSION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1355",13,"CDISCPILOT01","ADAE","718","1355","VERBATIM_0342","HYPERTENSION","VASCULAR DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,,,,,,,8/15/2013 0:00:00 AM,,169,169,8/29/2013 0:00:00 AM,183,"Placebo","Pbo",0,79,"65-80",2,"CAUCASIAN",1,"M","Y","Y","Y","Y","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0476","HLT_0228","HYPERTENSION",8/29/2013 0:00:00 AM,183,2/28/2013 0:00:00 AM
"01-718-1371",1,"CDISCPILOT01","ADAE","718","1371","VERBATIM_0555","FATIGUE","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"POSSIBLE","Y","Y","Y",1,1,1,,,,,5/9/2013 0:00:00 AM,,14,14,5/11/2013 0:00:00 AM,16,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0181","HLT_0043","FATIGUE",8/1/2013 0:00:00 AM,98,4/26/2013 0:00:00 AM
"01-718-1371",2,"CDISCPILOT01","ADAE","718","1371","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MILD","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,5/9/2013 0:00:00 AM,,14,14,5/11/2013 0:00:00 AM,16,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",8/1/2013 0:00:00 AM,98,4/26/2013 0:00:00 AM
"01-718-1371",3,"CDISCPILOT01","ADAE","718","1371","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE","Y","Y","Y",,,1,,,,1,5/24/2013 0:00:00 AM,,29,29,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",8/1/2013 0:00:00 AM,98,4/26/2013 0:00:00 AM
"01-718-1371",4,"CDISCPILOT01","ADAE","718","1371","VERBATIM_0245","PARTIAL SEIZURES WITH SECONDARY GENERALISATION","NERVOUS SYSTEM DISORDERS","SEVERE","Y",1,"NONE","Y","Y","Y",,1,1,1,1,1,,6/2/2013 0:00:00 AM,,38,38,6/5/2013 0:00:00 AM,41,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","Y","N","HLGT_0719","HLT_0603","PARTIAL SEIZURES WITH SECONDARY GENERALIZATION",8/1/2013 0:00:00 AM,98,4/26/2013 0:00:00 AM
"01-718-1371",5,"CDISCPILOT01","ADAE","718","1371","VERBATIM_0057","HALLUCINATION, VISUAL","PSYCHIATRIC DISORDERS","MODERATE","N",0,"POSSIBLE","Y","Y","Y",,1,1,,,,,6/2/2013 0:00:00 AM,,38,38,6/3/2013 0:00:00 AM,39,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0663","HLT_0369","VISUAL HALLUCINATIONS",8/1/2013 0:00:00 AM,98,4/26/2013 0:00:00 AM
"01-718-1371",6,"CDISCPILOT01","ADAE","718","1371","VERBATIM_1336","APPLICATION SITE IRRITATION","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE","Y","Y","Y",,,,,,,1,5/24/2013 0:00:00 AM,,29,29,,,"Xanomeline High Dose","Xan_Hi",2,69,"65-80",2,"CAUCASIAN",1,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0346","HLT_0061","APPLICATION SITE IRRITATION",8/1/2013 0:00:00 AM,98,4/26/2013 0:00:00 AM
"01-718-1427",1,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1583","BACK PAIN","MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS","MILD","N",0,"NONE",,"Y","Y",1,1,1,,,,,12/18/2012 0:00:00 AM,,2,2,12/18/2012 0:00:00 AM,2,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0508","HLT_0115","BACK PAIN",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",2,"CDISCPILOT01","ADAE","718","1427","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"REMOTE",,"Y","Y",,1,1,,,,,12/26/2012 0:00:00 AM,,10,10,12/26/2012 0:00:00 AM,10,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",3,"CDISCPILOT01","ADAE","718","1427","VERBATIM_0320","AMNESIA","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,1,1,,,,,1/1/2013 0:00:00 AM,,16,16,1/19/2013 0:00:00 AM,34,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0641","HLT_0501","SHORT-TERM MEMORY LOSS",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",4,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1111","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,1/3/2013 0:00:00 AM,,18,18,1/9/2013 0:00:00 AM,24,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",5,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1091","LETHARGY","NERVOUS SYSTEM DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,1,,,,,1/5/2013 0:00:00 AM,,20,20,1/5/2013 0:00:00 AM,20,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0448","HLT_0027","LETHARGY",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",6,"CDISCPILOT01","ADAE","718","1427","VERBATIM_0775","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,1/16/2013 0:00:00 AM,,31,31,1/16/2013 0:00:00 AM,31,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",7,"CDISCPILOT01","ADAE","718","1427","VERBATIM_0320","AMNESIA","NERVOUS SYSTEM DISORDERS","MILD","N",0,"NONE",,"Y","Y",,,,,,,,1/1/2013 0:00:00 AM,,16,16,1/19/2013 0:00:00 AM,34,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0641","HLT_0501","SHORT-TERM MEMORY LOSS",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",8,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1111","NAUSEA","GASTROINTESTINAL DISORDERS","SEVERE","N",0,"PROBABLE",,"Y","Y",,,,,,,,1/21/2013 0:00:00 AM,,36,36,1/24/2013 0:00:00 AM,39,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",9,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1408","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,1,1,,,,1,1/27/2013 0:00:00 AM,,42,42,1/28/2013 0:00:00 AM,43,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",10,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1435","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,1,,,,1,1/27/2013 0:00:00 AM,,42,42,1/27/2013 0:00:00 AM,42,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",11,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1408","APPLICATION SITE PRURITUS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MODERATE","N",0,"PROBABLE",,"Y","Y",,,,,,,1,1/27/2013 0:00:00 AM,,42,42,1/28/2013 0:00:00 AM,43,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0338","HLT_0317","APPLICATION SITE ITCHING",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",12,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1216","APPLICATION SITE DERMATITIS","GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS","MILD","N",0,"PROBABLE",,"Y","Y",,,,,,,1,1/29/2013 0:00:00 AM,,44,44,,,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0241","HLT_0343","APPLICATION SITE RASH",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",13,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1250","DECREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,1,1,,,,,2/4/2013 0:00:00 AM,,50,50,2/25/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0231","HLT_0574","DECREASED APPETITE",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",14,"CDISCPILOT01","ADAE","718","1427","VERBATIM_0943","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/4/2013 0:00:00 AM,,50,50,2/25/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",15,"CDISCPILOT01","ADAE","718","1427","VERBATIM_1250","DECREASED APPETITE","METABOLISM AND NUTRITION DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/4/2013 0:00:00 AM,,50,50,2/25/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0231","HLT_0574","DECREASED APPETITE",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
"01-718-1427",16,"CDISCPILOT01","ADAE","718","1427","VERBATIM_0943","NAUSEA","GASTROINTESTINAL DISORDERS","MODERATE","N",0,"POSSIBLE",,"Y","Y",,,,,,,,2/4/2013 0:00:00 AM,,50,50,2/25/2013 0:00:00 AM,71,"Xanomeline High Dose","Xan_Hi",2,74,"65-80",2,"AFRICAN DESCENT (NEGRO, BLACK)",2,"F","Y","Y","Y","N","MedDRA version 8.0 (partially masked by request of MSSO)","N","N","N","N","N","N","HLGT_0326","HLT_0742","NAUSEA",2/11/2013 0:00:00 AM,57,12/17/2012 0:00:00 AM
